Characterisation of cdc2-Related Kinases From Trypanosoma brucei by Glasssmith, Gareth
Characterisation of cdc2-related kinases 
from Trypanosoma brucei
A thesis submitted for the degree of Doctor of Philosophy 
at the University of Glasgow
by
Gareth Glasssmith
Wellcome Unit of Molecular Parasitology 
Institute of Genetics 
Anderson College 
Glasgow
April, 1997
i
ProQuest Number: 13815540
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 13815540
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
Dedicated to Kieran, 
thanks for keeping me up enough to finish this.
ii
“Basically, Gareth, your cells are ******’’, J. Mottram.
The research reported in this thesis is my own 
original work, except where otherwise stated, 
and has not been submitted for any other degree.
Table of Contents
Contents v
Abbreviations xvii
Measurements xviii
Acknowledgements xix
Summary xx
Chapter 1 Introduction. 1
1.1 T. brucei and the Kinetoplastids. 2
1.1.1 Trypanosome basic biology. 2
Figure 1.1.1 Evolutionary relationship of T. brucei and other eukaryotes. 3
Figure 1.1.2 Predicted evolutionary relationships of the Kinetoplastida. 4
1.1.2 The T. brucei lifecycle. 5
Figure 1.1.3 The life cycle of Trypanosoma brucei. 6
1.1.3 The molecular biology of T. brucei. 9
1.1.3(i) Genomes and genes. 9
1.1.3(ii) Homologous recombination and reverse genetics in the Kinetoplastida. 11 
1.1.3(iii) Transcription. 13
1.1.4 The mitochondrion of T. brucei, editing of RNA 14
and mitochondrial translation.
1.2 The Eukaryotic Cell Cycle. 16
1.2.1 Introduction - the typical eukaryotic cell cycle. 16
Figure 1.2.1 A simplified eukaryotic cell cycle. 17
1.2.2 The T. brucei cell cycle. 18
Figure 1.2.2 The cell cycle of procyclic form T. brucei. 19
1.2.3 CDC2-function and the family of related genes within the eukaryotes. 23
1.2.4 Control of the cdc2 kinase activity in yeast. 36
v
1.2.5 CDK control in higher eukaryotes. 29
Figure 1.2.3 Positive and negative regulation of cdc2/Cyclin B 30
complexes during mitosis.
1.2.6 CDK/Cyclin complexes in Metazoans, and control of the cell cycle. 32
Table 1.2.1 CDK complexes and functions. 33
1.3 Project Aims. 36
1.4 Addendum-recent publications. 36
1.4.1 The Eukaryotic cell cycle; kinases, phosphatases and the cytoskeleton. 36
1.4.2 Trypanosoma brucei, the cytoskeleton and the cell cycle. 38
Chapter 2 Materials and methods. 40
2.1 Buffers/Media/Stock solutions. 41
2.2 General methods. 44
2.2.1 DNA protocols. 44
2.2.1.1 Restriction enzyme digestion of plasmid and lambda DNA. 45
2.2.1.2 Agarose gel electrophoresis. 45
2.2.1.3 Extraction of DNA from agarose. 45
2.2.1.4 Labelling of DNA fragments by random priming. 46
2.2.1.5 Southern blotting and hybridisation. 46
2.2.1.6 PCR from genomic DNA. 47
2.2.1.7 Preparation of vector DNA for ligations. 48
2.2.1.8 Ligations. 48
2.2.1.9 Cloning tbcrkl/2/3 into expression vectors by PCR. 48
2.2.1.10 Sequencing of plasmid DNA. 49
Table 2.2.1.1 Plasmids used during this thesis. 50
Table 2.2.1.2 Oligonucleotides used during this thesis. 51
2.2.2 Protein protocols. $2
2.2.2.1 SDS-polyacrylamide gel electrophoresis. 52
vi
2.2.2.2 Western blotting. 52
2.2.23 Purification of p l3sucl and formation of pl3sucl beads. 53
Table 2.2.2.1 CRK antisera used. 54
2.3 Protocols for E. coli. 55
2.3.1 General protocols (Ec). 55
2.3.1.1 Bacterial strains used during this thesis. 55
2.3.1.2 Transformation of E. coli. 55
2.3.1.3 Screening libraries. 56
2.3.1.4 Stabilate formation. 56
2.3.2 DNA protocols {Ec). 57
2.3.2.1 Plasmid preparation. 57
2.3.2.2 Lambda DNA preparation. 57
2.3.2.3 PCR screening of transfectants. 58
2.3.3 Protein protocols (Ec). 59
2.3.3.1 Purification of poly histidine tagged fusion proteins. 59
2.4 S. pombe protocols. 59
2.4.1 Transfection of S. pombe. 59
2.4.2 Preparation of S. pombe protein extracts. 60
2.5 T. brucei protocols. 61
2.5.1 General protocols (Tb). 61
2.5.1.1 T. brucei strains used. 61
2.5.1.2 The growth of procyclic form T. brucei. 61
2.5.1.3 Preparation of T. brucei for microscopic examination. 61
2.5.1.4 Formation of T. brucei stabilates. 62
2.5.2 DNA protocols (Tb). 62
2.5.2.1 Trypanosome genomic DNA preparation. 62
2.5.2.2 Restriction Enzyme digestion of genomic DNA. 62
2.5.2.3 Transfection of procyclic T. brucei. 63
vii
2.5.2.4 PCR from T. brucei lines. 63
2.5.3 Protein protocols (Tb). 64
2.5.3.1 Trypanosome protein extracts. 64
2.5.3.2 sucl/CKSl selections from S100 protein extracts. 64
2.5.3.3 Histone HI kinase assays. 65
2.5.3.4 35S labelling of procyclic T. brucei brucei. 65
Chapter 3 Isolation of T. brucei genes homologous to those 66
involved in cell cycle control in other organisms.
3.1 Introduction. 67
3.2 Attempted isolation of mitotic cyclin genes from T. brucei and L. mexicana. 67
3.2.1 Background and experimental design. 67
Figure 3.2.1 Mitotic cyclin domains and oligonucleotide 68
positions and sequences.
3.2.2 Cloning attempts. 69
Figure 3.2.2 Touchdown PCR. 72
3.2.3 Cloning a human Cyclin B. 73
Figure 3.2.3 DNA and predicted protein sequence of the 74
probable human PCR contaminant.
Figure 3.2.4a Comparison of the DNA sequence of the PCR 75
contaminant and the HeLa Cyclin B1 gene.
Figure 3.2.4b Comparison of the predicted human Cyclin B1 protein 76
sequence and the translated pLpCY C12 insert.
3.2.4 Reasons for the failure to clone a kinetoplastid cyclin. 77
3.3 Isolation of the tbcrk3 gene. 78
3.3.1 The background to cloning the tbcrkS gene. 78
3.3.2 Isolating a lambda phage clone containing tbcrk3. 78
Figure 3.3.1 Cloning cdc2-related kinases by 79
viii
degenerate oligonucleotide PCR.
3.3.3 Mapping pCD70E(S)3 and 8. 80
Figure 3.3.2 Subcloning of the tbcrk3 containing 81
fragments from lambda CD47.2.
Figure 3.3.3 Mapping the tbcrk3 genomic locus. 82
3.3.4 Sequencing the tbcrk3 ORF. 83
Figure 3.3.4 Restriction map of the pCD70E(S)8 insert. 84
Figure 3.3.5 Sequencing the tbcrk3 genomic locus. 85
Figure 3.3.6 Coding strand DNA and the predicted 86
protein sequence of tbcrk3.
3.3.5 Analysis of the protein sequences of TbCRKl-3. 87
Figure 3.3.7 Comparisons of the TbCRK family 88
with CDC2 related proteins.
Table 3.3.1 Conservation between members of the Kinetoplastid CRK 90 
family and CDC2 related proteins from Humans and yeast.
Figure 3.3.8 Kinetoplastid CRK protein conservation 91
at CDK control motifs.
Figure 3.3.9 Dendrogram of the TbCRK family and 94
other CDC2 related kinases.
3.4 Partial cloning of the T. brucei mitochondrial Elongation 100
Factor G gene (tbme/g).
3.4.1 Cloning and sequencing tbmefg. 100
3.4.2 Comparisons with other EF-G proteins. 100
Figure 3.4.1 Sequencing tbmefg. 101
Figure 3.4.2 The DNA and predicted protein sequence of tbmefg. 102
3.4.3 Discussion of the trypanosome mEF-G. 104
Figure 3.4.3 Comparison of TbmEF-G with the S. cerevisiae 105
homologue and bacterial EF-G proteins.
ix
Table 3.4.1 Conservation between T. brucei mEF-G, yeast 106
mEF-G and eubacterial EF-G.
Figure 3.4.4 Dendrogram of the putative Kinetoplastida 107
mitochondrial Elongation Factor-G protein 
with EF-G proteins from other organisms.
3.5 Discussion. 109
Figure 3.5.1 Comparison of TbCRK3 and LmmCRK3. 112
Chapter 4 Organisation and expression of the tbcrk gene family. 114
4.1 Introduction. 115
4.2 Gene organisation. 115
4.2.1 Introduction. 115
4.2.2 Organisation of the tbcrk gene family. 116
4.2.3 Pulse field gel electrophoresis of T. brucei chromosomal DNA. 116
Figure 4.2.1 Map of the tbcrkl-3 genomic loci. 117
Figure 4.2.2 Southern blot of STIB247 genomic DNA hybridised 118
to tbcrkl, tbcrkl, and tbcrk3 gene specific probes.
Figure 4.2.3 Pulse field gel electrophoresis of T. brucei 121
chromosomal DNA and hybridisation to tbcrkl, 
tbcrk2 and tbcrk3 gene specific probes.
4.3 Fusion protein expression for antibody production and analysis of antisera. 123
4.3.1 Introduction. 123
4.3.2 Cloning of the histidine tagged TbCRK proteins. 125
Figure 4.3.1 The QIAGEN His-tagged expression vector 126
and tbcrk oligonucleotides.
4.3.3 Expression and purification of TbCRK3/His. 127
Figure 4.3.2 Coomassie stained SDS-PAGE showing 129
purification of denatured TbCRK3/H.
X
4.3.4 Expression and purification of TbCRKl/His. 131
Figure 4.3.3 Coomassie stained SDS-PAGE showing 132
purification of native TbCRKl/H.
4.3.5 Expression of TbCRK2/His. 134
4.3.6 Cloning and expression of TbCRK2 and TbCRK3 without 134
the N-terminal extensions.
Figure 4.3.4 Attempted purification of native TbCRK2/H. 135
Figure 4.3.5 Attempted purification of native TbCRK2/H/-5’ext. 138
Figure 4.3.6 Attempted purification of native TbCRK3/H/-5’ext. 140
4.4 The detection of E. coli expressed TbCRK proteins by Western blotting. 142
4.4.1 Antisera believed to cross-react with the TbCRK proteins. 142
4.4.2 Antibody detection of TbCRKl/H. 142
Figure 4.4.1 PSTAIR mAb detection of TbCRK/H proteins. 143
Figure 4.4.2 TbCRKl/H detection by CRK and CDK antisera. 144
4.4.3 Antibody detection of TbCRK2/H. 145
Figure 4.4.3 PSTA VR antiserum detection of TbCRK/H proteins. 146
Figure 4.4.4 EVREE detection of TbCRK2/H. 147
Figure 4.4.5 CITAA antiserum does not recognise TbCRK2/H. 148
4.4.4 Antibody detection of TbCRK3/H. 149
Figure 4.4.6 TbCRK3/H detection by CRK and CDK antisera. 150
Figure 4.4.7 TbCRK3/H is not detected by antisera 151
raised to the N-terminal oligopeptide.
4.4.5 Discussion of antisera specificity. 152
Table 4.4.1 Recognition of the TbCRK proteins by various antisera. 153
4.5 Analysis of TbCRK expression in different life cycle stages. 155
4.5.1 Available life cycle stages and protein extracts. 155
4.5.2 TbCRK expression in three life cycle stages of T. brucei. 156
Figure 4.5.1 TbCRK2 expression in T. brucei. 157
xi
Figure 4.5.2 PSTAIR mAb reacting proteins in long slender 158
form T. brucei and TbCRKl expression in different 
life cycle stages.
Figure 4.5.3 PSTAIR mAb reacting proteins in short stumpy 160
form T. brucei
Figure 4.5.4 PSTAIR mAb reacting proteins in procyclic 161
T. brucei S100 supernatants.
Figure 4.5.5 TbCRK expression in bloodstream form T. brucei. 162
Figure 4.5.6 TbCRK3 expression in long slender form T. brucei. 163
Figure 4.5.7 Insolubility of TbCRK3 in short stumpy form T. brucei. 165
Figure 4.5.8 TbCRK3 expression in procyclic T. brucei. 166
4.6 Discussion. 167
Figure 4.6.1 Detection of LmmCRK3/H by the TC3HG antiserum. 171
Figure 4.6.2 A 26kDa band detected by the EVREE antiserum. 173
Chapter 5 Analysis of TbCRK function by yeast complementation 174
and protein binding studies.
5.1 Introduction. 175
5.2 Complementation assay of a S. pombe cdc2 temperature 176
sensitive mutant with tbcrk3.
5.2.1 Introduction. 176
5.2.2 Cloning tbcrk3 into a S. pombe expression vector, and 177 
transfection of S. pombe cdc2-33.
Figure 5.2.1 The S. pombe complementation vector 178
and tbcrk3 oligonucleotides.
5.2.3 Results of the complementation assay. 180
Table 5.2.1 Results of the complementation assay. 181
Figure 5.2.2 Bar chart showing the complementation results. 181
xii
5.2.4 Discussion. 182
Figure 5.2.3 Western blot showing the expression 183
of TbCRK3 in S. pombe.
5.3 The activation of histidine tagged TbCRK proteins in vitro. 185
5.3.1 Introduction. 185
5.3.2 Activation of E. coli expressed TbCRKl/H. 185
Figure 5.3.1 Activation of TbCRKl/H using sonicated T. brucei 188
procyclic extract, without added Triton X-100.
Figure 5.3.2 Activation of TbCRKl/H using a T. brucei 191
Triton X-100 procyclic extract.
5.3.3 Attempted in vivo histidine tagging of TbCRK3. 193
Figure 5.3.3 Construct for the integration of tbcrk3/h into 195
the tbcrk3 genomic locus.
5.4 Isolation of TbCRK proteins by binding to p i2LmmCKS1. 196
5.4.1 Introduction. 196
5.4.2 Preparation of p l3sucl beads. 196
5.4.3 Binding histone HI kinase activity to p i3sucl/pi2LmmCKS1 beads. 197
Figure 5.4.1 Histone HI kinase assay of T. brucei 199
extracts bound to p l3sucl beads.
Figure 5.4.2 Histone HI kinase assay of T. brucei procyclic 200
and S. pombe extracts bound to p l3sucl beads.
Figure 5.4.3 Histone HI kinase assay of T. brucei procyclic 201
extracts bound to p l3sucl or p i2LmmCKS1 beads.
5.4.4 Detection of TbCRK proteins bound to pl2LmmCKS 1 202 
beads by Western blotting.
Figure 5.4.4 Western blot of T. brucei procyclic extract bound 203
to p i2LmmCKS1 or control beads.
xiii
Figure 5.4.5 Western blot of T. brucei mixed bloodstream form 204
extract bound to pi2LmmCKS1 or control beads.
5.4.5 Metabolic labelling of T. brucei proteins to assess components 205 
of the complexes binding p i2 LmmCKS1.
Figure 5.4.6 35S methionine labelling of procyclic T. brucei 207
protein extracts selected on pl2LmmCKS1 beads.
5.4.6 Discussion of p ^ ^ / p ^ 1^ 1110^ 1 binding studies. 210
5.5 Discussion. 212
Chapter 6 Assessment of tbcrk3 function by reverse genetics. 216
6.1 Introduction. 217
6.2 Creation of putative null mutants of tbcrk3. 218
6.2.1 Construction of the plasmid background for resistance cassette insertion. 218
6.2.2 Construction of the replacement vectors. 220
Figure 6.2.1 The tbcrk3 knockout vectors. 221
6.2.3 Disruption of one allele of tbcrk3 with the bleomycin knockout vector. 222
Figure 6.2.2 Southern blot of DNA from the phleomycin resistant 224
T. brucei culture showing disruption of one tbcrk3 allele.
6.2.4 Integration of the neomycin resistance gene into tbcrk3. 226
Figure 6.2.3 Southern blot of DNA from the G418 resistant T. brucei 229
cultures showing replacement of the ble resistance 
cassette by the neo resistance cassette.
6.3 Analysis of putative tbcrk3 null mutants. 231
6.3.1 PCR analysis of tbcrk3 mutants. 231
Figure 6.3.1 PCR of tbcrk3 mutant cell line NB1 with tbcrk3 233
specific oligonucleotides.
6.3.2 PCR analysis of the T. brucei B4D cell line: null mutants or 234
xiv
multiple tbcrk3 loci?
Figure 6.3.2 PCR of wild type and tbcrk3 mutant cell lines 237
using tbcrk3 specific oligonucleotides.
Figure 6.3.3 PCR of wild type and tbcrk3 mutant cell lines 238
using ble amplifying oligonucleotides.
Figure 6.3.4 PCR of wild type and tbcrk3 mutant cell lines using tbcrk3 239
specific oligonucleotides with a longer extension time.
6.3.3 Analysis of tbcrk3 mutants using DAPI staining and 240
fluorescence microscopy.
Table 6.3.1 Analysis of the number of nuclei and kinetoplasts 242
in tbcrk3 mutant cells.
Figure 6.3.5 The percentage of cells in each category for each cell line 243
(from Table 6.3.1).
Figure 6.3.6(A) Phase contrast and fluorescence photographs of DAPI 244
stained cells from the NB4 culture treated with phleomycin. 
Figure 6.3.6(B) Phase contrast and fluorescence photographs of DAPI 
stained cells from the NB4 culture grown in the presence 
medium from the B4D culture.
Figure 6.3.6(C) Phase contrast and fluorescence photographs of DAPI 
stained cells from the B2D putative null mutant culture.
Figure 6.3.6(D) Phase contrast and fluorescence photographs of DAPI 
stained cells from the B4D putative null mutant culture.
6.4 Discussion.
Chapter 7 Discussion of the data and further work.
7.1 Conclusions.
7.2 Future work.
7.2.1 T. brucei Elongation Factor-G.
XV
246
248
251
255
260
261
267
267
7.2.2 The TbCRK family. 267
7.3 Concluding remarks. 270
References 271
xvi
Abbreviations.
ATP Adenosine triphosphate.
BSA Bovine serum albumin.
DAPI 4 ,6-diamino-2-phenylindole.
DTT Dithiothreitol.
EDTA Ethylenediaminetetraacetate (disodium salt).
EtBr Ethidium bromide.
EtOH Ethanol.
FCS Fetal calf serum.
IPTG Isopropylthio-beta-D-galactoside.
PBS Phosphate buffered saline.
PCR Polymerase chain reaction.
SDS Sodium dodecyl sulphate (sodium lauryl sulphate).
Tris T ris(hydroxymethyl)aminomethane.
X-Gal 5-bromo-4-chloro-3-indolyl-beta-D-galactoside.
ZPFM Zimmerman post-fusion medium.
Measurements.
bp base pairs,
kb kilobases.
Mb megabases.
kDa kilo Dalton,
s seconds,
min minutes,
hr hours,
mm milimeters.
pg, mg and g micrograms, miligrams and grams,
pi, ml and 1 microlitres, mililitres and litres.
pM, mM and M micromolar, milimolar and molar.
V Volts.
A Amperes.
pF microfarads.
C degrees centigrade,
rpm revolutions per minute.
xviii
Acknowledgements
Thanks to Jeremy for his (usually) patient supervision, humour when it would 
have been easier to attack me, and all the hours put in reading this work as the page 
number gradually grew. Thanks also to the members of WUMP for solutions, advice 
and the occasional drink, especially to Jane for support with the yeast, and Andy and 
Norma for the pulse field gel blots. Thank you to Bemie for taking my data and 
helping it through the PAUP programme. Without the prep room ladies much of this 
work would be stuck at the, T i l  get around to making up the media tomorrow,” stage; 
having left the department the huge contribution the prep room makes has been made 
clear to me. Great thanks to Piers Emson and Steve Holman who both employed me 
during this writing up time.
The football team kept me (relatively) sane through the later years, you have my 
gratitude for not kicking me too hard during the five-a-side games. Thank you for 
everything you’ve done for me Paul, it’s not everyday some-one travels 400 miles to 
pop in for a few drinks and a curry.
To Martin and Tracey, my God some of those films were bad, but the 
hospitality, beyond the call of duty, was the best. Jamie and Lorraine may have taken 
years off my liver’s life expectancy but those evenings will be remembered for a long 
time (if my memory returns).
I wouldn’t have got this far without the love and support of Leslie. I suppose 
that now I’ve finished I’m going to have to do some tidying up. Finally, all this is for 
Kieran, you’re pretty amazing considering you share some of my genes.
xix
Summary.
Trypanosoma brucei is a kinetoplastid protozoan parasite of man and other 
mammals in Africa, that is transmitted by the bite of the tsetse fly. T. brucei has a 
complicated life cycle involving both dividing and non-dividing stages. The non­
dividing stages are to some extent pre-adapted to the environment of the next host, and 
as such are essential for efficient transmission from both tsetse fly to mammal and 
mammal to tsetse fly. It was the aim of this project to initiate the analysis of cell cycle 
controlling genes from T. brucei, with a view to assessing their involvement in the 
regulation of the division status of the various life cycle stages.
The Cyclin Dependant Kinases (CDKs) are a highly conserved family of 
serine/threonine protein kinases, many members of which are vital for the regulation of 
the cell cycle in eukaryotes. The archetypal CDK is cdc2, a protein that regulates both 
S phase and mitosis in yeast; the homologous protein in higher eukaryotes regulates 
mitosis, while a closely related protein, CDK2, is involved in S phase control. The 
kinase activity of the CDK proteins is tightly regulated by phosphorylation (both 
negative and positive) and by the association of a regulatory subunit (a cyclin).
Two cdc2-Related Kinase genes (crks) from T. brucei had already been cloned 
and sequenced at the start of the Ph.D. (tbcrkl and tbcrkl) and another gene fragment 
(tbcrk3) had been isolated by PCR. The genomic locus of the tbcrk3 gene was 
subcloned and sequenced. Analysis of the predicted protein sequences for the TbCRK 
proteins revealed no obvious candidate for the role of cdc2 homologue.
The three TbCRK proteins were expressed in E. coli, and used to raise antisera, 
as well as to assess the cross reactivity of the antisera available in the laboratory. These 
antibodies were then used to analyse the expression of the TbCRK proteins in three of 
the parasite's life cycle stages. No important differences in expression were observed 
between dividing and non-dividing stages. TbCRK3 was found to be in the insoluble 
fraction of the protein extracts made, implying an association with either DNA or the
XX
cytoskeleton.
suclAnother component of the cdc2/cyclin complex in fission yeast, pl3 , has 
previously been used to purify cdc2 related kinases from a variety of organisms. This 
approach was followed using both p l3sucl and a homologue (pl2LmmCKS1) from the
kinetoplastid parasite, Lzishmania mexicana. Kinase activity could be bound to the 
p l2LmmCKSi keacjs  ^an(j bQth TbCRKl and TbCRK2 were shown by Western blotting
to be part of the protein fraction purified on the beads.
An attempt was made to analyse TbCRK3 function by reverse genetics. Null 
mutants were created by homologous recombination and their phenotype assayed. The 
mutant cultures did not survive longer than three months. Microscopy using DNA 
binding dyes show a phenotype of aberrant cytokinesis, morphological abnormalities 
and a breakdown in cell polarity. The relevance of this phenotype to the insoluble 
nature of TbCRK3 is discussed.
CHAPTER ONE 
INTRODUCTION
1.1 T. brucei and the kinetoplastids.
1.1.1 Trypanosome basic biology.
Trypanosomes are unicellular, flagellated, protozoan parasites of the order 
Kinetoplastida. The kinetoplastids form an extremely early branch of the eukaryotic 
kingdom as shown in Figure 1.1.1 (adapted from Sogin etal., 1986), and therefore the 
degree of divergence between them and other members of the eukaryotes is large.
Trypanosomes are responsible for a number of diseases that cause human 
fatalities, as well as severe economic damage. In Africa, Trypanosoma brucei causes 
sleeping sickness in humans and Nagana in domestic animals. There are three sub­
species of T. brucei', T. b. gambiense and T. b. rhodesiense cause the chronic and acute 
forms of sleeping sickness respectively, while T. b. brucei causes Nagana (Hoare,
1972). Both T. b. gambiense and T. b. rhodesiense are resistant to lysis by human 
serum (Takayanagi etal, 1992) but the genetic basis for the differences between the 
sub-species is still unclear. T. congolense also causes serious disease in farmed animals 
in Africa (Hoare, 1972). All these trypanosomes are spread by insect vectors, and so 
are restricted to the vectors' habitats. Both T. congolense and T. brucei are transmitted 
by the tsetse fly ( Glossina). Within the region of sub-Saharan Africa where the tsetse 
fly is common, the farming of domestic livestock is extremely difficult. Due to 
variation of the major surface protein of T. brucei, the infection avoids clearance by the 
immune system , and infected animals which do recover are not fully protected against 
further challenges by T. brucei The mode of transmission of trypanosomes varies, but 
both T. brucei and T. congolense are salivarian trypanosomes, infecting the host via the 
bite of the fly, when the parasites are injected into the mammalian bloodstream. Some 
trypanosomes have eliminated the need for a specific vector, and in one case, any 
vector. T. evansi is spread by mechanical means, without replication in the biting 
insect. T. equiperdum has no vector, and is spread as a venereal disease of horses.
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Figure 1.1.1 Evolutionary relationship of T. brucei and other Eukaryotes
/  Rat
/  \Xenopus laevis
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>  Plants
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rp r p v is t in p
Rice
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Escherichia coli
Figure 1.1.1 The phylogenetic tree is adapted from Sogin et al., 1986.
It was calculated using nuclear small subunit ribosomal RNAs. The degree 
of evolutionary divergence is represented by the horizontal distance between 
any two points.
Figure 1.1.2 Predicted evolutionary relationships of the Kinetoplastida
Crithidia fasciculata100
Leishmania tarentolae
Phytomonas serpens
Herpetomonas muscarum
100
Trypanosoma cruzi
Trypanosoma brucei
Euglena gracilis
Figure 1.1.2 The consensus tree for the Kinetoplastida (adapted from Maslov and 
Simpson, 1995; Landweber and Gilbert, 1994) was derived using nuclear 18S rRNA sequence. 
The numbers shown are the bootstrap support for each branch. The early branching of 
T. brucei is well supported, as is the late divergence of the Leishmania and Crithidia branches.
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Within the Kinetoplastida, the relationships of different species is now 
becoming clearer with the increase in available molecular data. Figure 1.1.2 shows a 
rooted tree of the Kinetoplastida (Euglena gracilis as the outgroup) previously analysed 
using nuclear ribosomal RNA sequence (Landweber and Gilbert, 1994; Maslov and 
Simpson, 1995). From this analysis it is clear that T. brucei and Leishmania, previously 
believed to be quite closely related, are considerably diverged, with T. brucei branching 
early in the kinetoplastid lineage. This is not what was previously postulated (Lake et 
al., 1988), as these two organisms share a digenetic lifestyle, that is they parasitise two 
different species (an insect vector and vertebrate host), whereas the other species on the 
tree are either non-parasitic or survive solely in the insect.
1.1.2 The T. brucei life cycle.
Like many other protozoan parasites, T. brucei has a complex life cycle (see Figure 
1.1.3) which consists of multiple stages within each host (Vickerman, 1985). The 
mammalian bloodstream forms are of two main types. There are dividing cells, the 
long slender form, and non-dividing cells, called the short stumpy form. Within the 
tsetse fly vector there are three major forms (Vickerman etal., 1988). The procyclic 
form is found in the fly midgut, and is rapidly dividing, as is the epimastigote form 
which is seen in the tsetse fly salivary glands. The metacyclic form is also found in the 
salivary glands of the fly, but is non replicating.
In the early infection, the parasitemia in the bloodstream of the mammalian host
is primarily of the rapidly replicating long, slender form. After the infection is
established a low level of the short, stumpy form occurs which increases as each
infection cycle progresses (Vickerman, 1985). These are non-dividing and primed to
adapt to the conditions within the Tsetse fly midgut. The bloodstream forms all have
the Variant Surface Glycoprotein (VSG) coat, and are complement resistant
(Takayanagi etal., 1992). The trypanosomes have been found to change the VSG
expressed on the parasite surface, which is thought to shield the other extracellular
5
Figure 1.1.3 The life cycle of Trypanosoma brucei.
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Figure 1.1.3 The life cycle of T. Arar^/consists of several morphologically distinct 
forms in both the mammalian and insect vector. Following initial infection of the 
mammalian host by a metacyclic trypanosome, the parasite differentiates into a long 
slender form trypanosome which is rapidly dividing. These parasites can differentiate 
through an intermediate stage to the non dividing short stumpy form which is infective 
to the tsetse fly. When taken up by the fly the short stumpy form differentiates to the 
dividing procyclic form. These differentiate into non-dividing proventricular 
mesocyclic forms which migrate from the midgut to the salivary glands, transforming 
into the epimastigote form which further divides. This form then differentiates to the 
non dividing metacyclic form, which is adapted to survive in the mammalian host. 
After injection by the tsetse fly the metacyclic form begins to undergo division and 
becomes long slender form trypanosomes, completing the cycle (From Vickerman, 
1985).
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components from the host immune system, up to once every 100 divisions (Barry,
1989; Barry and Turner, 1991). These switches, to VSGs that the immune system has
not yet been exposed to, allow the parasitemia to last for a long period with repeated
peaks of infection. The mitochondrial citric acid cycle is non-functioning in the
bloodstream form, although the mitochondrion of the short stumpy form is partially
developed as a step towards differentiation into the procyclic form (Williams etal.,
1991; Bienen etal., 1991; Durieux etal., 1991). The bloodstream trypanosomes'
energy needs are provided predominantly by glycolysis, which takes place in organelles
specific to the trypanosomes, called glycosomes (Aman and Wang, 1986; Aman etal.,
1985; Opperdoes, 1985; Opperdoes, 1990). These organelles catalyse the metabolism
of glucose to pyruvate with an extremely high throughput rate, but low efficiency of
ATP synthesis. This lack of efficiency is not important to a parasite living in the
nutrient rich environment of the mammalian bloodstream. When taken up in a
bloodmeal by the feeding fly, the short stumpy forms differentiate to the procyclic form
trypanosomes which divide and set up the infection within the midgut (Vickerman,
1985). In in vitro experiments, it is possible for long slender form T. brucei to
differentiate into procyclic form trypanosomes in a non-synchronous fashion (Simpson
etal., 1985; Matthews and Gull, 1994a and 1994b). It appears that the long slender
form is only responsive to the extracellular signals for differentiation during a short
period in the G1 phase of the cell cycle, and in the Tsetse fly midgut, if differentiation
does not occur quickly the cell dies (Matthews and Gull, 1994b). During the
differentiation process, the trypanosomes lose the VSG coat, synthesise a new
glycoprotein (called PARP or Procylin) coat, and the mitochondria start producing
ATP, with proline apparently used as the main source of energy (Durieux etal., 1991;
Brown etal., 1973; Priest and Hajduk, 1994a and 1994b; Matthews and Gull, 1994b)
The procyclic form trypanosomes migrate to the salivary glands of the Tsetse fly and
differentiate into the other dividing stage, the epimastigote. In the salivary glands the
trypanosomes stop dividing and re-express VSG (Lenardo etal., 1986; Hirumi etal.,
1992). The metacyclic form is pre-adapted to the environment of the mammalian
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bloodstream. It is resistant to complement (this is possibly due to the expression of 
VSG), has a mitochondrion without functional cytochromes, and is infective to the 
mammal when injected by the fly (Vickerman, 1985). After infection of the mammal, 
the block on replication is released, and the metacyclic form divide and transform into 
morphologically long slender form trypanosomes (Bran et al., 1984).
Procyclic T. brucei can be grown in axenic culture in high numbers (> lxl07 / 
ml) and this form is apparently identical to those isolated from tsetse fly midgut 
infections in all tests performed (Pearson etal., 1987; Bran and Schonenberger, 1979). 
The bloodstream forms of some strains can be grown in culture, but at present only to 
very low concentrations i.e. lxlO 6 / ml. Because of this, laboratory strains adapted to 
grow in mice and rats are usually used if large quantities of bloodstream trypanosomes 
are required. These adapted pleomorphic lines, when grown in irradiated animals can 
result in populations of T. brucei containing >90% of the short stumpy form. After 
serial passage several of the laboratory adapted strains have lost the ability to 
differentiate to the short stumpy form, and these monomorphic lines can be used to 
isolate pure long slender form cells.
1.1.3 The molecular biology of T. brucei.
(i) Genomes and genes.
The method of Pulse Field Gel Electrophoresis (PFGE) has enabled the 
visualisation of the chromosomes of T. brucei (Van der Ploeg etal., 1989). This was 
not previously possible as the chromosomes do not condense during the cell cycle.
Used with Southern blotting techniques this has shown the diploid nature of most of the 
genome. The total (diploid) genome size is approximately 6x l07bp, and consists of 
chromosomes of sizes varying from 50 kb to 6 Mb (Van der Ploeg et al., 1989; 
Gottesdiener etal., 1990). They consist of three main types:
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1) the minichromosomes, of 50-150 kb which apparently consist of repetitive 
sequences and VSG genes. It is therefore presumed that these chromosomes, which are 
predominantly haploid (Weiden etal., 1991; Chung etal., 1990), act as a resevoir of 
VSG genes to increase the VSG repertoire.
2) intermediate chromosomes of 200-450 kb.
3) the megabase chromosomes of 700 kb to 6 Mb.
Both of these larger types of chromosomes carry housekeeping genes (as well 
as VSGs), and are typically diploid. Variation in chromosome number, e.g. triploidy, 
can be seen in some stocks, typically those which have undergone genetic crosses 
(Gibson etal., 1992; Wells etal., 1987), and therefore this may be an artefact of these 
experiments. Southern blotting and hybridisation to specific gene sequences has shown 
that homologous chromosomes can be considerably different sizes (up to 200-300 kb 
difference), possibly due to variations in the copy number of some of the large tandem 
arrays of genes seen in the Kinetoplastida (see below). However, the large variations 
seen in T. brucei imply that there are other causes as well, probably changes in the sub- 
telomeric repeats (Myler etal., 1988; Van ddr Ploeg etal., 1984). These differences in 
size, and the rapid changes seen in passaged cells, show why there can be a high level 
of karyotype variation between different stocks of T. brucei.
Using these PFG and Southern blotting techniques, along with isoenzyme 
analysis and resistance markers integrated into the T. brucei genome (Gibson and 
Bailey, 1994), it has also been shown that some form of mating can take place during 
passage through the Tsetse fly (Turner etal., 1990; Jenni etal., 1986; Schweizer etal., 
1994). There is no evidence for, or against, a mating type comparable to that seen in 
yeast, or other unicellular organisms. In the published data there has been no 
combination of stocks tried for which hybrids have not been isolated, but there are 
extremely low levels of such hybrids, implying that the process is not obligatory for 
successful passage through the fly. Crosses within a heterozygous, clonal population 
have also been observed, but this does not preclude a mating type system, presuming
such a system could switch between types (as in Schizosaccharomyces pombe).
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Many of the genes isolated from trypanosomes have been found to be 
multicopy. In some cases they are found in tandem arrays of almost identical genes, 
e.g. the genes for actin, calmodulin, glyceraldehyde-3-phosphate dehydrogenase, hsp70, 
hsp83 and ubiquitin (Ben Amar etal., 1988; Tschudi etal, 1985; Michels et al., 1986; 
Lee and Van der Ploeg, 1990; Mottram etal., 1989a; Chung and Swindle, 1990). In 
other cases, e.g. the tubulin locus, the genes alternate between copies of alpha and beta 
tubulin, and there can be over 13 copies of each of the 2 tubulin genes per haploid 
genome (Thomashow etal., 1983). Of the more recently isolated genes from T. brucei, 
many are single copy, e.g. those for the Glycosyl-phosphatidylinositol specific 
Phospholipase C, the RNA polymerase I large subunit, the Ef-hand 5 protein (Mensa- 
Wilmot et al., 1990, Jess etal., 1989, Wong etal., 1993). There may be a crude link 
between the number of gene copies and the level of transcription of those genes 
transcribed by RNA polymerase II in T. brucei, although experiments in a related 
kinetoplastid (Leishmania enriettii) show that loss of genes in a tandem array can be 
partially compensated for by an increased level of transcription and/or post 
transcriptional controls, e.g. mRNA stability (de Lafaille and Wirth, 1992).
(ii) Homologous recombination and reverse genetics in the Kinetoplastida.
The diploid nature of the Kinetoplastida and their lack of, or difficulty in using,
a sexual cycle have made the use of genetic techniques to analyse gene function
problematical. Recent advances in DNA transfection techniques have allowed
expression of plasmid encoded genes in a variety of different kinetoplastids, including
T. brucei (Clayton etal., 1990; Rudenko etal., 1990; Zomerdjk etal., 1990;Cobum et
al., 1991; Ryan etal., 1993). These experiments initially showed transient transfection
to be possible, this was followed by the development of stable episomal vectors
(Metzenberg and Agabian, 1994). Further experiments showed evidence of efficient
pathways of homologous recombination (Tobin etal., 1991; Lee and Van der Ploeg,
1990). This mechanism has been used to insert heterologous DNA into specific sites in
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the nuclear genome (Cruz and Beverley, 1990; Eid and Sollner-Webb, 1991; Ten 
Ashbroek etal., 1990). Relatively small regions of homologous DNA (200bp) are 
enough for precise insertion (Tobin and Wirth, 1992). Linear DNA has been found to 
integrate with higher efficiency than circular, but it is not necessary for both of the 
termini of the DNA molecule to be homologous to the genomic sequence (Cooper and 
Cross, 1993). These techniques have allowed the use of reverse genetics to assess gene 
function. Cloned regions of DNA can be precisely targeted for deletion (de Lafaille and 
Wirth, 1992; Cooper etal., 1993; Cruz and Beverley, 1990; Cruz etal., 1993), 
replacing them with a selectable marker. There are now several such independent 
markers conveying resistance to different antibiotics, including the genes neo 
(neomycin phosphotransferase) (Ten Ashbroek etal., 1990), hyg (hygromycin 
phosphotransferase) (Lee and Van der Ploeg, 1991), pac (puromycin resistance) 
(Freedman and Beverly, 1993) and phleo (phleomycin binding protein) (Jefferies et al.,
1993). Antibiotic resistance markers are necessary as auxotrophs have been difficult to 
produce in the diploid Kinetoplastida.
By repeating the insertion event with two different selectable markers it is 
theoretically possible to create null mutants, and thereby assess mutant phenotypes 
(Cooper etal., 1993). This is easier if the gene of interest is single copy within each 
haploid genome, but tandem arrays can be targeted, and replacing large amounts of 
genomic DNA (>44 kb) with a relatively small selectable marker (1 kb) does not 
seriously compromise the efficiency of the replacement (de Lafaille and Wirth, 1992).
If the gene targeted is essential to parasite in vitro viability, then null mutants 
cannot be isolated. Instead, organisms which show tetraploidy or aneuploidy (Cruz et 
al., 1993), the amplification of the targeted gene, or the creation of extra-chromosomal 
elements containing either copies of the targeted gene (de Lafaille and Wirth, 1992), or 
the selectable marker (J. Mottram, unpublished data), are isolated.
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(iii) Transcription.
All alpha-amanitin sensitive transcription in T. brucei is polycistronic, and no 
well characterised promoters for RNApolII protein coding genes have been isolated 
(Wong etal., 1993; Ben Amar etal., 1991; Muhich and Boothroyd, 1988; Tschudi and 
Ullu, 1988). The promoters for the highly expressed PARP/Procyclin and VSG genes 
have been isolated, but they are not typical (Sherman etal., 1991; Zomerdijk etal., 
1990; Zomerdijk et al., 1993). Transcription of PARP and VSG is performed by an 
alpha-amanitin resistant RNA polymerase, either Pol I or a modified Pol II, unlike the 
other protein coding genes isolated whose transcription is as sensitive to alpha-amanitin 
as that seen in other organisms (Konig etal., 1989; Kooter and Borst, 1984; Grondal et 
al., 1989). Although transcription is polycistronic, the mature mRNA is monocistronic. 
This processing occurs rapidly, initially by the trans-splicing of a 39 nucleotide mini­
exon from the 140bp Spliced Leader RNA (SLRNA) to a region upstream of each gene, 
called the splice acceptor site (Murphy etal., 1986; Sutton and Boothroyd, 1986; Ullu 
etal., 1993). This spliced leader contains the functional equivalent of the 5' cap seen in 
other eukaryotes, and is necessary for expression of the protein. The trans-splicing 
event is also, apparently, one factor involved in directing the polyadenylation of the 
upstream region of the transcript, which may also rely on some extremely degenerate 
sequence motifs (Schurch etal., 1994) e.g. a polypyrimidine tract. Genes transcribed in 
the same polycistronic precursor RNA have been found to have widely varying steady 
state mRNA levels, and regulation at the post transcriptional stage appears to be 
important for the control of gene expression (Gibson etal., 1988). No c/s-splicing has 
been described in the Kinetoplastida, except for an intron in a tRNA (Schneider et al.,
1993), and to date no protein coding genes containing sequences that look like introns 
have been described.
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1.1.4 The Mitochondrion of T. brucei, editing of RNA and mitochondrial translation.
Unlike other eukaryotes, the kinetoplastids have only one mitochondrion per 
cell. The mitochondrial genome, the kinetoplast, is a huge concatenated network of two 
classes of circular molecules (Simpson, 1986). The maxicircles, which are the 
equivalent of the mitochondrial genome in other cells, are approximately 20 kb in 
length in T. brucei, and there are numerous (~35) identical copies. These are joined by 
~ lx l0^  interconnected minicircles of about 1 kb in size, which are very diverse in 
sequence (>400 different classes) with multiple copies of each sequence type. Notably, 
T. evansi and T. equiperdum, which do not pass through an insect vector, only have a 
very restricted variety of minicircle types (Barrois etal., 1981; Ou etal., 1991). 
Transcripts from the maxicircle consist of tRNAs, rRNAs and the mRNAs which 
encode proteins presumably translated in the mitochondrion (Simpson and Shaw, 1989). 
Many of the genes in the maxicircle, however, require editing before translation of the 
correct Open Reading Frame is possible. This editing is guided by short (~70bp), 
complementary (allowing for G:U wobble pairing) RNAs (gRNAs) transcribed from the 
minicircles, and proceeds from the 3' to the 5' of the mRNA, by inserting, or 
occasionally removing, uridine residues in the precursor RNA. The editing takes place 
in a large protein/RNA complex which has been called the editosome (Goringer etal., 
1994, Koller etal., 1994). Each type of minicircle encodes 3 gRNAs which gives 
enough coding capacity for editing all the known transcripts even given the high levels 
of overlapping in the gRNA sequences, which may ensure processivity and be a proof 
reading mechanism (Corell etal., 1993). Not all of the mRNAs are edited, and the 
amount of editing is variable. In some cases the editing process forms the starting AUG 
codon, which gives in built regulation of translation of the message. Although there is 
no stage specific regulation of maxicircle transcription, there is stage specific regulation 
of the editing of a number of transcripts, with COII and CYb completely edited in the 
procyclic stage only (Feagin etal., 1985), while ND7 has its 3' domain edited only in 
the bloodstream forms (Corell etal., 1994). It is not clear how this occurs, but is
presumably due to control of gRNA function or presence. The processive nature of 
editing, with one gRNA often editing the region to which another will anneal, means 
that the control of one gRNA can cause the editing of the whole transcript to be 
abortive.
As mentioned above, the bloodstream form T. brucei do not have a functional 
citric acid cycle, and it is possible to isolate strains in bloodstream culture that have lost 
the kinetoplast (Agbe and Yielding, 1994), similar to the trypanosome species that have 
lost the ability to multiply in insect vectors with a commensurate loss of minicircle 
variation. The mitochondrion may still, however, carry out tasks encoded by the 
nucleus, and the retention of the maxicircles in the kinetoplast in T. evansi and T. 
equiperdum is evidence that some unedited genes in the mitochondrion are needed for 
optimum viability in vivo even in bloodstream form T. brucei. The reduction in growth 
rate of akinetoplastic T. evansi compared to the wild type (Silvatahat et al., 1995) points 
to the fact that the mitochondrial DNA is still important in the bloodstream form T. 
brucei. If this is true, then translation of mitochondrial transcripts may be important in 
both bloodstream and procyclic stages.
The translation machinery in other eukaryote mitochondria is apparently related 
to that seen in eubacteria, with similar rRNAs and protein factors. One of the protein 
factors, for which a gene has been isolated from eukaryotes, is mitochondrial 
Elongation Factor G (mEF-G). EF-G is a GTP binding protein that is involved in 
controlling the tri-nucleotide translocation of the eubacterial ribosome during 
translation. This gene is nuclear encoded in Saccharomyces cerevisiae and rat 
(Vanbutas et al., 1991; Barker etal., 1993), the two eukaryotes from which the gene has 
been isolated, and the protein has been shown to be imported into the mitochondria of 
S. cerevisiae and cows (Vanbutas etal., 1991; Chung and Spremulli, 1990). The gene 
responsible for the same activity in the cytoplasm of eukaryotes, and in archaebacteria, 
Elongation Factor 2, is related, but distinct (see Chapter 3.3.1).
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1.2 The Eukaryotic Cell Cycle.
1.2.1 Introduction - the typical eukaryotic cell cycle.
The typical mitotic eukaryotic cell cycle consists of 4 stages (Figure 1.2.1). 
There are three major control points during the cell cycle. During G1 (Gap 1) there are 
a series of decision points at each of which the possible development options are 
reduced. At some point the cell becomes committed to another division cycle; this is 
called START in yeast, or the Restriction Point in higher eukaryotes. The other control 
points are at the entry and exit of mitosis, at which DNA replication and chromosome 
separation, respectively, must be complete.
After division the cell enters G1 phase, during which the cell synthesises 
proteins necessary for cell growth (e.g. enzymes required for DNA synthesis) and 
division. Prior to START the cell is responsive to outside factors, such as mating 
pheromones (Obara-Ishihara and Okayama, 1994; Fujimara, 1994; Peter and 
Herskowitz, 1994) in yeast, and growth factors in higher eukaryotes (Kato et al., 1993; 
Duronio and O ’Farrell, 1994). These different factors can cause the cell to stop its 
progression through the cell cycle, and force it onto an alternate pathway, i.e. into 
conjugation/mating in yeast, cellular differentiation or apoptosis in other organisms. In 
multicellular organisms the cells can also exist in a state called GO. Cells in this state 
are not growing, and have not passed through the restriction point. However they are 
neither senile nor terminally differentiated as they can be stimulated to re-enter the cell 
cycle and undergo division. GO can be considered a separate stage of the cell cycle, or 
as a sub-state of Gl. At some point after START, nuclear DNA synthesis begins. This 
is the defining characteristic of S phase. The synthesis of mitochondrial DNA in all 
eukaryotes examined, apart from the kinetoplastida (see Chapter 1.2.3), is less tightly 
regulated, with replication being continuous throughout the cell cycle (Bogenhagen and 
Clayton, 1977), but possibly predominantly during S phase and G2 (Clayton, 1991;
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Figure 1.2.1 The eukaryotic cell cycle
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Figure 1.2.1 The four stages of the typical eukaryotic cell cycle, plus GO.
  Arrows with bold text show occurances during the cell cycle.
Starred lines show checkpoint controls during the cell cycle.
Attardi, 1988). An increase in mitochondrial DNA synthesis during this time may be 
simply to do with the availability of DNA precursors. When nuclear DNA synthesis 
stops the cell continues to grow, and in this G2 phase the cell synthesises the proteins 
involved in controlling the G2 to M phase transition, and those which carry out many of 
the necessary enzymatic and mechanical functions. During M phase the replicated 
chromosomes condense, the nuclear envelope disassembles (in higher eukaryotes), the 
mitotic spindles form and separate the chromosomes, which are partitioned. After 
mitosis, the nuclear envelope reforms and the cell is divided into two daughter cells 
(cytokinesis). Analysis of conditional temperature sensitive mutants in both S.pombe 
and S. cerevisiae discovered a large number of genes (>100) that were essential for cell 
cycle progression. These genes included those encoding enzymes responsible for DNA 
synthesis (e.g. CDC2 in S. cerevisiae). Most of these mutations caused arrest in a 
single, particular, phase of the cell cycle. One of the isolated genes, cdc2 from S. 
pombe, could cause cell cycle arrest in both G1 and at the G2/M phase boundary. It 
was then discovered that the homologous S. cerevisiae gene, CDC28, could 
complement S.pombe mutants of cdc2, and vice versa, indicating a high level of 
conservation in the pathway of cellular division in yeast.
1.2.2 The T. brucei cell cycle.
The cell cycle of the trypanosome differs from that of other eukaryotes in a
number of respects (Sherwin and Gull, 1989; Gull etal ., 1990). The presence of a
single mitochondrion and flagellum per cell means that the replication and division of
the nucleus, kinetoplast, mitochondrion, basal bodies and flagellum must be tightly
controlled. Figure 1.2.2 shows a schematic of the cell cycle of procyclic T. brucei
grown in culture (Gull etal., 1990). The early G1 cell contains one basal body attached
to the flagellum, with a pro-basal body next to it. The first visible event in the T. brucei
cell cycle, detectable with specific monoclonal antibodies, is the elongation of the pro-
basal body and the formation of the basal plate. Next, the new flagellum begins to form
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Figure 1.2.2 The cell cycle of procyclic form T. brucei.
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Figure 1.2.2 A schematic figure of the procyclic T. brucei cell cycle shows the changes 
in cell structure during division (taken from Gull etal., 1990). The earliest stage of the 
cell cycle that is presently detectable is the growth of the second basal body from the 
pro basal body (II), which is followed by the formation of two new pro basal bodies 
(III). The new flagellum then starts to form (IV) and is always the posterior of the two 
flagella. As the new flagellum elongates the basal bodies separate, along with the 
attached kinetoplasts (V). By the time the flagella are of equal length the nucleus has 
replicated the DNA and nuclear division has started (VI). Once the two new nuclei are 
positioned correctly with respect to the basal body/kinetoplast (VIII), division of the 
cell begins at the anterior end (IX) and continues until the two cells are just connected 
by the posterior ends (X), when the cells separate.
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on the new basal body. This is accompanied by the formation of two new pro-basal
bodies. An example of the tight control over the cell cycle is the observation that the
new flagellum is always the more posterior of the two. As it continues to elongate the
basal bodies begin to separate. At this point the kinetoplasts have already divided, and
are also observed to separate with the basal bodies. Experiments with drugs which
inhibit protein microtubular motors (thought to be involved in organellar movement) or
topoisomerase II (which allows the unlinking of concatenated circular DNA molecules),
suggest that there is a physical linkage between the two organelles (Robinson and Gull,
1991). Purification of flagella from T. brucei after dissociation of the sub-pellicular
microtubules with 1-3 mM Ca2+ has shown a stable linkage between the basal body and
the kinetoplast DNA (Robinson and Gull, 1991). Electron microscopy of T. brucei cells
has shown an electron dense region between the kinetoplast and the basal body, which
implies a dense protein link (Robinson etal., 1991). Labelling experiments have shown
that unlike other eukaryotes, kDNA replication takes place in a well defined period of
the cell cycle (Sk), starting at around the beginning of nuclear S phase (Sn) and
finishing before nuclear replication ends (Woodward and Gull, 1990). In other
organisms the evidence suggests that while some mitochondrial genomes may duplicate
many times in one cell cycle, other mitochondrial genomes in the same cell will not
replicate at all (Bogenhagen and Clayton, 1977). There is evidence that replication of
each molecule of the kDNA, however, takes place only once in Sk (Hajduk et al.,
1984). This may be controlled by regulation of the final ligation reaction, which repairs
the nick left by replication, during the G2 stage of the cell cycle. The division of the
kinetoplast does not appear to carefully segregate the DNA content evenly, and the
precise number of maxi and minicircles received by each cell may be uneven. This is
presumably a reason for the multiple copy of the kDNA (e.g. 20-50 copies of the
maxicircle), which ensures that each cell receives all the necessary DNA for viability.
In this, the mitochondrion of T. brucei is similar to those found in other organisms.
After basal body separation the next visible event is the start of nuclear mitosis. As in
most lower eukaryotes, there is no nuclear envelope breakdown, and there is also no
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visible condensation of the chromosomes in T. brucei. After nuclear division there is a 
delay, during which extensive rearrangement of the organelles occurs, so that each 
nucleus is paired with a kinetoplast/basal body prior to the start of cytokinesis. When 
this has been achieved, the cell divides longitudinally from the anterior end, with final 
separation occurring with the cells joined by the extreme posterior of each daughter 
cell.
Analysis of the T. brucei cell cycle has been held up by the present inability to 
synchronise cultures of trypanosomes. Procyclic cells in the same culture, at the same 
point in the cell cycle, can vary considerably in size, so making selection by elutriation 
difficult. Drugs affecting microtubule function which have been used in other 
organisms to synchronise cells in G2/M phase, cause trypanosome death. For those 
compounds which destabilise microtubules this is probably due to the complicated 
basket of sub-pellicular microtubules under the plasma membrane of T. brucei being 
essential for cell viability. Drugs which stabilise microtubules can also block cells 
within mitosis. In these cases, e.g. treating the procyclic form T. brucei cultures with 
rhidoxin (Robinson etal., 1995), the cells do not undergo mitosis but do divide, 
creating anucleate fragments which contain a kinetoplast and a flagellum (zoids) and 
tetraploid cells. There is therefore a lack of checkpoints at this point in the cell cycle. 
Other reagents which usually block DNA synthesis, and so halt cells specifically in S 
phase, have been tried e.g. aphidicolin or hydroxyurea. The bloodstream form 
trypanosomes did stop dividing, but during the G2 phase of the cell cycle, DNA 
synthesis was not blocked. These experiments did result in a synchronised population 
of cells, but they did not undergo mitosis after release from the block, and the cells 
became polyploid and eventually died (Mutoba and Wang, 1996). Serum starvation has 
also been used with limited success (Morgan etal., 1993, Gale etal., 1994). The major 
problem being an apparent lack of a GO stage in trypanosomes capable of division 
(Diffley and Mama, 1989), which results in a large number of cells that are not released 
from the block after starvation.
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1.2.3 CDC2 - function and the family of related genes within the eukaryotes.
In S.pombe the cdc2 gene encodes a 34 kDa protein kinase often called p34cdc2. 
Different alleles of cdc2 can cause temperature sensitive cell cycle arrest during G1 
and/or at the G2/M phase transition when at the restrictive temperature. This indicated 
an important role for cdc2 in the cell cycle, as functional p34cdc2 was necessary at both 
of these transition points. Different mutations in cdc2 can result in different 
phenotypes, with the cell cycle block being predominantly in G l, at the G2/M 
boundary, or sometimes both. This implies that p34cdc2 interacts with specific factors at 
each of these control points.
S. cerevisiae has two genes closely related to cdc2. The protein encoded by 
CDC28 has high sequence identity to p34cdc2 (65 %) and the fact that it can 
complement, and be complemented by the S.pombe homologue implies functional 
homology. The other such gene, PH085, is less well conserved, and does not 
complement a cdc2 mutant. Until recently the PH085 protein was not thought to be 
directly involved in cell cycle control (but see below). As with cdc2, different 
temperature sensitive mutations in CDC28 may cause arrest preferentially in either Gl 
or G2/M phase, and is therefore involved in control of both of these checkpoints.
Functional homologues of cdc2ICDC28 genes have been isolated by
complementation of the yeast temperature sensitive mutants from many organisms,
ranging from plants to humans (Lee and Nurse, 1987, Jimenez etal., 1990, Feiler and
Jacobs, 1991, Hirayama etal., 1991, Paris etal., 1991, Hashimoto etal., 1992,
Michaelis and Weeks, 1992). These closely related genes (CDC2) which complement
have predicted protein sequence identities of around 60-65% (see Chapter 3.3.5), and
initially, because of the complementation of both yeast transitions, were believed to be
involved in both restriction point and mitosis control. It has now become clear that
there is a large family of related kinases in the multicellular eukaryotes, many of which
are involved in control of the cell cycle, and that the original cdc2 genes from higher
eukaryotes are involved principally in post-S phase control (Hamaguchi et al., 1992,
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Fang and Newport, 1991). There are other cdc2 related genes which complement the 
yeast mutants, e.g.human cdk2 (Cyclin Dependant Kinase 2) (egl in X. laevis) and 
cdk3 (human) (Elledge and Spottswood, 1991; Meyerson etal., 1992). The encoded 
proteins are also 60-65 % identical to the yeast cdc2/CDC28 kinases. Outside of this 
closely related group are many protein kinases from humans and mouse (isolated by 
PCR directed at conserved kinase domains) with significant, but lower, homology (45- 
55 %) to cdc2/CDC28. These genes (including cdk4, cdk5, cdk6, the PCTAIR 
subfamily and cdk7) do not complement yeast mutants of cdc2/CDC28, but in a number 
of cases the proteins have been shown to be involved in control of the mammalian cell 
cycle (Fesquet etal., 1993, Meyerson etal., 1992; Matsuoka etal., 1994). The reasons 
for such a large number of kinase subunits is not clear, but may be due to the tight 
control needed in a multicellullar organism to stop the selective advantage of rapid 
division leading to carcinogenesis. Another possible reason is the large numbers of 
tissues which undergo differentiation in higher eukaryotes.
The kinase activity of CDC2, and the closely related CDK2, can be assayed in 
vitro by phosphorylation of histone HI (Draetta and Beach, 1988). This may be a 
physiological substrate for CDC2, and possibly plays a role in chromosome 
condensation during M phase. The less conserved members of the CDK family, e.g. 
CDK4/5/6, have low activity when assayed with histone HI, but protein substrates have 
been found to which they have high activity e.g. the Retinoblastoma protein (Kato et 
al., 1993; G ranada/., 1994;Kitagawa etal., 1994; Schnier etal., 1994), neurofilament 
H (Hisanaga etal., 1991, Pan and Hurwitz, 1993) and pl07, a retinoblastoma-like 
protein (Pan etal., 1993).
The kinase activity of the CDK family of proteins, as the name suggests, is
usually reliant on the kinase subunit forming a dimer with a controlling protein called a
cyclin (see CDK5 for exception). These were first discovered in oocytes of starfish and
sea urchins, and named for their property of increasing in quantity through the cell
cycle until the end of the M phase, when they were rapidly degraded. Several related
genes have been isolated, and as with the CDC2 related proteins, the cyclins are
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conserved between different organisms. However, the similarity is considerably lower
than that seen in the CDK family. Typically the sequence identity is between 30-40 %
within the region of the protein called the cyclin box, and very low outside this region
of approximately 150 amino acids. This lower level of conservation is presumably due
to there being less selective pressure on a regulatory subunit as opposed to the
functional enzyme. The cyclin genes cloned from the higher eukaryotes are divided
into several different families on the basis of conserved residues within the cyclin box,
with Cyclins A to H so far isolated. Cyclin A (Pines and Hunter, 1989; Takahisa etal.,
1992) has been shown to bind both CDC2 and CDK2, and is involved in both sustaining
DNA replication (with CDK2) in S phase (Cardoso etal., 1993; Pagano etal., 1992;
Pines and Hunter, 1992), and in control of the G2/M transition (Minshull etal., 1990,
Pagano etal., 1992, Rosenblatt etal., 1992) with CDC2. The B type cyclins can consist
of a gene family with up to 8 members in any given organism. They associate with
CDC2 and, in the higher eukaryotes, are involved in controlling the G2/M transition
(Minshull etal., 1990, Hoffmann, 1993), as well the exit from mitosis. Expression of
some mutated Cyclin B proteins results in a block in the final stages of M phase (Ghiara
etal., 1991; Luo etal., 1994). This is due to the loss of a region (called the destruction
box) involved in controlling the cyclin degradation pathway, showing that proteolysis
of the Cyclin B molecules is a necessary step for exit from mitosis. Some of the large
family of B type cyclins in S. cerevisiae are also involved in S phase control (Schwob
and Nasmyth, 1993). A large number of different cyclins that are probably involved in
Gl and S phase control have been cloned from mammalian cell lines (Lew etal., 1991).
The role of Cyclin C is not clear, but a related protein has been found in Drosophila
(Leopold and O'Farrell, 1991), which implies that it will be conserved across the
multicellular eukaryotes. Cyclins D and E have been shown to regulate passage
through G l, and into S phase (Xiong etal., 1992; Motokura etal., 1992; Koff et al.,
1991; Richardson etal., 1993). Cyclins F, G and H have also been isolated (Bai et al.,
1994; Okamoto and Beach 1994; Makela etal., 1994) and Cyclin H has been shown to
bind to CDK7 (Fisher and Morgan, 1994). The Gl cyclins from S. cerevisiae consist of
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another class, called CLN1-3 (Rowley etal., 1992), and a number of cyclin genes from 
the lower eukaryotes are not clearly members of any one particular category e.g. mcs2 
from S.pombe (Molz and Beach, 1993) and CLG1 from S. cerevisiae (Matsumoto and 
Wickner, 1993).
1.2.4 Control of the cdc2 kinase activity in yeast.
To be functional as a kinase, S.pombe p34cdc2 must bind a cyclin. For the G2/M
phase transition the activating subunit is encoded by cdcl3 (Hagan etal., 1988). The
protein encoded by this gene is a member of the Cyclin B family. The B type cyclins,
and until recently, also the A type cyclins found in metazoans, are sometimes called the
mitotic cyclins. The activity of the kinase complex is further controlled by the
phosphorylation of the cdc2 subunit. Phosphorylation of a tyrosine residue (Tyr-15) in
the ATP binding site of cdc2 causes inhibition of kinase activity (Lundgren etal.,
1991). Replacement of this residue by non-phosphorylatable residues, e.g.
phenylalanine, causes premature division of the cell, resulting in a lowering of viability
due to divisions occurring when the cell has not completed DNA replication or nuclear
separation, a phenotype described as mitotic catastrophe (Gould and Nurse, 1989).
Mutations in another gene, weel, cause a similar, though less severe, phenotype, with
the cell dividing at a considerably smaller size than normal (Creanor and Mitchison,
1994). The protein encoded by weel has been shown to phosphorylate cdc2 on the Tyr-
15 residue (McGowan and Russell, 1993), as has the product of a related gene, mikl,
which appears to co-operate in the phosphorylation of Tyr-15 (Lundgren et al., 1991).
If both of these genes are non-functional, the yeast cell viability becomes exceptionally
low (approx. 4% ), a phenotype described as mitotic lethality (Lundgren etal., 1991).
Mutations in another gene, cdc25, were found to alter the phenotype of weel mutants.
The encoded protein, cdc25, is a phosphatase, and has been shown to be responsible for
the dephosphorylation of Tyr-15 (Millar etal., 1991). For the cdc25 phosphatase to
become highly active, the substrate cdc2 must be bound to Cyclin B. This is because
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the Cyclin B molecule includes a region (the P box) important for phosphatase 
activation (Zheng and Ruderman, 1993). In addition to control of Tyr-15, it is 
necessary for threonine 167 of cdc2 to be phosphorylated for the cdc2/cyclin complex 
to be active (Gould etal., 1991). The gene that encodes the kinase responsible for this 
is known as CAK, or CDK7, in higher eukaryotes (Fesquet etal., 1993; Poon etal., 
1993; Solomon etal., 1993; Wu etal., 1994). Another gene involved in G2/M phase 
control, implicated by genetic and biochemical studies, is sucl (Ducommun etal:, 
1991, Brizuela etal., 1987; Hayles etal., 1986). This is an essential gene, mutations in 
which can suppress certain cdc2 mutant phenotypes. Crystallographic studies of the 
p l3sucl protein have shown a dimer (Endicott etal., 1995), unlike the human 
homologue, CKS2Hs (Brizuela etal., 1987), which forms hexamers (Parge etal.,
1993). It is postulated that the p l3sucl/CKSHs proteins may have a structural role in 
forming active CDK/cyclin complexes (Brizuela etal., 1987; Booher et al., 1989), 
bringing into close proximity different complexes. The difference in multimerisation 
may be related to the different numbers of both CDK and cyclin types in the respective 
organisms. The p l3 sucl protein binds cdc2 with high affinity and has been used to 
isolate cdc2 related kinase activity, and the proteins responsible, from many organisms 
(John etal., 1991; Tang etal., 1994).
Experiments have shown that some cdc2 temperature sensitive mutants, which 
are blocked in G2 when raised to their restrictive temperature, undergo cdc2 
degradation after a heat shock at 56 °C. In this case, the cells 'reset' to Gl phase even 
though they have already undergone DNA replication and have a DNA content of 2N. 
This results in cells that have a DNA content of 4N prior to division. It therefore 
appears that, in S. pombe, a modification of the cdc2 protein is one method by which 
the cell prevents itself from undergoing repeated replication (Broek etal., 1991).
As with cdc2, the S. cerevisiae homologue CDC28, needs to bind a cyclin to be
active. It also appears to be regulated by very similar phosphorylation events aswell as
by the control of transcription (Nasmyth, 1993). Unlike S.pombe, the budding yeast
cell cycle controls are well characterised at START, although CDC28 mutants that
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preferentially stop at the G2/M phase boundary have also been characterised (Amon et 
al., 1993; Surana etal., 1991). A large number of cyclins have been isolated from S. 
cerevisiae, including CLB1-6 (Ghiara etal., 1991; Surana etal., 1991; Grandin and 
Reed, 1993; Schwob and Nasmyth, 1993), CLN1-3 (Rowley etal., 1992; Cvrckovaand 
Nasmyth, 1993), OrfD (Measday etal., 1994) and HCS26 (Espinoza etal., 1994). 
Genetic studies have shown that the CLB family, and the CLNs form complexes with 
CDC28 at different stages of the cell cycle. There is a high element of redundancy 
shown by the S. cerevisiae cyclins. A cell expressing any one of the CLN genes, the 
products of which are primarily involved in control of START [although CLN3 also 
affects cell size at mitosis (Vienot-Drebot etal., 1991)], is viable, albeit possibly with 
imperfect cell cycle control e.g. in response to mating pheromones. A triple null 
mutation is however, lethal. Equally, either one of the CLB5 and 6 genes, involved in 
CDC28 control during S phase (Schwob and Nasmyth, 1993), can apparently be 
dispensed with, and CLB1 and 2 have overlapping functions in M phase, allowing 
single mutants to be viable where double mutants are not. The cyclins encoded by 
OrfD and HCS26 bind to PH085. PH085 was originally thought to be only involved in 
regulating phosphate metabolism, by its binding to PHO80, and phosphorylation of the 
transcription factor PH04 (Kaffman etal., 1994). The activating subunit, PHO80, was 
found to have a region of relatively high homology to regions found in OrfD and 
HCS26 and it was subsequently found that PH085 does indeed bind to OrfD and 
HCS26. Either one of these kinase complexes is essential for passage through START 
in strains of S. cerevisiae that lack CLN1 and 2 (Measday etal., 1994; Espinoza etal.,
1994). This implies that the CDC28/CLN1, CDC28/CLN2, PH085/0rfD, and 
PH085/HCS26 complexes form four parallel pathways, any one of which is sufficient 
for traversing the START restriction point. The reason for S. cerevisiae having so 
many cyclins is not clear. It is possible that S.pombe has a similar number of cyclins 
but that these have not yet been isolated.
Other proteins involved in control of kinase activity have been isolated from S.
cerevisiae, including a sucl homologue, CKS1 (Hadwiger etal., 1989), and several
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CDK Inhibitory proteins (CKIs). The CKI class of proteins has been characterised by 
their mode of inhibition. They bind to, and inactivate, the CDK or CDK/cyclin 
complex, but do not covalently modify the complex components, unlike the weel 
kinase. The CKI proteins cloned from S. cerevisiae do not share sequence similarities. 
Different CKIs are involved in controlling constitutive pathways and responses to 
extracellular signals. SIC1 /p40 binds to complexes containing CDC28 with CLB5&6 
(Schwob etal., 1994), so regulating passage through S phase. FAR1 inhibits kinase 
complexes of CDC28 with CLN1-3 in response to mating pheromones (Peter and 
Herskowitz, 1994). This is responsible for the block in G1 which occurs under these 
conditions. PH081 binds to the PHO85/PHO80 complex involved in regulating 
phosphate metabolism (Hirst etal., 1994).
1.2.5 CDK control in higher eukaryotes.
The basic mechanisms controlling the kinase activity of the different CDK
complexes seems to be well conserved between yeast and higher eukaryotes. Figure
1.2.3 shows the major controlling modifications and associations of HsCDC2 at the
G2/M phase boundary. The CDC2 related kinases of higher organisms bind to a large
family of cyclin subunits (Pines, 1993). CDC2 and CDK2 undergo the same inhibitory
phosphorylation of the Tyr-15 tyrosine residue as in the yeast system, by weel related
proteins but also are phosphorylated on the conserved threonine residue adjacent, Thr-
14, a modification which has not been seen in yeast (Gu etal., 1992; Igarashi etal.,
1991; Norbury etal., 1991; Krek and Nigg, 1991). This threonine phosphorylation is
not performed by weel, but rather a membrane bound kinase, which in Xenopus is
encoded by the mytl gene (Mueller et al., 1995). There are also well conserved
homologues of the CDC25 gene, the products of which are involved in
dephosphorylating the Tyr-15 of CDC2 and CDK2 (Jimenez et al., 1990; Jinno et al.,
1994). The equivalent of Threonine-167 is also well conserved in the human family of
CDC2 related kinases, and this residue, as in yeast, needs to be phosphorylated for the
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Figure 1.2.3. Positive and negative regulation of
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kinase to be active (Gu etal., 1992; Lorca etal., 1992; Norbury etal., 1991). The 
kinase responsible for this activity, or at least capable of it, has been cloned from X. 
laevis and human, and has been shown with purified extracts to be capable of activating 
various kinase complexes including those containing CDC2, CDK2 and CDK4 from 
humans (Fesquet etal., 1993). This protein is itself related to the CDC2 family, and 
also has an activating subunit with homology to the cyclin family. These similarities 
have resulted in this complex being named CDK7/Cyclin H by some investigators, 
although the original nomenclature of CDK Activating Kinase (CAK) is often still used. 
As noted previously, homologues of the sucl gene have been isolated from humans and 
these have been shown to bind CDC2 (Azzi etal., 1992), and one of the human CKS 
proteins has been crystallised, allowing the structure to be analysed (Parge etal., 1993). 
The crystal structure has shown a hexamer, which agrees with the evidence of size 
fractionation using soluble CKS2Hs. As noted before, if as seems likely, one kinase 
complex binds each CKS sub-unit, the resulting close association may allow specific 
targeting of CDK/cyclin phosphorylation by other CDK complexes.
CKIs have also been isolated from mammalian cell lines. As with the inhibitory 
proteins in budding yeast, there are those that play a role in controlling the cell cycle 
generally (p21/CIPl and pl6), as well as those that control the response to outside 
factors, e.g. antimitogens (p27) (Xiong etal., 1993; Serrano etal., 1993; Gu etal.,
1993). Although p21 and p27 share sequence homology, possibly due to the 
overlapping target of the CDK2/Cyclin E complex, there is no significant homology 
between other members of the CKI proteins either within an organism, or between 
organisms. This may mean that they perform functions that are evolutionary fine 
tuning, specific for different organisms, as opposed to essential parts of a basic cell 
cycle control system. The FAR1 gene from S. cerevisiae is non-essential, which gives 
credence to this idea, but the gene encoding p l6  in humans has been implicated as a 
tumour suppresser gene (Okamoto etal., 1994), and mutations have been found in 
familial cases of melanoma (Wainwright, 1994), suggesting that this gene may be
important and conserved in multicellullar organisms.
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1.2.6 CDK/Cyclin complexes in Metazoans, and control of the cell cycle.
Table 1.2.1 briefly shows the present published data as to which CDK binds to 
which cyclin in mammalian cells. In the case of CDK3, partners are not known, and 
there are some cyclins (F and G) for which kinase subunits have not been assigned.
The presence of CDK/cyclin complexes in early G l, immediately after 
cytokinesis, that play a role in cell cycle progression has not been clearly shown.
At START, the major complexes appear to be those containing D type cyclins, 
possibly complexed with any of 3 different CDK's (Xiong etal., 1992). There is a 
consensus that CDK2, CDK4 and CDK6 form complexes with the Cyclin D family.
The three D type cyclins are expressed at different levels in different cell types, and it is 
not clear how the different cyclin D's roles differ. Differences are apparent, D2 and D3 
have been shown to bind to the Retinoblastoma gene product (Rb), whereas D1 does 
not (Hatakeyama etal., 1994). All three can promote phosphorylation of Rb in vitro 
when co-expressed with CDK4, but in an in vivo assay, D 1 did not cause Rb 
phosphorylation (Kato etal., 1993). The hyperphosphorylation of Rb removes the 
block to cell cycle progression by interfering with the binding of Rb to the transcription 
factor E2F. The role of complexes containing Cyclin D1 is still unknown, but Cyclin 
D1 does form complexes which contain E2F ( Zhang and Kumar, 1994; Schulze etal.,
1994), as well as those containing Proliferating Cell Nuclear Antigen, a protein 
involved in the control of nuclear DNA synthesis (Xiong etal., 1992; Matsuoka etal.,
1994). Therefore it may be involved in controlling the start of DNA synthesis. The 
importance of the CDK4 complexes in control of cell cycle progression can be seen in 
experiments performed on a mink cell line, MvlLu. The antimitogen TGF-Beta-1, 
which arrests cells in Gl phase, was shown to be able to act by down regulation of 
CDK4 levels (Ewen etal., 1993), which resulted in the accumulation of 
unphosphorylated Rb. Levels of Cyclins D1 and D2 (D3 not being expressed in 
MvlLu) were unaffected, as were levels of CDK2 and Cyclin E. Furthermore,
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unregulated expression of CDK4 resulted in the cell line showing unimpaired growth 
when exposed to TGF-p-1, while similar expression of D type cyclins or CDK2 had no 
effect.
The expression of CDK5 varies in different cell lines, and although it has been 
shown to bind to D type cyclins, and Proliferating Cell Nuclear Antigen, kinase activity 
in this case has not been shown (Xiong etal., 1992). What has been proved is that 
CDK5 is highly expressed in terminally differentiated neurons, which do not express 
CDC2 (Hayes etal., 1991), and it forms a complex with a 35 kDa protein that shares no 
homology to cyclins (Helmich etal., 1992). This complex is active without further 
modification, unlike those containing other CDK molecules and can phosphorylate 
components of neurofilaments. Therefore, it seems to be involved in regulation of the 
cytoskeleton, specifically in the central nervous system. It is possible that the CDK5 
association with cyclins D1 and D3 seen previously is an artefact of the system used, 
and CDK5 has no role in the regular cell cycle, or it may be that the physiological 
substrate has yet to be found.
CDK2 has been shown to be part of a complex with the D cyclins, and interacts
with other components of the complexes, e.g. Rb, in a similar way to CDK4 in vitro.
However, in vivo most of the CDK2 is associated with Cyclin E, and the evidence is
that its interactions with the D type cyclins are limited and unlikely to be limiting
factors in cell cycle progression (see above). CDK2 binds to Cyclin E, which is
synthesised during G l, forming a complex that also contains pl07 (which is related to
Rb) and E2F. Levels of this complex, and the kinase activity associated with it, peak at
the Gl/S phase boundary, after which Cyclin E is degraded. As the levels of the
CDK2/Cyclin E complex decrease, the levels of a complex containing CDK2/Cyclin A
start to rise (Elledge etal., 1992; Harper etal., 1992). The different roles of the two
complexes is unknown, although evidence suggests that the CDK2/Cyclin A complex is
involved in maintaining DNA synthesis (Pagano etal., 1992; Cardoso etal., 1993).
The control of kinase activity is apparently performed in a very similar way to the
control of S.pombe cdc2, and a cdc25 homologue active during Gl and S phase has
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been characterised from human cells (Jinno etal., 1994). E2F has been shown to 
regulate the transcription of genes necessary for S phase, but the reason for different 
complexes in G l and S phase with pl07 is unclear. Also unclear is why, and how, the 
control of E2F by association with Rb and pl07 overlaps during Gl. During S phase, 
complexes containing CDK2 and Cyclin A have been co-localised to areas of DNA 
replication in the nucleus (Cardoso etal., 1993). This co-localisation may have 
something to do with the binding seen in G l between CDK2 and PCNA, which is an 
essential protein associated with DNA polymerase delta, and which also shows punctate 
staining of S phase nuclei.
By the end of S phase CDC2 is bound to A and B type cyclins (Draetta etal., 
1989), but the Cyclin B complexes are predominantly inactive due to the 
phosphorylation of Thr-14 and Tyr-15. It appears that the complexes containing Cyclin 
A have limited activity, but when this reaches a threshold activation of the 
CDC2/Cyclin B kinase activity occurs at the G2/M phase boundary extremely rapidly. 
This is achieved by a control system exhibiting positive feedback. Activated 
CDC2/Cyclin complexes phosphorylate CDC25 (Hoffmann, 1993; Izumi and Mailer,
1993), which is then far more efficient at activating more CDC2/Cyclin. The negative 
regulators are less active in mitosis, and this may be regulated by the CDC2 kinase 
complex, probably one or more steps removed. In the case of weel, phosphorylation 
causes the Tyr-15 kinase activity to be down-regulated. This combination results in a 
very rapid activation of all the available CDC2/Cyclin A and B complexes, which then 
phosphorylate the required substrates for M phase progression. Amongst these are the 
components of the nuclear lamina, which results in their disassembly (Nigg etal., 1991; 
Peter etal., 1990; Peter etal., 1991). CDC2 complexes have also been shown to be 
associated with the mitotic spindle (Ookata etal., 1993) and intermediate filament- 
associated proteins (Skalli etal., 1992).
The degradation of the mitotic cyclins is another regulatory step necessary for 
the completion of mitosis. The Cyclin A molecules are degraded first, with the Cyclin
B degradation occurring at the transition from M phase into Gl (Minshull etal., 1990).
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The degradation of the cyclins is signalled by their polyubiquitination, the control of 
which is to some degree regulated by CDC2 activity (Hershko etal., 1994). The loss of 
the cyclins results in the loss of kinase activity (Draetta etal., 1989). As mentioned 
previously, the expression of N terminal truncated mitotic cyclins, which lack a region 
targeting them for degradation (see Chapter 3.2.1), results in cell cycle arrest at the 
point that the proteins are usually broken down.
1.3 Project Aims.
The specific aims of the project were:
1) To attempt the isolation of cyclin gene(s) from T. brucei, and/or the related 
kinetoplastid Leishmania mexicana.
2) To isolate and sequence the genomic locus of tbcrk3, one of the T. brucei cdc2- 
related kinases, for which a gene fragment amplified by PCR was available.
3) To raise antisera to TbCRK3, and with other antisera available in the laboratory, 
analyse the expression, and if possible activity, of the members of the TbCRK family in 
the different T. brucei life cycle stages.
4) To analyse the function and activity of the TbCRK proteins, using biochemical and 
reverse genetic approaches.
1.4 Addendum-recent publications.
1.4.1 The Eukaryotic cell cycle; kinases, phosphatases and the cytoskeleton.
New research into CDK/cyclin complexes has shown more links between cell
cycle control and transcription. The CDK7/Cyclin H complex has been found to form
part of the Transcription Factor II H (THIH) complex, involved in the initiation of
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RNA polymerase II transcription (Serizawa etal., 1995; Sheikhattar etal., 1995). It is 
thought that the CDK7/Cyclin H complex phosphorylates the C-terminal tail of the 
RNA polymerase II large subunit. It is thought that this complex is also the CDK 
Activating Kinase, but evidence from homologues of lower eukaryotes is contradictory. 
The CDK7 homologue of S.pombe (crkl or mopl) can act as CAK in vitro, and is 
essential with mutant cells arresting in late M phase (Damagnez et al., 1995). The 
homologue in S. cerevisiae (KIN28) is part of the TFIIH complex and necessary for 
transcription but shows no CAK activity (Cismowski etal., 1995). The CAK purified 
from budding yeast is encoded by a seperate gene, CAK1, with low homology to CDK7 
(Kaldis etal., 1996; Espinoza etal., 1996). The CAK1 protein is essential with a G2 
arrest in mutant cells. All of the CDK7 and CAK kinases show no variation in activity 
through the cell cycle.
The CDK kinase subunit that binds Cyclin C in higher eukaryotes has been 
identified (CDK8) and this complex has been shown to be part of the RNA polymerase 
II holoenzyme (Tassan etal., 1995). These proteins are homologous to the SRB10 and 
SRB11 proteins in S. cerevisiae which are also part of the RNA Polymerase II 
holoenzyme (Liao etal., 1995), which interacts with the TFIIH complex during 
transcriptional initiation. No cell cycle controlling role has so far been shown for the 
CDK8/Cyclin C complex, although the RNA polymerase II holoenzyme has also been 
implicated in DNA damage recognition/repair, possibly suggesting a role of these 
kinase complexes in cell cycle checkpoint control.
Microtubules have been shown to be involved in the cell cycle, and to possibly
interact with B type cyclins in S.pombe. In fission yeast mutations in both alpha and
beta tubulin genes can result in lethally abnormal mitochondrial distribution, showing a
link between microtubules and mitochondrial movement (Yaffe etal., 1996). A cdclO
null mutant of S.pombe that causes Gl arrest can be suppressed by an uncharacterised
mutation in a transcription factor (sctl) which causes low levels of cells to show
aberrant cytoskeletal and nuclear DNA morphologies. The DNA sometimes appeared
fragmented, the nuclei were occasionally displaced and binuclear cells were seen. Both
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microtubular and microfilament perturbations were seen in the mutants (Marks etal.,
1992). The S.pombe sspl protein kinase gene mutants show a cell cycle arrest in G2 
with altered actin deposition patterns. This is accompanied by a failure to correctly 
regulate the growth polarity of the cells (Matsusaka etal., 1995).
Protein phosphatases have also been shown to be involved in cell 
morphogenesis in eukaryotes. Mutations of PP2A subunits in S. cerevisiae cause cells 
to become multibudded and multinucleated (Van Zyl etal., 1992). S.pombe mutants 
result in aberrant cytoskeletal organisation and a block in cytokinesis (Kinoshita etal., 
1996). Similar mutations in Drosophila melanogaster cause mitotic arrest, a lack of 
microtubule organisation and the uncoupling of the nuclear and centrosome cell cycles 
in the embryo (Snaith etal., 1996).
1.4.2 Trypanosoma brucei, the cytoskeleton and the cell cycle.
A putative RNA polymerase II promoter region has now been isolated from the 
T. brucei hsp70 locus (Lee, 1996). This region directs transcription of heterologous 
genes, but does not result in an upregulation of the level of mRNA under heat stress, 
once again suggesting that the major control of mRNA levels is post-transcriptional.
The microtubule cytoskeleton of T. brucei has been shown by a variety of 
methods to be highly polarised with the positive ends of the microtubules at the 
posterior end of the cell (Robinson etal., 1995). Other work has shown that the sub- 
pellicular array grows by the insertion of new microtubules into the array 
predominantly in the posterior region of the cell (Sherwin and Gull, 1989). The 
movement of the kinetoplast during the differentiation between short stumpy and 
procyclic forms is microtubule mediated, just as the division and movement of the 
organelle is during the cell cycle (Matthews etal., 1995).
Treatment of procyclic T. brucei cultures with the protein phosphatases inhibitor
okadaic acid has indicated a role for PP1/PP2A proteins in the coordination of DNA
synthesis, mitosis, organellar rearrangement and cytokinesis (Das etal., 1994). The
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cells treated with okadaic acid became multinucleate, but while they replicated the 
kinetoplast DNA they neither divided the organelle nor underwent cytokinesis.
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CHAPTER TWO 
MATERIALS AND METHODS
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2.1 Buffers/Media/Stock solutions
Alkaline lysis buffers
Solution I 50 mM Glucose, 25 mM Tris-HCl (pH 8.0), 10 mM EDTA
(pH 8.0).
Solution II 0.2 M NaOH, 1 % SDS.
Solution III 6 ml 5 M K acetate, 1.15 ml glacial acetic acid, 2.85 ml dH20.
Antibiotics
Ampicillin Stock ( lOOOx) 50 mg / ml in dH20
Tetracyclin Stock ( lOOOx) 5 mg / ml in 50 % ethanol
Phleomycin Stock 20 mg / ml in dH20
G418 Stock 10 mg / ml in dH20
Blot electrode buffer 3.25 g Tris HC1, 14.4 g Glycine, 200 ml Methanol, made up to 1
litre with dH20.
Denaturation solution 0.5 M NaOH, 1.5 M NaCl.
50xDenhardts 10 g Ficoll, 10 g polyvinylpyrrolidine, 10 g BSA, made up to 1
litre with dH20.
EDTA A 0.5 M solution was made up in dH20 and adjusted to pH 8.0
with 10 M NaOH.
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5 x Final Sample Buffer (5 x FSB) 1.25 ml 0.5 M Tris-HCl, pH 6.8, 1.0 ml Glycerol,
2.0 ml 10 % (w/v) SDS, 0.5 ml 2-Beta 
mercaptoethanol, 0.25 ml 0.05 % (w/v) 
Bromophenol blue, 5.0 ml dH20
Hybridisation buffer 6 x SSC, 5 x Denhardt’s reagent, 0.5 % SDS, 100
pig / ml denatured fragmented salmon sperm DNA
Kinase Assay Buffer (KAB) 50 mM MOPS pH 7.2, 20 mM MgCh, 2 mM
DTT, 10 mM EGTA
Kinase Assay Mix (KAM) (per 200 pi\) 5pi\ 10 mg / ml Histone HI
1 pi 1 gamma 32P rATP
8 pi\ 100/<M rATP 
186 pi 1 KAB
L broth 10 g Tryptone, 5 g yeast extract, 5 g NaCl, made up to 1 litre with dH20,
adjusted to pH 7.0 with 10M NaOH.
LB agar As LB broth plus 15 g of agar/litre.
5 x Loading Buffer (5 x LB) 0.25 % Bromophenol blue, 0.25 % Xylene cyanol FF,
10 mM EDTA (pH 8.0), 15 % Ficoll.
Lysis Solution (LS) 50 mM MOPS (NaOH to pH 7.2), 100 mM NaCl, 1 mM EDTA,
1 mMEGTA, 1 mM N aV 03, 10 mM NaF, 1 % Triton X-100.
Lysis Solution with Inhibitors (LSI) per 10 ml.
9.75 ml Lysis solution 
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50 ja \ 200 mM 1,10 Phenanthroline (in 50 % ethanol)
50 pi\ 1 mg / ml Pepstatin A (in 100 % methanol)
100pi\ 10 mg / ml leupeptin (in dH20)
50 pi\ 10 mg / ml PMSF (in 100% ethanol)
MB medium 0.5 g KH2PO4, 0.36 g K acetate, 0.5 g MgS04.7H20,0.1 g NaCl, 0.1 g 
CaCk.2H20,5 g (NH4)2S04,500pig H3BO4, 40pig CuS04.5H20 , 100 
pig KI, 200 pig FeCb.6H20,400 pig MnS04.H20,200 pig Na 
molybynate, 400pig ZnS04.7Fk0,5 g glucose, 10 pig biotin, 1 mg Ca 
pantothenate, 10 mg nicotinic acid, 10 mg inositol. Make up to 1 litre 
with dFkO and filter sterilise. Add leucine to 150 pig / ml for the culture 
of leu- strains.
10 x MMA 10 g KH2PO4, 5 g MgS04.7FkO, 1 g NaCl, 1 g CaCk.2H20,50 g 
(NH4)2SC>4, 5 mg H3BO4, 400pig CUSO4.5H2O, 1 mg KI, 2 mg 
FeCl3.6H20,4 mg MnSCXFkO, 2 mg Na molybynate, 4 mg 
ZnS04.7H20,100 g glucose, 100 pig biotin, 10 mg Ca pantothenate,
100 mg nicotinic acid, 100 mg inositol. Make up to 1 litre with dFkO 
and filter sterilise. For plates, add 1/10 volume to agar autoclaved in 
9/10 dFkO. Final agar concentration 2 %.
Neutralisation solution 1.5 M NaCl, 0.5 M Tris.HCl (pH 7.4).
Phosphate buffered saline (PBS) 8 g NaCl, 0.2 g KC1, 1.44 g Na2HP04, 0.24 g
K H 2 P O 4 ,  adjust to pH 7.4, add dH20to 1 litre.
5 x SDS-PAGE Running Buffer 15 g Tris base, 72 g Glycine, 5 g SDS, made up to
1 litre with dH20.
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SM buffer 5.8 g NaCl, 2 g MgS04.7H20 , 50 ml 1 M Tris.HCl (pH 7.5), 5 ml 2 % 
gelatin solution, made up to 1 litre with dH20.
20 x SSC 175.3 g NaCl, 88.2 g Sodium citrate, made up to 1 litre with dH20.
50 x TAE 242 g Tris base, 57.1 ml glacial acid, 100 ml 0.5 M EDTA (pH 8.0), 
made up to 1 litre with dH20.
5 x TBE 54 g Tris base, 27.5 g boric acid, 20 ml 0.5 M EDTA (pH 8.0),
made up to 1 litre with dH20.
TBS-Tween 8 g NaCl, 0.2 g KC1, 3 g Tris base, 0.5 ml Tween-20, adjust to pH 7.4, 
add dH20to 1 litre.
TE 10 mM Tris-HCl (pH 8.0), 1 mM EDTA (pH 8.0).
l/2YEL+leu 0.25 % yeast extract, 1.5 % glucose, 30 pig / ml leucine.
2 x YT broth 10 g Tryptone, 10 g yeast extract, 5 g NaCl, made up to 1 litre with 
dH20.
ZPFM 7.71 g NaCl, 0.60 g KC1, 1.14 g Na2HP04 (anhydrous), 0.20 g KH2PO4
(anhydrous), 0.20 g Mg acetate.4H20,16 mg Ca acetate, made up to 1 
litre with dH20.
2.2 General Methods
2.2.1 DNA protocols
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2.2.1.1 Restriction Enzyme digestion of plasmid and lambda DNA.
Typically 0.5-2 pig of DNA were digested in 20 pi\ containing the recommended 
enzyme buffer and 5-10 Units of enzyme. After 1 hour at the appropriate temperature 
the incubations were placed on ice and 5 pi\ of 5 x Loading Buffer (5 x LB) were added. 
For sequential digests the first R.E. was either heat inactivated or removed by Magic 
DNA Cleanup Columns (Promega) before the second digestion. For transfection of 
trypanosomes, 25-50 pig of plasmid DNA were digested in 100-200 pi\ using 30-50 U of 
each enzyme. The digests were incubated for 3-5 hours before gel electrophoresis and 
band extraction.
2.2.1.2 Agarose Gel Electrophoresis.
0.7-2 % gels were used for separating plasmid and PCR derived DNA 
depending on the size of the expected fragments. The gels were normally run in 1 x 
TBE at 100-150 Volts and contained 0.1 pig I ml of Ethidium Bromide. LMP agarose 
gels were run in 1 x TAE at 50 V.
Digests of genomic DNA were run on a 300 ml, 0.7 %, 1 x TBE gel without 
Ethidium Bromide at 50 V overnight. The gel was then stained in 1 x TBE containing 1 
pig I ml Ethidium Bromide for 30 minutes and destained in dFLO for 30 minutes. The 
DNA was visualised by UV illumination.
2.2.1.3 Extraction of DNA from Agarose.
The bands of interest were cut from agarose gels under UV illumination with a 
sterile scalpel blade. To extract the DNA, three methods were employed during the 
Ph.D.:
(1) Low melting point agarose in 1 x TAE was initially used at the start of the
Ph.D.
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(2) Geneclean (BIO 101 inc.) was later used to extract DNA from high 
percentage 1 x TBE gels (using the TBE modifier supplied) when the fragments were 
smaller than 500 bp.
(3) Spin-X columns (Sigma). Used for 1 x TAE gels and fragments larger than 
500 bp. The tube containing the agarose slice was frozen at -20 °C before being 
centrifuged at maximum speed in a microfuge for 15 minutes.
2.2.1.4 Labelling of DNA fragments by random priming.
25 ng of gel purified DNA were labelled using the Prim-it kit (Stratagene), with 
50 pi Ci of Super 32P-dCTP. The unincorporated label was removed using Nuctrap 
columns (Stratagene). Before hybridisation the probe was denatured by boiling for 5 
minutes, then spun down and kept on ice before adding to the hybridisation tube.
2.2.1.5 Southern Blotting and Hybridisation.
Agarose gels containing digested lambda or genomic DNA were treated with 0.2 
M HC1 for 15 minutes to ensure transfer of the larger fragments. The gels were then 
rinsed with dH20 and placed in denaturing solution for at least 30 minutes. The DNA 
was then transferred onto Hybaid Nylon membrane by capillary transfer overnight, the 
blotting buffer being alkali transfer buffer. Gels only containing plasmid DNA smaller 
than 7 kb were not treated with HC1. After transfer the positions of the wells were 
marked with pencil, and the membranes washed with 2 x SSC. The DNA was fixed by 
baking the filters at 80 °C for 2 hours.
The membranes were pre-hybridised in 20 ml of hybridisation buffer containing
100 pig / ml of denatured herring sperm DNA at the hybridisation temperature. 15 ml of
buffer were then removed and the probe added. Hybridisation took place overnight,
usually at 65 °C. In the morning the membranes were washed in 0.1 x SSC, 0.1 % SDS
at 65 °C for lhour, with 3 changes of wash buffer. The membranes were either sealed
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in a plastic bag or wrapped in clingfilm before exposure to X-ray film at -70 °C in 
cassettes with enhancer screens.
2.2.1.6 PCR from genomic DNA.
PCR with degenerate oligonucleotides was performed on purified genomic 
DNA from T. brucei and L. mexicana. The 'touchdown' method was employed, where 
the starting annealing temperature is high, and then the temperature is lowered very few 
cycles before the major amplification cycles (Don etal., 1991). Typically the 
conditions were:
Step 1 94 °C for 5 min (initial denaturation)
Step 2 60 °C for 30 sec 5 /d  of each primer (20 pM stock)
Step 3 72 °C for lmin 5 /d  of 2 mM dNTPs
Step4 94 °C for 30 sec 5 /d  of 10 x Taq buffer
(repeat steps 2-4 for 3 cycles) 0.5//I of Taq DNA polymerase (5 U / /d)
Then continue to cycle, and drop the 0.5 pi 1 of template
annealing temperature by 2 °C every dH20 to 50 /d
third cycle until theannealing temperature
gets to 48 °C. Then;
15 cycles with annealing for 30 sec at 48 °C. Then;
48 °C annealing for 2 min 
72 °C for 10 min.
10] i\  of the reactions were added to 3 /d  of 5 x LB and run on agarose gels. Blunt end 
cloning was performed when the oligonucleotides had no R.E. site engineered in.
These oligonucleotides had been kinased and the PCR fragments generated could 
therefore be ligated into Smal cut and CIPed pBluescript.
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2.2.1.7 Preparation of Vector DNA for ligations.
20pig of DNA were digested in 100 pi 1 total volume in the appropriate 
restriction buffer. After digestion 5 Units of Calf Intestinal Phosphatase (CIP) were 
added to the tube and incubated at 37 °C for 15 minutes. The CIP was then heat 
inactivated at 65 °C for 15 minutes. The DNA was EtOH precipitated, dried and 
resuspended in 10 //I of TE. 1 pi\ was used in each ligation.
2.2.1.8 Ligations.
When the insert DNA was in LMP agarose, lpi\ of vector DNA was added to 4 
]A of 5 x Ligation buffer, 1 pi\ of T4 DNA ligase and 4 pi\ of dTLO. The agarose with 
insert was melted at 65 °C and \0pi\ added to the ligation mix. This was left at 4 °C 
overnight, and 5 pi\ used for each transfection.
When the insert had been purified by other means, 1 pi \ of vector DNA was 
added to enough insert DNA to give a ratio of approximately 1 vector:3 insert free 
sticky ends. The mixture was ethanol precipitated and resuspended in 7.5pi\ of dTLO. 
2 /d  of 5 x Ligation buffer and 0.5pi\ of T4 DNA ligase were added. The ligation was 
left at r.t. for at least 3 hours, or overnight at 4 °C, before using 2 pi\ for each 
transfection.
When the fragments were blunt ended the ratio of vector to insert ends was 
raised to 1:10, or higher, and 1 pi\ of T4 DNA ligase was used in the 10pi \ reaction.
2.2.1.9 Cloning tbcrkl/2/3 into expression vectors by PCR.
Oligonucleotides were designed to anneal to the 5' and 3' extremities of the 
respective gene. The oligos included an adaptor sequence of a restriction enzyme site 
that would allow the cloning of the PCR product into the correct frame of the
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expression vector. Pfu DNA polymerase was used due to its much reduced mutation 
rate, instead of Taq DNA polymerase . The PCR conditions were:
Step 1 94 °C for 5 min
Step 2 60 °C for 30 sec
Step 3 72 °C for 1 min 30 secs
Step 4 94 °C for 30 sec
(repeat Steps 2-4 for 30 cycles)
Step 5 60 °C for 30 sec
Step 6 72 °C for 10 min
(initial denaturation)
5 /d  of each oligo (20 pM stock)
5 /d  of 2 mM dNTPs
5 /d  of 10 x Pfu buffer
0.5 /d  of Pfu DNA polymerase (5 U //d)
dl-hO to 50 /d
After 5 /d  of the reactions were run on a 1 % agarose gel to check the product the rest 
of the amplified product was purified using Magic PCR cleanup columns (Promega). 
The DNA was then digested with the appropriate enzymes, and gel purified. After 
extraction, this DNA was used for ligations.
2.2.1.10 Sequencing of Plasmid DNA.
5-10 ]Ag of plasmid DNA were used to obtain double stranded sequence using a 
rapid NaOH denaturing protocol (Hsiao 1991). The Sequenase Version 2.0 (United 
States Biochemical Corporation) kit was used with dITP buffers used for resolving 
compressions.
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Table 2.2.1.1 Plasmids used during this thesis.
Name
pBluescript II 
pMNS21L
pMNS/Hscdc2+
pMNS/Hscdc2-
pSpcdc2
pBle
pNT
Use and/or insert Source
E. coli cloning vector. Stratagene
Regulatable S.pombe expression vector. J. Kinnaird,
WUMP.
pMNS21L with the human cdc2 ORF J. Kinnaird,
in the correct orientation. WUMP.
pMNS21L with the human cdc2 ORF J. Kinnaird,
in the reverse orientation. WUMP.
Non-regulated S. pombe expression vector . J. Kinnaird,
with wild type S. pombe cdc2 insert. WUMP.
pUC18 with the T. brucei PARP promoter/ S. Graham,
ble resistance gene/PARP 3 ’ untranslated WUMP.
region insert.
pUC8 with PARP promoter/weo resistance gene/ D. Jeffries,
T. brucei tubulin 3 ’ untranslated region insert. WUMP.
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Table 2.2.1.2 Oligonucleotides used during this thesis.
degenerate 5 ’ cyclin PCR primer 
degenerate 3 ’ cyclin PCR primer 
degenerate 3 ’ cyclin PCR primer 
degenerate 5 ’ cyclin PCR primer 
degenerate 3 ’ cyclin PCR primer 
tbcrk.3 sequencing. 
tbcrkS sequencing. 
tbmefg sequencing. 
tbmefg sequencing. 
tbmefg sequencing. 
tbmefg sequencing. 
tbmefg sequencing. 
tbmefg sequencing. 
tbcrk3 /H PCR 5’ primer. 
tbcrk3 /H PCR 3 ’ primer. 
tbcrk3 /H (-5’ext) PCR 5’ primer. 
tbcrkl /H PCR 5’ primer. 
tbcrkl /H PCR 3 ’ primer. 
tbcrkl /H PCR 5 ’ primer. 
tbcrkl /H PCR 3 ’ primer. 
tbcrkl/H (-5’ext) PCR 5’ primer. 
tbcrkl 5 ’ PCR primer for the yeast 
expression vector pMNS21L. 
tbcrk3 3 ’ PCR primer for the yeast 
expression vector pMNS21L. 
tbmefg 5 ’ PCR primer for His-tagged 
Integration Vector fragment. 
tbmefg 3 ’ PCR primer for His-tagged 
Integration Vector fragment.
Degeneracy codes used: B - C, G and T; D - A, G and T; K - G and T; N - A, C, G and 
T; R - A and G; S - C and G; Y - C and T.
The underlined bases are engineered restriction enzyme sites, and may not be identical 
to the sequence used as template in the PCR reaction.
ATG CGS GCS ATY YTS ATY GAC TGG
SGG SGG CTA CAT CTC CTC GTA CTT
AK CTC CAT SAR GTA CTT SGC
C GGATCC GCN DSN AAR TAY GAR GAR
C GAA TTC YTC NAB NAR RTA YTT NGC
GAA GTT ATG GGT GTC TCC
CCA TCT AAA ATC TGA TTG
CAC AGT GCA AAT GGG GTG
GCT TGG GGG TGA ATG CCG
GTT CTT GTA GGC TGA ACC
TAC CTA TTT TAC TGT GCC
AGG GTT AGC ATT GTC ACG
GCG ATT CGG CGC ACC ACG
GA GGATCC ATG ACA ATG CTT GGG GCG
GC AGA TCT AAA CAT GGC ATC ACT AAA
AT CCC ATG GAC CGC TAT AAT CGA ATG
G CCC ATG GGG AGT CGT TAC GAG C
CGC GGATCC GAA CTC GAC AGA AAA GTA T
G CCC ATG GAG GTG CAG GTG CAG GAA GG
CG CAG ATC TAG CTC CGT TGA ACC GCA TC
CC ACC ATG GAC CGG TAT AGC CGA ATA
GA CAT ATG ACA ATG CTT GGG
TG GGATCC GAT CTA AAA CAT GGC ATC
CG GGT ACC GTG TTG GAA TAC A AC CG
CC GAG CTC TGA TCC CCC TTT AAC
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2.2.2 Protein protocols.
2.2.2.1 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE).
Protein samples were separated by SDS-PAGE, using the discontinuous gel 
method (Laemmli, 1970).
Separating gel - 0.375 M Tris-HCl, pH 8.8.
Stacking gel - 0.125 M Tris-HCl, pH 6.8,4.0 % acrylamide.
Depending on the size range needing separation, 12 to 17.5 % acrylamide separating 
gels were used. Most gels were run using minigel kits as per the protocol (Biorad).
The gels were either stained using Coomassie R250 brilliant blue, or electroblotted for 
Westerns.
For staining, the gels were placed in dH20 containing 30 % methanol, 10 % 
glacial acetic acid and 0.1 % Coomassie R-250 brilliant blue for 30 minutes.
Destaining took approximately 2 hours in frequent changes of dH20 containing 30 % 
methanol and 10 % glacial acetic acid. The gels were then left in dH20 overnight 
before being transferred to 3MM paper and dried down at 80 °C under vacuum for 45 
minutes.
2.22.2 Western Blotting.
The Western blots described in this thesis were predominantly performed using
PVDF membrane (Bio-Rad) used as per the protocols given. Proteins from unstained
gels were transferred to the membrane in Blot Electrode Buffer, either at 0.2 Amperes
for 2 hours in the cold room, or at 0.1 A overnight on the bench. The PVDF was
allowed to dry to fix the protein. Often the bound protein could be visualised as
translucent areas of the membrane using a lightbox, allowing the markers to be labelled
with a pencil and the membrane to be cut up with a scalpel blade without staining of the
membrane. If necessary the membrane was moistened with 100 % ethanol and
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Ponceau-S stained (Sigma) to allow detection of the protein. The blot was then rinsed 
with Tris Buffered Saline containing 0.05 % Tween-20 (TBS-Tween). The ECL 
Western blotting protocol (Amersham) was followed, except that the blocking solution 
contained 10 % Horse Serum as well as 5 % Marvel powder. Primary antibody 
dilutions varied, and are detailed in the respective figure legends. Preabsorbtion of 
oligopeptides to the primary antiserum was performed by incubating the antiserum with 
1 ]i% / ml of the oligopeptide in the blocking solution at r.t. for 2 hours before it was 
applied to the membrane. The secondary antibodies were used at a dilution of 1:2500.
2.2.23 Purification of p l3 sucl and formation of p l3 sucl beads.
2.5 mg of semi-purified p l3 sucl protein expressed in E. coli was further purified 
by anion exchange on a HPLC column (See Chapter 5.4.2). Fractions were run on 17.5 
% SDS-PAGE and stained with Coomassie R250 brilliant blue to assess the level of 
purity. Several fractions were pooled and dialysed into phosphate buffer overnight at 4 
°C. These fractions contained a total of 1.5 mg of protein according to O.D. 280 readings 
and Bradford assays. This protein was linked to 0.5 ml of Aminolink™ beads (Pierce) 
as per the protocol. Control beads were prepared in parallel with the p l3 sucl beads by 
blocking the reactive sites of 2 ml of the Aminolink beads with 1.0 M Tris-HCl, pH 7.4.
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2.3 Protocols for E. coli.
2.3.1 General protocols (Ec).
2.3.1.1 Bacterial strains used during this thesis.
Strain Genotype Source
XLl-Blue RecAl endAl gyrA96 thi-1 hsdR17 supE44 relAl Stratagene
2.3.1.2 Transformation of E. coll
Competent E. coli were prepared using the Calcium Chloride procedure 
(Sambrook etal., 1989). For storage 100/d  aliquots had sterile glycerol added to 15 % 
and were then frozen in an ethanol/dry ice bath before storage at -70 °C in screw top
1.5 ml eppendorf tubes. 10 /d  of ligations in LMP agarose, 2 /d  of other ligations, or 1 
/d of 1 pig / ml super coiled plasmid were added for the transformation. After the heat 
shock (1 minute at 42 °C), 1 ml of 2 x YT was added to each tube and the bacteria 
allowed to recover at 37 °C for 45 minutes before plating onto selective media. For 
blue/white selection 20/d  of 0.5 MIPTG and 50 //I of 50 mg / ml X-Gal were spread 
onto the 90 mm diameter agar plates and allowed to dry before spreading the 
transformed bacteria. The plates were incubated at 37 °C for 12-16 hours (typically 
overnight).
lac[F ’ proAB lacHZAM15Tn70(Tetr)] 
LE392 el4  (McrA-) hsdR514 supE44 supF58 lacYl
galK2 galT22 metBl trpR55
J. Mottram,
WUMP.
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2.3.1.3 Screening libraries.
For screening on circular 87 mm plates, titrations of lambda in SM buffer were 
added to 100 ja \ of an overnight culture of LE392 that had been centrifuged and 
resuspended in l/10th volume of 10 mM MgSCU. These were incubated for 20 minutes 
at r.t. to allow preabsorbtion of the phage to the cells. The cells were then added to 3 
ml of top LB agar that had been cooled to 45 °C and then plated onto LB bottom agar, 
and incubated overnight at 37 °C.
Plaques were transferred to Hybond-N nitrocellulose filters for 2 minutes. The 
filter and agar were pierced with an ink filled syringe needle to enable the duplicate 
filter to be aligned and the autoradiograph orientation to be worked out. The duplicate 
filter transfer lasted 4 minutes. After transfer the filters were placed in denaturing 
solution for 2 minutes, neutralising solution for 2 minutes, and washed in 2 x SSC for 1 
minute before baking at 80 °C for 2 hours. The plates were sealed with parafilm and 
stored at 4 °C.
Hybridisation was performed as for Southern blots. Positive plaques were 
removed from the plate by pipetting the agar into a 1 ml pipette tip that had had the end 
removed with a scalpel blade. This was then placed into 1 ml of SM buffer and briefly 
vortexed to help release the phage particles. 50pi \ of chloroform was then added to 
suppress bacterial growth and the phage stored at 4 °C.
2.3.1.4 Stabilate formation.
E. coli strains were grown overnight at 37 °C in 2 x YT. 0.75 ml of the culture was 
added to 0.75 ml of 30 % glycerol, mixed by pipetting and stored at -70 °C.
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2.3.2 DNA protocols (Ec)
2.3.2.1 Plasmid Preparation.
Single colonies of E. coli were picked with a sterile toothpick, and grown 
overnight in 2 ml of 2 x YT medium at 37 °C with constant shaking. Alkaline lysis 
minipreps of 1.5 ml of culture were used for screening ligations (Sambrook etal.,
1989). The protocol was followed up to the neutralisation step (addition of potassium 
acetate). An equal volume of chloroform was then added to the tube, shaken 
vigourously by hand, centrifuged at full speed in a microfuge for 5 minutes, and the 
aqueous phase transfered to a clean tube and precipitated with 0.7 volumes of iso­
propanol (propan-2-ol). After washing the pellet with 70 % ethanol and drying, the 
DNA was typically resuspended in 30 /d  of TE. Plasmid DNA was extracted from 3 ml 
of a 5 ml 2 x YT overnight culture using Magic or Qiagen Minipreps for subcloning, 
sequencing and labelling (Promega and Qiagen respectively).
For Eukaryotic transfections DNA was extracted from 30 ml of a 2 x YT culture 
grown overnight from a single colony, using Qiagen Midiprep columns (Qiagen).
2.3.2.2 Lambda DNA preparation.
The lambda plaque was placed in 1 ml of SM buffer with 50 /d  of chloroform, 
briefly vortexed, and left at 4 °C overnight. 0.5 ml of this buffer was added to 20 ml of 
LB media containing 10 mM MgCh 10/d  of an overnight culture of LE392 that had 
been centrifuged and resuspended in 1/10th volume of 10 mM MgSCU were added and 
the tubes incubated at 37 °C overnight with shaking. At the same time a 40 ml 
overnight culture of uninfected LE392 was set up from a single colony.
The next morning the lambda culture was cleared by centrifugation at 11 000 g 
for 5 minutes. The supernatant was added to 140 ml of LB media plus 10 mM MgCh 
and the 40 ml overnight culture of LE392. This was grown at 37 °C with shaking for 6
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hours or until the culture cleared. DNAse I and RNAse A were added to 1 pig I ml and 
left at r.t. for 30 minutes. The culture was centrifuged at 11 000 g for 10 minutes at 4 
°C and the supernatant decanted into a new flask. Solid NaCl was added to 1 M and 
PEG 6000 to 10 % (w/v). This was allowed to dissolve slowly at r.t. and the solution 
then left at 4 °C overnight.
The tube was then centrifuged at 11 000 g for 10 minutes at 4 °C and the pellet 
resuspended in 3.2 ml of SM buffer. An equal volume of chloroform was added, the 
solutions mixed and spun at 1 600 g for 15 minutes. The aqueous phase was removed 
to another tube, avoiding disturbing the interface, and the extraction repeated. This was 
repeated until there was no white material at the interface. Then EDTA was added to 
20 mM, Proteinase K to 50 pig / ml and SDS to 0.5 %. This was incubated at 65 °C for 
1 hour. The solution was then extracted twice with phenol/chloroform, once with 
chloroform, and the DNA precipitated with ethanol/ammonium acetate at -20 °C. The 
DNA was washed with 70 % ethanol, dried and resuspended in TE buffer.
2.3.2.3 PCR screening of transfectants.
A numbered bacterial colony was touched with a sterile toothpick. This was 
then dipped into 20 pi \ of dPhO in a 0.5 ml eppendorf tube. The tubes were boiled for 5 
minutes, spun briefly in a microfuge and placed on ice. The rest of the PCR ingredients 
were added to a final volume of 50 pi\ and overlaid with mineral oil. The PCR 
conditions were generally:
Step 1 94 °C for 5 min (initial denaturation)
Step 2 55 °C for 30 sec 5 /d  of each oligo (20 pM stock)
Step 3 72 °C fo ri min
Step 4 94 °C for 30 sec
(repeat Steps 2-4 for 30 cycles) 
Step 5 55 °C for 30 sec
5/<l of 2 mM dNTPs
5 /d  of lOxTaq buffer
0.5/d  of Taq DNA polymerase (5 U //d)
dH2Oto50 /d
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Step 6 72 °C for 10 min
10/d  of each reaction was added to 3 pi\ of 5 x LB and run on an applicable percentage 
agarose gel.
2.3.3 Protein protocols (Ec)
2.3.3.1 Purification of poly Histidine-tagged fusion proteins.
For screening transformants, the rapid screening of small scale expression 
cultures protocol was used (Qiagen). Large scale preparation of denatured His-tagged 
protein used a scaled up version of this method. The 10 ml overnight culture was added 
to 90 ml of fresh 2 x YT, grown at 37 °C with shaking. After 1 hour IPTG was added 
to a final concentration of 0.2 pig / ml. After a further 3 hours the cells were spun 
down, the supernatant removed, and the cell pellet kept at -20 °C until the protein 
purification. The 1.5 ml of Ni2+/agarose used per purification was contained in a 
column for the large scale purification of the TbCRK3/H protein. The bound protein 
was eluted by lowering the pH of the urea buffer, instead of using EDTA addition to 
elute the protein as in the small scale screening protocol.
Native purification of His-tagged protein was as per the Qiagen protocol for 
cytoplasmic location, with imidazole washes and elution at varying concentrations 
depending on the experiment.
2.4 S.pombe protocols.
2.4.1 Transfection of S. pombe.
The lithium acetate procedure was used for yeast transfection. A 150 ml culture
of the starting strain was grown at 25 °C in MB medium with constant shaking to a
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concentration of ~ lx l0 7 cells / ml. The cells were pelleted at 3000 rpm for 5 minutes, 
washed with 50 ml of dl-teO and re-pelleted. The cells were resuspended at lxlO9 cells
1 ml in lithium acetate (pH 4.9), aliquoted into microcentrifuge tubes (100ji\ / tube) and 
incubated at 25°C for 90 minutes. 15 pt\ of TE containing 1 pig of plasmid DNA was 
added and the tubes gently vortexed to mix, not allowing the tubes to cool down. 290 
y\ of prewarmed (25 °C) 50 % PEG-4000 was added, mixed by gentle vortexing and 
incubated at 25 °C for 1 hour. The cells were heatshocked at 43 °C for 15 minutes, 
then allowed to cool to r.t. for 10 minutes. The tubes were centrifuged at 5000 rpm for
2 minutes and the supernatant removed. The pellet was resuspended in 1 ml of 
l/2YEL+leu by repeated pipetting, transfered to a 50 ml flask containing 9 ml of 
l/2YEL+leu and incubated at 25 °C with shaking for 1 hour to allow recovery. 100 pi\ 
of this was spread on MMA plates, with and without thiamine.
2.4.2 Preparation of S.pombe protein extracts.
10 ml of yeast culture was grown to a density of approximately 5x10 6 cells / ml 
in minimal medium ( O . D . 5 9 5  = ~0.25). The culture was then spun down by gentle 
centrifugation, washed with 1 ml of ice cold stop buffer (150 mM NaCl, 50 mM NaF, 
10 mM EDTA, 1 mM NaN3, pH 8.0), and re-centrifuged and left to drain. The cell 
pellet was resuspended in 4 jt\ of RIPA buffer (10 mM sodium phosphate pH 7.0, 1 % 
Triton X -100,0.1 % SDS, 2 mM EDTA, 150 mM NaCl, 50 mM NaF, 0.1 m M NaV03, 
4//g / ml leupeptin, 1 mM PMSF). 0.5 ml of acid washed glass beads (0.5 mm 
diameter, Sigma) were added and the tube vortexed for 1 minute. 20 pi\ of 1 % SDS 
was added and the tube boiled for 3 minutes. 200 p \  of 2 x FSB was then added before 
a further 5 minutes of boiling. The extract was then centrifuged at 4 °C in a microfuge 
for 15 minutes at maximum speed and the supernatant removed to another tube. 15 ja \ 
of the extract was used in each lane for Western blotting.
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2.5 T. brucei protocols.
2.5.1 General protocols (Tb)
2.5.1.1 T. brucei strains used.
The procyclic cultures used for DNA extraction, protein extracts and the 
creation of mutants was from the STIB247 strain, as were the mixed bloodstream forms 
and the short stumpy forms. The monomorphic long slender line used was IstatC123.
2.5.1.2 The growth of procyclic form T. brucei.
The procyclic form T. brucei were cultured at 28 °C in 5 ml cultures of SDM-79 
medium (Brun and Schonenberger, 1979) + 10 % fetal calf serum (FCS), passaged 
approximately every third day to a concentration of 0.5 x 106 cells / ml. Antibiotics 
were added to the flasks where selection was desired.
2.5.1.3 Preparation of T. brucei for microscopic examination.
10-25 ]i \ of log phase procyclic form T. brucei were spread across each slide. Low 
density cultures, such as the putative tbcrk3 null mutants, first had 0.5 ml spun down in 
a microfuge at 1 OOOrpm for 5 minutes. 475 ja \ of the supernatant was removed and the 
pellet gently resuspended. This was then spread onto the slide. The slides were air 
dried in a tissue culture hood before the cells were fixed in 100 % methanol for 1 
minute. The slides were then washed with PBS for 2 minutes and then rinsed with 
dFhO before air drying again. The cells were stained with 1 pig / ml DAPI for 5 
minutes before washing with PBS and mounting.
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2.5.1.4 Formation of T. brucei stabilates.
Stabilates were made by centrifugation of 5 ml of a mid log-phase culture, 
resuspension in 1 ml of SDM-79 (without FCS), and addition of 0.5 ml of 22.5 % 
glycerol. The samples were transfered to cryotubes and frozen surrounded by cotton 
wool in a expanded polystyrene box in a -80 °C freezer overnight, and then storage in 
liquid nitrogen.
2.5.2 DNA protocols (Tb).
2.5.2.1 Trypanosome Genomic DNA Preparation.
High molecular weight DNA was prepared from pellets of procyclic T. brucei 
kept at -70 °C, or freshly spun down cultures of procyclic T. brucei, using the Nucleon 
reagents (Scotlab). Typically, 5 x 10^ cells were used per extraction. The protocol was 
followed precisely, without the RNAse step, with the DNA being recovered from the 
ethanol precipitation step by spooling with a closed glass pipette. A 1/100 dilution was 
assayed by a spectrometer at 260 nm and 280 nm to assess the concentration and purity 
of the samples. All manipulations of the genomic DNA were performed with cut down 
tips.
2.5.2.2 Restriction Enzyme digestion of Genomic DNA.
3-6 yig of T.brucei DNA were digested per lane in 3 0 //I total volume. For each 
lane, 10 U of enzyme were added at the start of the digest and the mixture gently 
stirred. After 1.5 hours at 37 °C 10 more Units of enzyme were added and mixed 
carefully. After another 1.5 hours 10 pi\ of 5 x LB were added, and 40 pt\ loaded onto 
the agarose gel using cut off pipette tips.
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10pig of Human high molecular weight DNA were digested per lane in a total 
volume of 100 pi\. As above, 10 U of enzyme were added at 0 hours and 1.5 hours into 
a 3 hour incubation. The DNA was then precipitated with ethanol, and gently 
resuspended in 30 pi\ of TE. 10 //I of 5 x LB were added, and 40 pi\ loaded onto the 
agarose gel using cut off pipette tips.
2.5.2.3 Transfection of Procyclic T. brucei.
Mid-log phase (~6 x 106 cells / ml) procyclic form cultures were gently pelleted 
by centrifugation at room temperature. The pellets were washed once with Zimmerman 
post-fusion medium (ZPFM), pelleted again, and resuspended in ZPFM at 6 x 107 cells / 
ml. ~50pig of the respective DNA at ~2 mg / ml in dH20 was added per 0.5ml of cells 
to be transfected. The transfection was by electroporation (Bio-rad Gene Pulser) using 
0.4 cm cuvettes at 1500 V and 25 piF. The pulse was applied to the sample twice before 
transfer of the cells into pre-warmed SDM-79 medium. After incubation overnight for 
recovery the cells were passaged to a concentration of 1 x 106 cells / ml in SDM-79 
medium containing the antibiotic needed for selection of the transfected DNA.
2.5.2.4 PCR from T. brucei lines.
500pi\ of procyclic form culture was placed in a screwtop eppendorf, DNAse I 
added to 10 pig / ml and incubated at 28 °C for 1 hour. EDTA was added to 4 mM and 
the trypanosomes pelleted in a microfuge at 1 000 rpm for 5 minutes. 480pi\ were 
removed, the pellet resuspended, and then incubated in a boiling water bath for 15 
minutes. 0.5 pi\ was used as a template in each reaction. The PCR conditions were 
generally:
Step 1 94 °C for 5 min (initial denaturation)
Step 2 60 °C for 45 sec 5 /d  of each oligo (20 pM stock)
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Step 3 72 °C for 1 min 30 sec 5 /d  of 2 mM dNTPs
5 /d  of 10 x Taq buffer
0.5/d  of 7a</ DNA polymerase (5 U //d)
0.5/ri of template
d H 2 O to 5 0  \i\
Step 4 94 °C for 45 sec
(repeat steps 2-4 for 40 cycles) 
Step 5 60 °C for 45 sec
Step 6 72 °C for 10 min
10/d of the aqueous phase were added to 3 /d  of 5 x LB and run on 1-1.4 % agarose 
gels.
2.5.3 Protein protocols (71b).
2.5.3.1 Trypanosome protein extracts.
Pellets of T. brucei procyclic and bloodstream forms were resuspended in 
approximately 1 ml of protein Lysis Solution + Inhibitors (LSI) per 5 x 10® cells. The 
tubes were kept on ice for 30 minutes. For whole cell extracts, the protein 
concentration was then determined by the Bradford assay (Biorad), and the extract 
diluted to 2.5 mg / ml with 5xFinal Sample Buffer (5 x FSB). For S100 extracts, the 
lysed cells were centrifuged at 35 000 rpm in a Ti50 ultracentrifuge rotor at 4 °C for 30 
minutes. The supernatant and pellet (resuspended in the same volume of LSI as used 
originally for cell lysis) were diluted to 2.5 mg / ml after Bradford assays.
For SDS-PAGE followed by Coomasie staining or Western blotting, the extracts 
were incubated in a boiling water bath for 5 min and 15 /ri of extract were usually 
loaded per lane on a mini-gel. For larger gels 40/ri of extract were loaded.
2.5.3.2 Sucl/LmmCKSl selections from S100 protein extracts.
For selections, 100 //I of sucl/CKSl or control bead slurry was used in each
experiment. The beads were washed in Lysis Solution (LS). 50 /ri of 50 mg / ml BSA
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and 200]a \ of LSI were added to the beads, which were incubated at 4 °C for 2 hours 
with agitation. 200 ja \ of T. brucei or S.pombe S I00 extract supernatant was added, 
and the beads incubated a further 2 hours. The beads were then washed twice with 1 ml 
of LSI, 3 times with LSI + 1 M NaCl, then once with LSI.
For Western blots, the bound protein was eluted by transferring the beads to a 
screw topped tube, adding 100 pi\ of 2 x F.S.B, heating to 50 °C for 5 minutes, and 
removing the supernatant.
2.5.3.3 Flistone HI kinase assays.
For Histone HI kinase assays the Aminolink beads or Ni2+/agarose were washed 
once with Kinase Assay Buffer (KAB) and transferred to a screw topped tube. The 
beads and the Kinase Assay Mix (KAM) were prewarmed separately at 30 °C for 5 
minutes, before adding 2 0 of KAM to each screw topped tube and incubating at 30 
°C for 20 minutes. 20 p\ of 5 x F.S.B was added before the samples were placed in a 
boiling water bath for 2 minutes. 15pi\ per sample was loaded onto 12.5 % SDS- 
PAGE. The gels were stained with Coomasie R250 brilliant blue, destained, dried 
down onto 3MM paper and exposed to Fuji X-ray film.
2.5.3.4 35S-Methionine labelling of procyclic T. brucei brucei.
Procyclic form STIB247 at 6 x 10^ cells / ml were pelleted at room temperature, 
washed with PBS and then resuspended in methionine free MEM-Eagles media at 6 x 
10^ cells / ml. After 1 hour at 28 °C, lOO^Ci of 35S-Methionine were added and the 
cells grown for another 6 hours. The cells were then pelleted, and stored at -70 °C 
overnight before S100 extracts were made and sucl/CKSl selections performed. 15p\ 
of the extracts were run on 12 % SDS-PAGE in duplicate. Both gels were Coomassie 
R250 brilliant blue stained, to visualise the markers, and one gel was soaked in
Intensify™. The gels were then dried onto 3MM paper and exposed to X-ray film.
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CHAPTER THREE 
ISOLATION OF T. BRUCEI GENES HOMOLOGOUS TO 
THOSE INVOLVED IN CELL CYCLE CONTROL IN
OTHER ORGANISMS
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3.1 Introduction.
The isolation of genes from the kinetoplastids that are homologous to those from 
other organisms has been successfully tried using several different techniques. Both 
PCR with degenerate oligonucleotides (Bangs e ta l., 1993) and heterologous 
hybridisation at low stringency (Wong etal., 1993) have isolated genes of interest. It 
was thought possible that a similar approach could be used to isolate cyclin genes from 
T. brucei and L. mexicana.
3.2 Attempted Isolation of Mitotic Cyclin genes from T. brucei and L. mexicana.
3.2.1 Background and Experiment Design.
In 1990 a number of cyclins had been cloned and the predicted protein 
sequences were available in the data base. The cyclin proteins could be assigned to a 
number of different classes on the basis of characteristic sequence motifs (Colas et a l, 
1993; Gallant and Nigg, 1994). The A and B type cyclins, shown to be involved in 
G2/Mitosis checkpoints (Pines and Hunter, 1992; Minshull et al., 1990), were better 
conserved than the CLN cyclins isolated from S. cerevisiae (Rowley et al., 1992). 
Therefore this category of cyclins was thought the most likely to be conserved enough 
for cloning from the kinetoplastida. Aligning the protein sequences showed that some 
regions of the A and B type cyclins were very well conserved between species. The 
domain of highest conservation was called the cyclin box. It was decided to design 
oligonucleotides that would hybridise to the DNA encoding 3 of the most conserved 
regions within the cyclin box, with the belief that these regions were the most probable 
to be conserved in the evolutionary distant protozoa (Figure 3.2.1). These would be 
used to isolate cyclin genes from T. brucei and L. mexicana using either PCR or library 
screening.
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Figure 3.2.1 Mitotic cyclin domains and oligonucleotide positions and sequences
Gol Go4
| | —  Destruction Box
[ill —  Cyclin Box
HeLa MRAILIDW KYEEMYPP AKYLMEL
A. punctulata - - L - - V - - .............- I
S. solidissima -----------A-
S. pombe - - G - - T - - ------ VNC- -------V- I
X. laevis B 1
X. laevis B2 .............V- - ...............T-
D. melanogaster ----- V ------- ------ LF- - S- - FI - -
CONSENSUS MRAILIDW KYEEMYPP AKYLMEL
Oligonucleotides Gol, Go2, Go3, Go4 and Go5 Degeneracy
M R  A I L I D W
Go1 ATG CG(C/G) GC(C/G) AT(C/T) (C/T)T(C/G) AT(C/T) GAC TGG 64 fold
p  P Y N I E E Y K
Go2 (C/G)GG (C/G)GG CTA CAT CTC CTC GTA CTT 4 fold
L E M  L Y K A
Go3 A(G/T) CTC CAT (C/G)A(A/G) GTA CTT (C/G)GC 16 fold
A A /S /T  K  Y E  E
Go4 C GATCGCN (A/G/T)(C/G)N AA(A/G) TA(C/T) GA(A/G) GA(A/G) 1536 fold
Ba/nHI
E M /L/V L Y K A
G°5 C GAATTC (C/T)TC NA(C/G/T) NA(A/G) (A/G)TA (C/T)TT NGC 
EcoRI
768 fold
t ^ Ure ^ 1  The sequences of conserved regions of the cyclin box are from B type cyclins from 
organisms: Arbaciapunctulata (sea urchin), Spisula solidissima (clam), Schizosaccharomyces 
I mbe (fission yeast), Xenopus laevis (frog) and Drosophila melanogaster (fruit fly).
Gol ^  nuc e^o ^ e  seQuence of each oligonucleotide is written 5 ' to3'. The bold letters above 
Go3 an  ^ are am*no ac^ s encoded by the nucleotide sequence. Oligonucleotides Go2,
J and Go5 are antisense and the bold letters above the sequence are the amino acids that would 
by the opposite strand. The sequences in italics are the added restriction enzyme sites
lmProved cloning efficiency.
6 8
L. mexicana genes show a definate codon bias for many of the amino acids 
(Langford et al., 1992). The third base in each codon is, on average, 84 % likely to 
G 1C. The oligonucleotides, Gol,2 and 3, were designed with this bias (Figure 3.2.1), 
which considerably reduced their degeneracy. The intention was to isolate genes, or 
gene fragments, from L. mexicana, and then use heterologous screening to isolate the 
related genes in T. brucei, which shows no extreme codon bias. Oligonucleotides Gol- 
3 had no restriction site engineered on the ends, and therefore were kinased to help 
blunt end cloning of the PCR fragments. Of these oligonucleotides, Gol was sense, to 
be used as the 5' primer in PCR, while Go2 and 3 were antisense, and were the 3' 
primers. Later in the project 2 more oligonucleotides were made which were identical 
to those that had been used to isolate B type cyclin genes from S. cerevisiae (Ghiara et 
al., 1991). Oligonucleotides Go4 and Go5 were designed to the regions also encoded 
by Go2 and Go3, but Go4 was a 5' primer for PCR, unlike Go2. Go4 and 5 contained 
BamHl and EcoRI sites respectively to improve cloning efficiency (Figure 3.2.1). By 
comparison with previously cloned cyclins, it was expected that PCR with Gol/2 
should result in a product of ~190 bp, while Gol/3 would result in a band at ~380 bp. 
Oligonucleotides Go4/5 were expected to produce a band at ~200 bp. Due to the lack 
of cis introns in the Kinetoplastida, these sizes could be predicted for PCR from 
genomic DNA as well as from cDNA.
3.2.2 Cloning Attempts.
One approach to cloning, that had previously been successful in isolating
cysteine protease genes from T. brucei (Mottram etal., 1989b), was direct screening of
cDNA libraries with degenerate oligonucleotides. To ascertain the correct hybridisation
conditions, the oligonucleotides Gol-3 were endlabelled with 32P and hybridised
individually to an L. mexicana genomic DNA Southern blot that had been run in
triplicate. All three oligonucleotides gave multiple bands, in multiple restriction
enzyme digests, although to the accuracy of the experiment, no two oligonucleotides
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gave the same band. (Data not shown) Even so, a L. mexicana cDNA library in lambda 
Zap (supplied by J.C.Mottram) was screened with Gol and Go2 endlabelled with 32P  
These two oligonucleotides were expected to hybridise to genes encoding both Cyclin 
A and B, unlike Go3, which is Cyclin B specific. -30  000 plaques were screened in 
duplicate, with one filter probed with Gol and the other with Go2. No plaques that 
hybridised to both probes were found. Of the 6 plaques that appeared to hybridise to 
Gol, none gave positive signals in the secondary screening. Three lambda clones 
which hybridised to Go2 were purified, the inserts rescued into Bluescript and single 
strand partial sequence obtained. No homology to any cyclin sequence in the data base 
was found. This approach had also been tried in T. brucei with an oligonucleotide 
equivalent to Go2 (M.Carrington, Personal communication). Many cDNA clones were 
sequenced but in each case the sequence hybridising to the oligonucleotide probe was 
found to be in the 3' untranslated region and antisense to the Open Reading Frame 
(ORF). As this approach was not successful in isolating a cyclin gene it was ceased.
PCR with different combinations of the 5 oligonucleotides was also tried, using
both L. mexicana and T. brucei genomic DNA as template. The annealing conditions
varied between 37 °C and 55 °C. All the oligonucleotide combinations gave a large
number of bands and smearing, even at high annealing temperatures. The relative
intensities of bands varied between experiments with few bands being consistent.
Initially the Gol/Go3 PCR products were seperated on an agarose gel, the DNA was
capillary blotted, and the membrane hybridised to endlabelled Go2, an internal
oligonucleotide. This attempt to find a specific cyclin fragment amongst the multiple
bands never resulted in a signal. In an attempt to reduce spurious annealing,
"touchdown" PCR was tried (Don etal., 1991). With this technique the first few rounds
of PCR have a higher than optimum annealing temperature, which should result in only
target sequences with good matches to the oligonucleotides priming DNA synthesis.
The annealing temperature is then reduced in steps over a number of rounds to less
stringent conditions, when several more amplifying rounds take place (See Materials
and Methods for further details). This should result in a decrease of the products that
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rely initially on a poor match annealing. This approach still gave multiple bands, but 
fewer than before, and with higher consistency. PCR with oligonucleotides Go4 and 
Go5 gave the most reproduceable results, and so 10 \i\ of each 50pi\ reaction was run 
out in a 1.8 % Imp agarose gel and bands cut out with sterile scalpel blades (Figure 
3.2.2). Bands LI, L2 and T1 were very consistent, though not of the expected size, 
while T2 was the area of the gel which contained a smear of DNA molecules of the 
expected size from the T. brucei templated reaction. 0.5 j*\ of Imp agarose from each 
slice was used as template in another PCR reaction, using the same primers, to increase 
the proportion of each band in the respective reactions. These reactions were cleaned 
up by phenol/chloroform extraction and digested with EcoRl and BamHl before 
running out on a 1.8 % Imp agarose gel. The four bands were again cut from the gel 
and ligated into pBS SK-. Most of the clones had inserts of the expected size, but when 
sequenced, none of the >15 differing clones showed any similarity to cyclins. Indeed 
most showed no ORF in any possible frame. This approach was tried many times with 
minor variations. Other approaches tried included PCR using cDNA as template, which 
also failed to reduce spurious bands. Nested PCR using cDNA template was also 
attempted. This involved a first PCR using Gol and an "adapter" oligonucleotide 
which hybridised to the sequence downstream of the poly(A) tail. When the cDNA is 
made, the 3' primer for synthesis of the first DNA strand consists of a poly(T) tract, 
followed by a region containing a number of restriction enzyme sites, to facilitate 
cloning of the cDNA into the vector. After the first strand synthesis, an oligonucleotide 
consisting of just the restriction enzyme sites is used as the 3' primer in a PCR to 
amplify the cDNA. The annealing of this "adapter" oligonucleotide is more specific, 
with a higher melting temperature, than that of a poly(T) oligonucleotide. The first 
stage of the nested PCR should specifically amplify any cyclin messages in the library, 
giving a smear of DNA due to variation in the length of the poly(A) tail and the position 
of the initial priming. A second PCR, using the products of the first as template, is then 
Performed with 2 oligonucleotides that are internal to the primers in the first PCR. The
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Figure 3.2.2 Touchdown PCR
L T
1 kbp
500 bp
350 bp
220 b'p 
150 bp
T1
LI
T2
L2
Figure 3.2.2 Touchdown PCR with Go4 and Go5 oligonucleotides. Lanes L and T; reactions 
with L. mexicana or T. brucei genomic DNA as template respectively. One fifth of the PCR 
reactions was run on a 1.8% agarose gel, and stained with Ethidium Bromide. The bands 1 and
2 from each lane were cut from the gel and used as template in another PCR with Go4 and 5.
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oligonucleotides used, Go4 and Go5, gave no consistent bands in these reactions, and 
normally no bands at all. In the end it was decided that the attempt to directly clone 
cyclins was not going to be successful, and a more productive approach to analysing 
CDK complexes in the trypanosomatids would be to concentrate on the kinase subunits 
of the complexes themselves.
3.2.3 Cloning a Human Cyclin B.
Prior to the start of the Ph.D., PCR had been tried by other members of the 
laboratory, with other oligonucleotides, to isolate cyclin genes from L. mexicana. One 
consistent band of the correct size which hybridised to an labelled internal 
oligonucleotide, was subcloned into pBS SK- using the £c<9RI sites added to each 
primer. The clone, Lcycl2, had the expected insert size of 350 bp and was sequenced 
on both strands with the T3 and T7 primers (Figure 3.2.3).
As Figure 3.2.4 shows the PCR product is almost identical to the Human Cyclin 
B1 gene already cloned (Pines and Hunter, 1989). It seems likely that during the early 
PCR stages of the experiment the L. mexicana DNA was contaminated by some HeLa 
DNA that was being used as a positive control. As expected, the random primed, 
labelled insert failed to hybridise to L. mexicana DNA on a Southern blot (Data not 
shown).
The sequence differences between Lcycl2 and the previously reported HsCyBl
sequence could be due to a number of reasons. The nucleotide variation could simply
be data base error, though the rate would seem considerably higher than previously
reported (~1 %). The multiple rounds of PCR are likely to cause a number of base
changes. Evidence supporting this is that there is no bias towards changes at the third
base in each codon, which results in few silent mutations. This implies that the
sequence was not under selection pressure when the changes occured. If the differences
are not due to PCR error, then the lack of silent mutations would suggest that the
Leycl2 sequence is unlikely to be allellic to the previously cloned human B1 gene
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Figure 3.2.3 DNA and predicted protein sequence of tfie probable
human PCR contaminant.
I  Q V Q M K ' F  R L L  Q E T  M Y M T
GATACAGGTT CAAATGAAAT TTAGGCTGCT GCAAGAGACT ATGTACATGA
V P I  I D R  F M Q D  N C A S K K
CTGTTCCCAT TATTGATCGA TTCATGCAGG ATAATTGTGC GTCCAAGAAG
M L Q L  V G V  T A M  F I  A S K Y E
ATGCTGCAGC TAGTTGGTGT CACTGCCATG TTCATTGCCA GCAAATATGA
E M Y  P P E I  G D F  A F V T N N T
AGAAATGTAC CCTCCAGAAA TAGGTGACTT CGCTTTTGTG ACTAACAATA
Y I  K H Q I  R P I E  M K I  L R V
CTTACATTAA GCACCAAATT AGACCAATTG AAATGAAGAT TCTAAGAGTT
L N F S  L G P  P L P  L H F F  H R A
CTAAACTTTA GTTTGGGTCC CCCTCTGCCT CTGCACTTCT TCCATAGAGC
S K I  G E V D  V E Q  H T L
ATCTAAGATT GGAGAGGTTG ACGTTGAACA GCATACTTTG
Figure 3.2.3. The above sequence from the insert of pLpCYC12 does not 
include the regions encoded by the oligonucleotides used in the PCR. The amino acid 
encoded by each codon is above the First base of the triplet.
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Figure 3.2.4a Comparison of the DNA sequence of the PCR contaminant
and the HeLa Cyclin B1 gene.
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1 I
CAG 
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1 1 I
CAA
1 1 1
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| |
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1 1 1 
ACT
1 1 
GAC AAC ACT TAT ACT AAG CAC
CAA
1 1 1
ATT
I 1
AGA 
1 1 1
CCA
1
ATT
I I
GAA
1 1 1
ATG
1 1 1
AAG
1 1 1
ATT
1 1 1
CTA
1 1 1
AGA
1 1 1
GTT
I 1
CTA
I I
AAC
1 1 1
TTT
1 1 11 1 1 
CAA
1 1
ATC
1 1 1 
AGA
1
CAG
1 1
ATG
1 1 1 
GAA
1 1 1 
ATG
1 1 1 
AAG
1 1 1 
ATT
1 1 I
CTA
1 1 1 
AGA
1 1 
GCT
1 1 
TTA
1 1 1 
AAC
1 1 1 
TTT
AGT
1 1
TTG
1 1
GGT
1 1 1
CCC
I
CCT CTG
I I
CCT
1 1 1
CTG
I I
CAC
1 1 1
TTC
1 1 1
TTC
I
CAT
I
AGA
1 1 1
GCA
1 1 1
TCT
1 1 11 1 
GGT
1 1 
CTG
1 1 1 
GGT
1
CGG CCT
1 1
CTA
1 1 1 
CCT
1 1 
TTG
1 1 1 
CAC
1 1 1 
TTC
1
CTT
1
CGG
1 1 1 
AGA
1 1 1 
GCA
1 1 1 
TCT
AAG
1 1 1
ATT
1 1 1
GGA
1 1 1
GAG 
1 ! 1
GTT
1 1 1
GAC
I I
GTT
I I
GAA
1 I
CAG
I I
CAT 
1 1 1
ACT
1 1 1
TTG
1 1 1I  ! 
AAG
1 1 1 
ATT
1 1 1 
GGA
1 1 1 
GAG
1 1 1 
GTT
1 1
GAT
1 1
GTC
1 1
GAG
1 1
CAA
1 1 1 
CAT
1 1 1 
ACT
1 1 1 
TTG
Figure 3.2.4a The homology between the two sequences is 88% over the 
340bp. Of the differing bases, 29% are at the first position of the codon, 14% at the 
second, and 57% at the third.
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Figure 3.2.4b Comparison of the predicted human Cyclin B1 protein 
sequence and the translated pLpCYC12 insert.
pLpCYC12 IQVQMKFRLL QETMYMTVPI IDRFMQDNCA SKKMLQLVGV
5 I II II II II II II II II I I I I I I I • I I • I I I I I I I I I 
Human B1 VQVQMKFRLL QETMYMTVSI IDRFMQNNCV PKKMLQLVGV
TAMFIASKYE EMYPPEIGDF AFVTNNTYIK HQIRPIEM KI LRVLNFSLGP
TAMFIASKYE EMYPPEIGDF AFVTDNTYTK HQIRQMEMKI LRALNFGLGR 
PLPLHFFHRA SKIGEVDVEQ HTL
PLPLHFLRRA SKIGEVDVEQ HTL
Figure 3.2.4b The predicted protein sequence comparison between the PCR 
derived insert and the previously cloned Human Cyclin B1 gene shows that the 
percentage identity is 87% with no gaps in the aligned sequences.
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sequence. The obvious possibility, if the changes are not artifacts of cloning, 
sequencing or data base error, is that this sequence has been amplified from a pseudo­
gene. The lack of Southern blot data in the human cyclin gene family leaves this open.
3.2.4 Reasons for the failure to clone a kinetoplastid cyclin.
Although the cell cycle machinery is extremely well conserved throughout the 
Eukaryotes, with many of the proteins from higher organisms capable of 
complementing yeast mutants, the Kinetoplastida are a very early branch from the 
eukaryote lineage (Sogin etal., 1986; Sogin, 1991). Even within the Kinetoplastida the 
organisms are highly diverged. Therefore the evolutionary distance between T. brucei 
and S.pombe is far greater than that between any of the higher eukaryotes (see Figure 
1.1.1). This extreme divergence can be seen in the relatively low conservation of the 
CDC2 related kinases from the Kinetoplastida that will be described later. As more 
cyclins have been cloned from diverse species it is now clear that the cyclin family is 
less well conserved than previously thought. It is likely therefore that kinetoplastid 
cyclins will have significant sequence divergence making cloning by PCR very 
difficult. A putative mitotic cyclin from T. brucei has been recently characterised 
(Affranchino etal., 1993). The protein described is relatively small, and has an unusual 
domain structure for a mitotic cyclin. The cyclin box is near the N-terminus, with the 
destruction box at the C-terminus. The cyclin box has considerably fewer conserved 
residues than usual with numerous insertions and deletions. One of these insertions, of 
12 residues, falls within the region to which Gol was designed. The normally 
conserved ASKYEEMYPP motif, parts of which Go2 and Go4 were designed to, is 
AEHSDSANPK, and the B type cyclin motif of Go3 and Go5 is also totally absent.
This is obviously the reason why the methods that I employed failed to isolate this 
particular T. brucei cyclin-like gene.
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3.3 Isolation of the tbcrk3 gene.
3.3.1 The background to cloning the tbcrk3 gene.
A PCR-based approach to cloning cdk related genes had been started in the 
laboratory prior to this Ph.D. Initially a cDNA from L. mexicana, homologous to cdc2, 
was isolated accidentally during a seperate experiment. This gene was designated 
Immcrkl (Mottram etal., 1993). Oligonucleotides were then designed by Dr. J.C. 
Mottram to hybridise to DNA encoding conserved regions of CDC2 related protein 
kinases and used for PCR with T. brucei or L. mexicana genomic DNA as template 
(Figure 3.3.1). Two gene fragments were amplified by PCR from T. brucei genomic 
DNA. with the new oligonucleotides. One T. brucei fragment showed a high level of 
homology to Immcrkl and so was named tbcrkl. Immcrkl was used to screen a T. 
brucei genomic lambda library under low stringency conditions and a T. brucei gene so 
isolated was named tbcrk2. The second gene fragment from the PCR approach was the 
least conserved, compared to other CDC2 related proteins, within the amplified region 
and was called tbcrk3. The genomic copies of the tbcrkl 12 and Immcrkl genes had all 
been cloned and sequenced prior to the start of the Ph.D.
3.3.2 Isolating a Lambda phage clone containing tbcrk3.
To isolate the genomic DNA containing the tbcrk3 gene, a EMBL4 genomic 
library (supplied by J.C.Mottram) was screened with a 350 bp tbcrk3 gene fragment 
which had been gel purified. ~30 000 plaques were screened and one hybridised. The 
hybridising plaque was purified by 2 further rounds of dilution and hybridisation. One 
clone, CD47.2, was chosen for a large scale preparation of DNA.
The phage DNA was digested with a number of restriction enzymes including
EcoW and Hind III. A Hindlll site was predicted from the PCR fragment sequence, and
was therefore expected to produce 2 hybridising fragments on the Southern blot. The
78
Figure 3.3.1 Cloning cdc2-related kinases by degenerate oligonucleotide PCR
Simplified map of a cdc2-related kinase ORF
oligo 1 oligo 2 Kinase
domain VIb
ATP binding PSTAIR 
domain box oligo 3
Figure 3.3.1 Degenerate oligonucleotides were designed to anneal to the DNA encoding three well 
conserved regions of the cdc2 family of serine/threonine kinases by Dr. J. Mottram. EcoRl restriction
sites were added to oligonucleotides 1 and 3 to facilitate cloning. PCR was performed with the two
32exterior primers (oligos 1 and 3), and the products screened by Southern blotting using a P labelled 
internal primer (oligo 2). The products were then digested with EcoRl and cloned into pBlues^ipt 
for sequencing. This work was performed prior to the start of my Ph.D.
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intention was to subclone a small fragment of the lambda clone into Bluescript plasmid 
(pBS) to facilitate further mapping and sequencing of the gene, and it was hoped that 
both the Hindlll fragments generated would be of an acceptable size for pBS. The 
digests were run on an EthBr stained, 0.7 % agarose gel (Figure 3.3.2a). The DNA was 
transferred to Hybond N nylon membrane by capillary blotting overnight and fixed by 
baking at 80 °C for 2 hrs. When hybridised to the tbcrk3 probe only two of the digests 
performed had resulted in a subclonable hybridising fragment. These exceptions were 
EcoRl, which gave an ~4.5 kb band, and Hindlll, which gave the expected 2 fragments, 
one >12 kb and one at 1.4 kb (Figure 3.3.2b). As the EcoRl digest resulted in a double 
band at 4.5 kb when stained with EtBr, it was difficult to be sure which band was 
hybridising. Therefore, 20 pig of CD47.2 DNA was cut with EcoRI, both bands were 
removed from Imp agarose and ligated into EcoRl cut pBS SK- that had been 
dephosphorylated using Calf Intestinal Alkaline Phosphorylase (CIP). After 
transformation of CaC12-competent XLl-Blue and plating on Tet/Amp plates plus X- 
Gal/IPTG, a number of white, recombinant colonies were picked for analysis. The 
plasmid DNA from the overnight cultures was prepared by a modified Bimboim-Doly 
procedure, restricted with £h?RI and Southern blotted. The 1.4 kb band in the Hindlll 
digest was also subcloned from Imp agarose into pBS SK-, DNA prepared from 8 white 
colonies, and the restricted DNA blotted, in an equivalent manner. The Southern blots 
were hybridised to the labelled tbcrk3 gene fragment, which identified pTgCD70H3 as 
containing the Hindlll fragment of interest, and the plasmids pTgCD70E(S)2/3/7 and 8 
as holding the correct EcoRl fragment.
3.3.3 Mapping pCD70E(S)3 and 8.
Digests of the plasmid DNA with Mwdlll gave identical patterns with
pCD70E(S)2/7 and 8. The pattern of pCD70E(S)3 differed slightly, lacking the 1.2 kb
band, with the 2.9 kb pBS band shifting to 4.1 kb. This was due to the insert being
reversed in orientation relative to the vector Multiple Cloning Site (MCS). Further
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Figure 3.3.2 Subcloning of the tbcrkS containing fragments from lambda CD47.2.
(A) (B)
1 2 1 2
12kb-
6kb
4kb‘
2kb-
1.6kb
lkb-
0.5kb-
1.6kb
Figure 3.3.2 DNA from lambda CD47.2 was digested with Hindlll or EcoRl and run on a 
0.7% agarose gel, stained with EtBr (Panel A). The DNA was then transfered (without HC1 
treatment) to a Hybond N membrane and fixed. The membrane was hybridised to a random 
primed PCR fragment of tbcrk3 (Panel B).
i
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Figure 3.3.3 Mapping the tbcrkS genomic locus.
4 5 6 7 8 9 10
0.22 kb
0.5 kb
0.3 kb—»
0.13 kb
3 kb 
2kb 1.6 kb'
0.4 kb
1 2 3 4 5 6 7 8 9  10
4
0.5 kb
0.4 kb 
0.3 kb
Figure 3.3.3 Purified pCD70E(S)8 plasmid was digested with multiple restriction 
enzymes to map the insert DNA. Lane 1 -//zwdlll, lane 2-Pstl, lane 3-Sail, lane 4-Xbal, 
lane 5-HindllUPstl, lane 6-Hindll\JSall, lane 1-Hindlll/Xbal, lane S-Pstl/Sall, lane 9- 
Pstl/Xbal, lane \0-Sal\IXba\. The two photographs show the same gel after two 
different run times.
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mapping showed no BamHl, Bglll, Clal, EcoRV, Notl, Smal, Sstl or Sstll restriction 
sites within the insert. The 4.4 kb £ce>RI insert was mapped with Hindlll, Pstl, Sail and 
Xbal (Figure 3.3.3). Further mapping using Sspl and Xhol was also performed, 
however the precise number and positions of Xhol sites within the 1.4 kb Hindlll 
fragment were not known until the coding region was sequenced [Figure 3.3.4 is a map 
of pCD70E(S)8].
3.3.4 Sequencing the tbcrk3 ORF.
A number of overlapping fragments from the area containing the ORF were 
subcloned into pBS to facilitate sequencing (Figure 3.3.5). The only difficult region was 
the 50 bp Xhol fragment within the tbcrk3 gene. To allow the sequencing of the non 
coding strand of this fragment a Hinfl digest of pTgCD70H3, followed by end filling 
with Klenow fragment, was performed. After a second digest with Xbal the products 
were run through a 1.8 % TAE agarose gel and the required band extracted with the 
Geneclean protocol. This was then ligated into pBS SK+ that had been digested with 
EcoRV and Xbal.
The overlapping subclones were sequenced using the various primers that 
hybridise to the pBS MCS. The second strand of the far 5' and 3' termini of the tbcrk3 
ORF were sequenced by designing oligonucleotides to hybridise to the sequence 
obtained from the first strand. This was due to a lack of useful cloning sites in these 
regions (Figure 3.3.5). The complete ORF of 936 bp encodes a protein of 311 amino 
acids and a termination codon (Figure 3.3.6). There is a stop codon in frame with the 
probable start ATG, 18 bp upstream.
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Figure 3.3.5 Sequencing the tbcrkS Genomic locus
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E
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 1----------
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X
H
I  .
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Figure 3.3.6 Coding strand DNA and the predicted protein sequence of tbcrk3
* V K G
1 TTTTGTC TC TGTTTTC C TC TTAAGTTCTTC AGGAAACGTTAGGTTAAAGG 50
G D M  T M L G  A L T  G R Q  L S S G
51 AGGAGATATG ACAATGCTTG GGGCGTTAAC CGGTCGACAA CTTTCCTCTG 10 0
L K D  Q F D  R Y N R  M D I  L G E
101 GTCTTAAGGA TCAGTTCGAC CGCTATAATC GAATGGACAT ACTTGGAGAA 1 5 0
G T Y G  V V Y  R A V  D R A T  G Q I
15 1  GGAACGTATG GAGTTGTATA CCGTGCTGTT GACAGGGCAA CGGGACAGAT 2 0 0
V A L  K K V R  L D R  T D E  G I P Q
201 CGTCGCACTG AAGAAAGTGA GATTAGATCG CACCGATGAG GGAATACCTC 2 5 0
T A L  R E V  S I L Q  E I H  H P N
251 AAACAGCTCT TCGGGAGGTA TCTATTTTGC AAGAAATCCA TCACCCCAAC 3 0 0
I V N L  L D V  I C A D  G K L  Y L I
301 ATTGTTAATC TTCTAGATGT TATATGTGCC GATGGGAAGC TTTACTTGAT 3 5 0
F E Y  V D H D  L K K  A L E  K R G G
351 ATTTGAGTAT GTTGATCATG ATCTCAAAAA GGCTCTCGAG AAGAGGGGTG 4 0 0
A F T  G T T  L K K I  I  Y Q L L E
401 GAGCATTCAC GGGAACTACA CTAAAAAAGA TAATTTACCA GCTACTCGAG 4 5 0
G L S F  C H R  H R I  V H R D  L K P
451 GGACTTTCGT TTTGTCATCG GCACCGCATT GTCCATCGAG ACCTAAAACC 5 0 0
A N I  L V T T  D N S  V K I  A D F G
501 AGCAAACATA CTTGTCACCA CGGATAATTC CGTTAAAATA GCAGACTTTG 5 5 0
L A R  A F Q  I P M H  T Y T  H E V
551 GATTGGCTCG CGCTTTCCAG ATTCCGATGC ACACTTACAC TCACGAGGTT 6 0 0
V T L W  Y R A P E I  L L G E  K H Y
601 GTCACACTCT GGTATAGAGC GCCAGAGATT CTCCTCGGTG AAAAGCACTA 6 5 0
T P A V D M W  S I G  C I  F A E L A
651 CACCCCGGCA GTGGATATGT GGAGCATTGG TTGTATTTTT GCTGAACTAG 7 0 0
R G K  V L F  R G D S  E I G  Q L F
701 CTCGAGGTAA GGTACTCTTT CGTGGTGACA GTGAGATTGG ACAGTTATTT 7 5 0
E I F Q  V L G  T P M  D A E G  S W L
751 GAGATTTTTC AGGTGCTTGG CACCCCAATG GATGCTGAGG GGTCGTGGTT 8 0 0
G V S S L P D  Y R D  V F P  K W S G
801 GGGGGTGTCG TCTCTTCCAG ACTATCGTGA CGTCTTTCCA AAGTGGAGTG 8 5 0
K P L  T Q V  L P T L  D G D  A V D
851 GAAAACCCCT CACTCAGGTG TTACCAACGC TTGACGGTGA TGCTGTTGAT 9 0 0
L L S Q M L R  Y N P  A E R I  S A K
901 CTGCTTTCTC AGATGCTGAG GTATAACCCT GCTGAACGTA TTTCAGCCAA 9 5 0
A A L  Q H P W  F S D  A M F *
951 GGCGGCACTG CAACATCCGT GGTTTAGTGA TGCCATGTTTTAGATCATTATA 100 2
Figure 3.3.6 The sequence of tbcrkS was obtained from overlapping regions of DNA 
subcloned from pCD70E(S)8. The DNA was sequenced on both strands to ensure 
accuracy. In frame stop codons and possible initiation codons are underlined. The 
predicted amino acid is given over the first base in each codon.
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3.3.5 Analysis of the protein sequences of TbCRKl-3.
The predicted TbCRK3 protein contains all 15 of the conserved residues 
indicative of a serine/threonine kinase (Figure 3.3.7) (Hanks and Quinn, 1991). The 
alignment of the three translated T. brucei crk genes with yeast and human CDC2 
related proteins (Figure 3.3.7) shows that the TbCRK proteins share the same conserved 
regions as other members of this family, e.g. the ATP binding region surrounding T-14 
and Y-15, the PSTAIR box, and the regions either side of T-161 (HsCDC2 numbering). 
The TbCRK proteins also show the same regions of low conservation; e.g. S-93 to V- 
117 (HsCDC2 numbering) and most of the C-terminal 70 amino acids. There are 
notable differences however, including the N-terminal extensions of TbCRK2 and 3, 
and the 6 and 5 residue insertions near the C-terminus of TbCRKl (Figure 3.3.7).
Table 3.3.1 shows the level of amino acid conservation between the 
kinetoplastid CRK proteins, fission yeast cdc2 and budding yeast CDC28 proteins, and 
the family of human CDC2 related protein kinases. For TbCRKl and TbCRK2 the 
highest levels of identity are 56 % and 52 % respectively. TbCRKl is approximately 
equally conserved to HsCDC2, HsCDK3 and HsCDK5 (54 %, 55 % and 56 % 
respectively). TbCRK2 has a generally lower level of identity with the highest scores 
being 52 % (HsCDK2) and 50 % (Spcdc2 and ScCDC28). For TbCRK3 the most 
similar human protein is HsCDK2 (59 %). Even this high level of identity though is 
notably lower than most recognised cdc2 homologues. Organisms as widely diverged 
as S.pombe and humans have cdc2 proteins that are 65 % identical. S. cerevisiae 
CDC28 though is only 60 % identical to HsCDC2, so the figures for the TbCRK 
proteins do not rule out the possibility of their being the functional trypanosome 
homologue.
Figure 3.3.8 shows 4 of the most highly conserved regions of the CDC2/CDK2
family of proteins with the equivalent regions of the kinetoplastid CRK proteins for
comparison. The most obvious variation is the lack, in any of the CRK proteins, of a
totally conserved PSTAIR box, a region implicated in cyclin binding (Pines and Hunter,
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Figure 3.3.7 Comparisons of the TbCRK family with CDC2 related proteins
*
HsCDC2  MEDYTKIE
Hs CDK2 .................................................................................................................................. — N FQ -V -
Spcdc2 .................................................................................................................................. — N -Q -V -
ScCDC28  MS GELAN-KRL-
TbCRK 1  MGSR-ERLQ
TbCRK2 MQVQVQEGQT ACDGSLRPLP SAGPASFVPR SLRPAPLRGT STPDR-SR—
TbCRK3  MTMLGAL TGRQLSSGLK DQFDR-NRMD
* j^ * k k * k ** * * * * * k**
Hs CDC2 KIGEGTYGW YJCG. . .PtffCT TGQWAMKKI RLESEEEGVP STAIREISLL
Hs CDK2 --------------------- — A . . .  L — E -------L  — D T -T  ----------------------
S pcdc2 - — —------------- — A . . .  L S - R I --------------------  D - S - -- -----------------------
ScCDC28 -V  ALDL-PGQ  GQR L-------------------D--------------------------------
TbCRKl  S ---F R A . . . - D V -  — T I — V -R ------------ K------------ C----------------- 1 -
TbCRK2 -V ------ S — I --------- C . . . H D N F  — RT--------R - P-IVNDG   V— V 
TbCRK3 I L ----------------------R A . . . V D R A  1 — L— V — DRTD— I -  Q— L— V - I -
* *  *
HsCDC2 K E L _______RHP NIVSLQDVLM QD. SRLYLIF EFLSMDLKKY L D S I..P P G Q
HSCDK2 ___ _N —  K -L — IH TE.N K -V -  HQ----------------F M -A . . . SALT
S pcdc2 — VNDENNRS - C - R - L - I - H  A E .-K -V -  D-M-R-SETGAT
ScCDC28 ___ ____ K D D ------- R -Y -IV H  S-AHK---- V - --------DL------- R - M E G -..-K D -
TbCRKl ___ _____ — E  R -L — CH S E .K — T -V - -CME------------- MDH V-G
TbCRK2 R — _______N—  Y V -R -L — VL H E .A K -L  -YMEQ— QGM -K Q  RNT
TbCRK3 Q - I  H-------------- N -L — IC  A -.G K -------------- YVDH A -E K  R-G
* * k k *k k
HsCDC2 YMDSSLVKSY LYQILQGIVF CHSRRVLHRD LKPQNLLIDD K . GTIKLADF
HsCDK2 G I P L P -I  F -L  LA H NT E . -A ------------
Spcdc2 S L -P R — QKF T— L V N -V N - ------------I I --------------------------- K E . - N L ----------
ScCDC2 8 PLGADI— KF MM-LCK— A Y  H - I   NK D . -N L — G—
TbCRKl DL-AGTIQEF M R SL -S-V R - — E -N ------------------P ---------SR E .KEL----------
TbCRK2 AFVGGKLRRI M F -L -L -L H E -FV I — S - I  R - E S W ----------
TbCRK3 AFTGTTL-KI I — L -E -L S --------- R H -IV -------------- A -I -V T T  D .N S V -I ------
k * * * * * * *  *kk j" * * * k k
HsCDC2 GLARAFGIPI RVYTHEWTL WYPSPEVLLG SARYSTPVDI WSIGTIFAEL
HsCDK2  V -V  - T ---------------- -------- A — I  -K Y -----A  — L -C --------- M
Spcdc2  S — V -L  -N -------1 ------- -------- A ------------ -R tf------- G — V -C --------- M
ScCDC28  V -L  -A -------1 ------- -------- A ------------GK£>------- G— T  C--------- M
TbCRKl — G V KKF-Q  D - T Q -G  — V -C ---------- M
TbCRK2 — G---------RV-L QT— T— M------------ A ------------DKQ-LPA— V — M-CV--------
TbCRK3 ------------ q — M HT--------------------------A — I  EKtf-TPA— M  C----------
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t  1 1 * ** * * * *
HSCDC2 ATKKPLFHGD SEIDQ LFRIF RALGTP..NN EVWPEVESLQ DYKNTFPK. .
HsCDK2 V-RRA— P— -T ------- . . DE V-----G-T-M P ------P S ----- . .
Spcdc2 IRRS-----P — -------EI-JC— QV-------. . -E --------g - t l — -----S----- R . .
ScCDC28 CNR— I - S — ----------I _ K — - V ------- . . - E A I — D IV Y -P - F - P S — Q . .
TbCRKl -IG A -----T-K NDA-----L ----- OF-------. . - R Q-----SMDTYP NSS-MLSRPE
TbCRK2 -RRRS— A— TA-N -----S — QL------- . . TE A T -R G -T — P HHNVN— R . .
TbCRK3 -R G -V — R— -----G----- E — OV-------MDAE G S -L G -S — P — RDV------. .
k *
Hs CDC2 ____ WKPGSL ASHVK............ NLDENGLDLL SKMLIYDPAFC RISGKMALNH
Hs CDK2 ____ -ARQDF S K V -P ............ P------DGRS— - Q - - H ------N - ----- A -A — A -
Spcdc2 . . . — RMD- H KV-P............ -G E -D A IE — - A — V---- H ----- A -R — QQ
ScCDC28 ____ -RRK D- S Q V -P ............ S — PR—I ----- D -L -A ------IN ----- A R R -A I-
TbCRKl FQQTLAATCE EQFQTNPAYA K -G P Q -I----- R W L-R -E -SE -LTAAQ— E -
TbCRK2 ____ -T A K P - R T A -P ............ A— D D -V----- RR— C- N -R E — TAYE— Q -
TbCRK3 ____ -S G K P - TQVLP............ T— GDAV----- -Q — R -N — E ----- A -A — Q -
HsCDC2 PYFNDLDNQI KKM
HSCDK2 -F-Q -V T K P V  PHLRL
Spcdc2 N -LR-FH
ScCDC28 ------QES
TbCRKl ------SVEF
TbCRK2 S — DEVREEE VEKLMRFNG
TbCRK3 -W -S-AM F
Figure 3.3.7 Pileup comparison of CDC2 related genes from: Hs-Homo sapiens 
(human), Sp -Schizosaccharomyces pombe (fission yeast), Sc - Saccharomyces 
cerevisiae (budding yeast) and Tb- Trypanosoma brucei.
* - Residues exposed to Solvent,
t  - Residues involved in sucl/CKS binding.
Italics - Regions implicated in sucl/CKS binding.
Bold - Residues involved in cyclin binding,
k - Residues conserved throughout the family of serine/threonine
kinases.
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Table 3.3.1 Conservation between members of the Kinetoplastid CRK family 
and CDC2 related proteins from Humans and yeast.
TbCRKl 7bCRK2 TbCRK3 HsCDC2
TbCRKl 47 47 54
TbCRK2 47 53 49
LmmCRKI 72 48 47 56
HsCDC2 54 49 54
HsCDK2 52 52 59 65
HsCDK3 55 49 56 65
HsCDK4 44 45 48 44
HsCDK5 56 48 51 57
HsCDK6 47 43 47 47
HsPCTAIR-1 50 40 45 52
SpCDC2 53 50 52 65
ScCDC28 52 50 52 60
Table 3.3.1 The figures shown are the percentage identity of the predicted 
protein sequences for the respective gene. Tb - T. brucei, Lmm - Leishmania 
mexicana, Hs - H. sapiens, Sp - Schizosaccharomyces pombe, Sc - Saccharomyces 
cerevisiae.
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Figure 3 3 8 Kinetoplastid CRK protein conservation at CDK control motifs.
HsCDC2
LmmCRKl
TbCRKl
TbCRK2
TbCRK3
LmmCRK3
ATP binding PSTAIR box Thr-167 DSEI BOX
* * *
KIGEGTYGVV EGVPSTAIREISLLKE YTHE GDSEID0
--------c -------------------- F -N - -KNDA—
---------s ------- IlIM1111111u1111 F - 0 - -KNDA—
---------S— I - G ----------V— V----- R- — T - — TAIN-
IL -------------- — I-Q — L— V - I - 0 - -------- G
XL---------------- — I - Q - - L — V -I-Q - -------- G
Figure 3 .3 .8  The predicted protein sequences from the five Kinetoplastid crk genes were compared 
tq the predicted sequence of the Human CDC2 kinase subunit in four regions involved in control of 
nase activity (see Chapter 3.5.2).
* labels a residue phosphorylated during the cell cycle.
- shows amino acids identical to the HsCDC2 sequence.
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1989; Ducommon etal., 1991b). Unexpectedly, CRK3, which has the least conserved 
PSTAIR box (10/16 identity) is the best conserved in some of the other control regions. 
CRK3 is well conserved around Thr-161 (HsCDC2 numbering), which is 
phosphorylated in the active kinase (Nigg etal., 1992; Krek and Nigg, 1992; Solomon,
1992), and is the most conserved CRK at the DSEI box, which is thought to be involved 
in controlling Thr-161 phosphorylation (Heig etal., 1992). The CRK1 proteins, though 
better conserved in the PSTAIRE region, have an unusual sequence around Thr-161 and 
are entirely missing the DSEI motif, while TbCRK2 has intermediate conservation in 
these areas.
The lack of a pattern of conserved, or not conserved, residues continues through 
the sequences (Figure 3.3.7). Of the residues involved in cyclin binding, TbCRKl has 
considerably better conservation with the human and yeast CDC2/CDK2 genes (one 
conservative change out of seven amino acids) than do either of TbCRK2 (three non­
conservative changes) orTbCRK3 (two conservative, two non-conservative). The three 
T. brucei proteins show many alterations of the amino acids implicated in sucl/cksl 
binding, however many of these residues are also non-conserved between the human 
and yeast sequences. A substitution common to the TbCRK family, not seen in other 
CDK proteins is Aspartic acid for Histidine-23 (HsCDC2 numbering) which is within a 
region believed to be involved in sucl binding. TbCRK2 and 3 also have Arg-22 
subtituted by Histidine and Valine respectively. In the surface area between R-180 and 
D-186, implicated in the sucl interaction, all of the TbCRK proteins have substitutions 
of S-182, and TbCRK2 and 3 both have the T-183 replaced by a proline residue. 
TbCRK2 and 3 also have substitutions at R-214 (to serine and glutamic acid 
respectively) and all three TbCRK proteins have a lysine to glutamic acid alteration at 
amino acid 274. Many of the other solvent accessible residues are also not conserved 
by the TbCRK proteins. These changes include:
for TbCRKl, S121E, R123N, Q132P, K238S and P242S;
for TbCRK2, R36P, Q132S, G154R, R158Q, P229R, D236H and K237N;
forTbCRK3, S121R, Q132A, G154Q, R158H and P229L.
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All of these residues are perfectly conserved in the yeast and human 
CDC2/CDC28/CDK2 proteins. Several other surface residues that are conserved in the 
CDC2/CDK2 proteins are conservatively substituted in the TbCRK proteins.
All three of the TbCRK proteins have substitutions at residues required for 
checkpoint control in S.pombe (Basi and Enoch, 1996). TbCRKl has the change E8Q, 
TbCRK2 has N62Y, and TbCRK3 has both E8D and K9I substitutions.
The above data suggest that none of the TbCRK proteins is well enough 
conserved to be clearly the homologous protein to CDC2 in other organisms. Certainly 
it is very unlikely that any of the tbcrk genes would complement temperature sensitive 
mutants of the yeast cdc2ICDC28 genes, a functional assay commonly used. All have 
mutations in important regulation sites, and it would seem likely that none of the 
proteins would interact correctly with components of the cell cycle regulation complex 
from other organisms.
In a further attempt to ascertain the relationship of the 3 trypanosome CRK 
proteins to the various members of the CDC2 related protein kinase family a 
dendrogram of the protein sequences was computed. A selection of proteins 
representative of the various classes were analysed by the PA UP programme (Swofford, 
1991), and bootstrap probabilities calculated for the branches of the shortest tree found 
(Felsenstein, 1985). PH085 from S. cerevisiae was used as the outgroup, as at the time 
it was thought to be a related cyclin dependent protein kinase with no direct cell cycle 
function (Kaffman etal., 1994). It has now been shown to be involved in the G1 phase 
of the S. cerevisiae cell cycle, binding a G1 cyclin, and is essential for passage through 
G1 in the absence of the CDC28 pathway (Espinoza et al., 1994; Measday et al., 1994). 
The consensus shortest tree found using PH085 as an outgroup is shown in Figure 
3-3.9. Changing the outgroup to another, more divergent, CDC2 related kinase would 
be unlikely to alter the result that none of the T. brucei CRK's are found within the 
branch containing the CDC2/28 proteins and the HsCDK2/3 and DmCDC2c proteins. 
Within this branch the 2 yeast proteins diverge first, followed by the split into CDC2
(G2/M control) and CDK2/3 (Gl/S control) groups.
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Figure 3.3.9 Dendrogram of the TbCRK family and other CDC2 related kinases.
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Figure 3.3.9 The dendrogram was calculated by the PAUP (Phylogenetic Analysis Using 
Parsimony) computer program using the entire open reading frames of each protein sequence, 
but extensions and insertions were effectively ignored for this comparison. The numbers show 
the percentage of bootstrap support for each branch.
Dd - Dictyostelium discoideum, Dm - Drosophila melanogaster \ Eh - Entamoeba histolytica,I
Hs - Homo sapiens, Mm - Mus muscularis, Sc - Saccharomyces cerevisiae,
Sc - Schizosaccharomyces pombe, Tb - Trypanosoma brucei,
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One interpretation of this data is that the joint ancestor of yeasts and the higher 
eukaryotes had a single gene for these multiple functions, as is presently found in S. 
pombe, which later underwent duplication and divergence into the seperate genes 
isolated from multicellular organisms. However, none of the cloned genes from 
protozoa are found on this branch, either due to their extreme divergence, or to the fact 
that the correct homologues have not yet been cloned. The D. discoideum and E. 
histolytica proteins as well as TbCRK2 and 3 were placed on the other major branch, 
with the Human CDK6, and the mouse CDK4. Both CDK6 and CDK4 have been 
shown to be involved in the early part of the cell cycle, prior to START and at the 
START restriction point respectively (Matsushime et al., 1992). CDK4 has also been 
shown to be involved in the negative regulation of the cell cycle by anti-mitogens, e.g. 
TGF (Ewen et al., 1993), which result in the cell arresting in G l. It seems likely 
however, that the apparent grouping of these less well conserved genes is due to the 
artifactual clustering of long branches that can occur during phylogeny analysis 
(Felsenstein, 1978). If the clustering of TbCRK2/3 with these Gl/S Phase active 
kinases is due to a role in Gl/S phase control instead of an artifact of the evolutionary 
divergence then one, or both of TbCRK2/3 could be regulators of the adaptive, Gl cell 
cycle block in short, stumpy form and/or metacyclic T. brucei.
The TbCRKl protein appears as an outgroup in this analysis, along with
proteins which have been shown to have non-cell cycle specific activities. PH085 is a
cyclin dependant kinase involved in controlling the transcription of genes involved in
phosphate metabolism (Kaffman etal., 1994), as well as having an apparently
redundant role in G l cell cycle control. The 2 different roles are controlled by
association with different cyclins. The PHO85/PHO80 complex can phosphorylate the
transcription factor PH04 resulting in repression of transcription of the secreted acid
Phosphatase PH05, while the PH085/HCS26 or PH085/0rfD kinase complexes have
heen found to be essential for passage through Gl when the CDC28/CLN complexes
are disrupted (Espinoza et al., 1994; Measday et al., 1994). By analogy it is possible
that LmmCRKl/TbCRKl may play similarly multiple roles, explaining the lack of
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relation between LmmCRKl kinase activity and cell cycle status in L. mexicana 
(Mottram etal., 1993).
CDK5 may also have multiple roles. The protein has been found at low levels 
in immunoprecipitates with the Gl cyclins, D1 and D3, but no kinase activity was 
detected (Xiong etal., 1992). The gene is expressed at higher levels in neuronal tissue, 
and the kinase activity of the CDK5 containing complexes increases with increasing 
cellullar differentiation, e.g. the highest levels of kinase activity are found in non­
dividing cells (Lew etal., 1992; Hisanaga etal., 1992; Helmich etal., 1992). The 
CDK5 complexes in brain contain an activating subunit with very little homology to 
cyclins. Unusually, the two subunits, when expressed in E. coli and purified, can form 
an active complex without the regulatory modifications necessary in other CDK 
systems. Purified CDK5 complexes phosphorylate neurofilament proteins and the tau 
protein, and in vivo co-localisation studies show CDK5 associated with the 
neurofilaments. The roles of the members of the PCTAIR subfamily is unknown.
The alignments of the TbCRK proteins, and their percentage identity 
comparisons with other CDK's, are inconclusive in determining which, if any, of the 3 
isolated trypanosome genes is the cdc2 homologue. An accepted test for functional 
homology is the ability of a CRK to complement yeast temperature sensitive mutants of 
cdc2/28 (Hirayama etal., 1991; Paris etal., 1991; Jimenez etal., 1990; Lee and Nurse, 
1987). Although lower than the conservation between the yeast and metazoan 
homolgues of CDC2/28, the TbCRK/yeast level of conservation (50-59 %) is not in 
itself a barrier to complementation. The Dictyostelium discoideum cdc2 encoded 
protein (DdCDC2) displays a similar (61 %) level of identity to yeast CDC2/28 and 
human CDC2 and is able to weakly complement a CDC28 temperature sensitive mutant 
of S. cerevisiae (Michaelis and Weeks, 1992a). DdCDC2 also contains conservative 
changes in the PSTAIR box and the DSEI motif. However, the level of conservation of 
DdCDC2 is far higher than that shown by TbCRK2 or TbCRK3 in the PSTAIR region, 
and higher than TbCRKl and TbCRK2 at the DSEI motif. The TbCRK proteins’ low
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level of conservation in the motifs shown to be neccessary for CDC2 function means 
that complemention of yeast cdc2 mutants is unlikely to succeed (see Chapter 5.2).
The use of a dendrogram to assign probable roles to the TbCRK proteins is 
problematic. Fission yeast has so far been shown to have only one cdc2 related gene 
involved in cell cycle control, while budding yeast also has PH085 as a redundant Gl/S 
CDK. As they branched from the eukaryotic tree long after the Kinetoplastida (Sogin et 
al, 1986; Sogin, 1991) this means that either the yeasts have lost genes that were 
present in the joint ancestor or that the vertebrate gene family results from gene 
duplications that occurred after the divergence from yeast. It seems unlikely that 
modem yeast require less control over the cell cycle than the primitive ancestor of 
fission yeast, budding yeast and higher eukaryotes, and so it might be expected that the 
second explanation is correct. If the second explanation is correct, then any similarity 
between different TbCRK proteins and classes of human CDK's may be artifactual and 
not related to shared function. There is the possibility of parallel evolution to result in 
shared sequence motifs for equivalent functions, i.e. a gene duplication occured on the 
kinetoplastid branch, followed by specialisation of the extra gene ( tbcrk3) as a Gl/S 
CDK, and a similar event also occured on the metazoan branch. For this to result in 
proteins that are apparently related, the substrates for the Gl/S CDK, and the regulatory 
proteins of the Gl/S CDK (eg W eel, CDC25, CIP1, etc) would have needed to share 
significant homology even after the amount of evolutionary time equivalent to the 
distance between mammals and the ancestral ancestor of Kinetoplastida and metazoans. 
Therefore, it is probable that the family of protozoan CRK's are not directly analogous 
to the isolated mammalian proteins, and the functions of the TbCRK proteins will have 
to be determined individually. An example of conserved function not being mediated 
by a conserved gene can be seen in the CDK Activating Kinase (CAK) activity in yeast 
and metazoans. In these organisms the CDC2/cyclin complex is phosphorylated on T- 
161 (HsCDC2 numbering) to regulate activity, but the kinases responsible in either S. 
cerevisiae or S.pombe/metazoans are not highly homologous at the sequence level.
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Although at present the large family of CDKs isolated from mammals has not 
been duplicated in other organisms, all multicellular organisms examined including 
plants (Hashimoto etal., 1992; Hirayama etal., 1991) and invertebrates (Lehnerand 
O’Farrell, 1990; Sugaya etal., 1994) have multiple CDK proteins, and in the vertebrate, 
Xenopus laevis, there are reports of CDC2, CDK2 (Egl), CAK (M015/CDK7), and a 
member of the PCTAIR family (Paris etal., 1991;Fesquet etal., 1993; Poon etal.,
1993). It seems likely that the large family of CRKs in multicellular organisms is a 
result of the need to tightly regulate division and differentiation, as unregulated growth 
would be disastrous, as would uncontrolled differentiation. If these gene duplications 
did occur as a result of the evolution of multicellular organisms, then the multiple genes 
isolated from protozoa are due to unrelated events and individual selection pressures. 
This leads to the expectation that each early branch of the eukaryotes is likely to have 
its own set of cdc2 related genes, without clear homologies between them, except in 
closely related organisms, e.g. no crkl-3 homologues have so far been isolated from 
any other protozoa exept the closely related T. congolense, which appears to have a 
crkl related gene (reviewed Mottram, 1994). Notably, although CRK1 and CRK3 are 
conserved between T. brucei and L. mexicana, the expected leishmanial homologue of 
tbcrk2 has not been isolated by PCR, and a 39 kDa protein has not been detected by 
cross reaction with either PSTAIR reacting antisera or antisera raised to TbCRK2.
These reagents would be expected to detect a putative LmmCRK2 protein (See Chapter 
4).
There is as yet no pattern of homologous proteins within the protozoa. Each
species, or family, seems to have its own group of more or less unique CDC2 related
proteins, e.g. Entamoeba histolytica (Lohia and Samuelson, 1993), Plasmodium
falciparum (Ross-McDonald etal., 1994), T. cruzi (reviewed Mottram, 1994),
Crithidiafasciculata (Brown etal., 1992) and Theileria annulata (Kinnaird etal.,
1^96). All of these genes share ~50 % identity with each other and with the CDC2
family from the multicellular organisms. Presumably this is due to the large
eyolutionary distance between each member of the protozoa resulting in the
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conservation of only the essential residues of the ancestral CRK protein. This is further 
evidence that the duplications and specialisation of CRK's within the various protozoan 
lineages happened after branching from the major eukaryote line, and therefore it will 
not be possible to assign roles to CRK's by analogy with other organisms. All of these 
protozoan genes have been cloned by PCR, and as yet none have been shown to 
complement yeast temperature sensitive mutants of cdc2/28, neither have they been 
shown by other means (e.g. mutagenesis, synchronisation) to be invoved in control of 
the cell cycle.
It is possible that the CDC2 homologue in T. brucei has not yet been cloned. 
Further PCR reactions have been tried by J. C. Mottram with CDC2 related kinase 
specific oligonucleotides, and one other gene has been cloned (Personal 
communication). This complements other evidence for the presence of further 
kinetoplastid CRK proteins. Western blots of protein extracts from kinetoplastids using 
PSTAIR reactive antisera often show more bands than the number of isolated CRK 
genes from that organism (see Chapter 4.4). A histone HI kinase activity from 
Leishmania, associated with the division status of the life cycle stage, can be bound to 
the S.pombe pl3sucl protein (Mottram et al., 1993), which has been shown to bind 
tightly to CDC2 related proteins from a variety of organisms. It is possible that this 
protein is LmmCRK3 (J. Mottram, personal communication) expressed at a very low 
level. This would suggest that the CRK3 proteins are likely to be at least involved in 
the execution of cell cycle specific modifications of proteins, even if they are not the 
CDC2 homologue responsible for cell cycle regulation.
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3.4 Partial Cloning of the T. brucei Mitochondrial Elongation Factor G gene ( tbmefg).
3.4.1 Cloning and Sequencing tbmefg.
When mapping and subcloning the pCD70E(S)8 plasmid the 0.9 kb and 0.7 kb 
Hindlll fragments downstream of the tbcrk3 ORF (Figure 3.3.4) were also ligated into 
pBS SK+, and the ends of the inserts sequenced. The predicted translation product of 
one end of the 0.9 kb fragment (pCD191) showed a high level of homology to the 
Elongation Factor G (EF-G) proteins of S. cerevisiae and eubacteria. EF-G is a GTP 
binding protein that controls the translocation of the eubacterial ribosome during 
translation of the mRNA. It has also been found in S. cerevisiae, where it is nuclear 
encoded, and then targetted to the mitochondria (Vanbutas etal., 1991). The equivalent 
protein in eukaryotic cytoplasmic translation is designated EF-2, and shows limited 
homology to EF-G. The rest of the ORF that was within pCD70E(S)8 was sequenced 
by designing oligonucleotides that hybridised to the ends of previously sequenced areas 
(Figure 3.4.1). The rest of the gene, predicted to be approximately another 900 bp 
encoding 300 aa may be present on CD47.2 but has not been subcloned to date.
3.4.2 Comparisons with other EF-G proteins.
The partial sequence of the tbmefg gene encoded 450 amino acids at the N- 
terminus of the protein (Figure 3.4.2). This was compared to that of the predicted 
protein sequences for the reported mitochondrial EF-G proteins, from S. cerevisiae 
(Vanbutas etal., 1991) and rat (Barker etal., 1993), and eubacterial EF-G proteins 
using the pileup programme (Figure 3.4.3). The level of conservation of these proteins 
is high, except at the extreme amino terminus. There is a 58 amino acid extension at 
the N-terminus in the yeast protein. The extension is 17 aa in TbmEF-G, and is not 
present in eubacterial proteins. The extension is expected to be a mitochondrial
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Figure 3.4.1 Sequencing tbmefg
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Figure 3.4.2 The DNA and predicted protein sequence of tbmefg
TTTGTCTATATACCTATTTTACTGTGCCTTTTCAATCCGTAGTCTGAG 4 8
I M R R F C D V
49 ATGAGGAGGT TTTGTGATGT
21 A F L K  N I D
109 GCTTTCTTAA AAAACATTGA
41 G K T T  V T E
169 GGAAAGACAA CTGTCACTGA
61 E V K G  G S E
229 GAAGTTAAAG GGGGATCAGA
81 R G I T  I R S
289 AGGGGGATAA CAATCCGTTC
101 I  I  D T P G H
349 ATAATAGACA CCCCTGGACA
121 L D G A V M L
409 CTCGACGGTG CAGTGATGCT
141 V D R Q M K R
469 GTGGACAGAC AGATGAAGAG
161 R D N A N P R
529 CGTGACAATG CTAACCCTAG
181 A A F I  H L N
589 GCCGCATTTA TTCATCTCAA
201 I  E S R A V Y
649 ATAGAGTCCC GTGCTGTATA
V F Y P N R F
CGTCTTTTAT CCGAACCGAT
K L R N I  G I
TAAGCTTCGA AATATCGGTA
R I  L F Y T G
ACGAATCCTT TTTTATACCG
V G A  T M D S 
GGTTGGTGCA ACAATGGATT
A A T Q C K W
CGCCGCAACA CAGTGCAAAT
V D F T I  E V
TGTCGATTTT ACTATTGAAG
M C G V G G V
GATGTGCGGA GTCGGTGGTG
V G V P R V C
GTATGGTGTG CCCCGTGTTT
R A L E M A R
GCGTGCATTG GAAATGGCGA
M G V A Q D F
TATGGGAGTT GCACAAGACT
F D G K N G E
CTTTGACGGT AAAAATGGGG
Y R L A S S  20  
TTTACCGATT GGCGTCGTCG 1 0 8
S A H I D S  40
TCAGCGCACA CATTGACAGT 1 6 8
R I D  K I  H 60
GTAGAATCGA CAAAATCCAC 2 2 8
M E L  E K E  80  
CGATGGAACT TGAAAAAGAA 2 8 8
G D H L I N  1 0 0
GGGGTGATCA TTTGATTAAT 3 4 8
E R A  L R V 1 2 0
TGGAACGTGC CCTTCGTGTC 4 0 8
Q S Q T L T 14 0
TGCAGAGTCA GACCCTTACG 4 6 8
F I N  K L D 1 6 0
GTTTTATCAA TAAACTAGAT 5 2 8
E R L  G V N 18 0
GGGAACGCTT GGGGGTGAAT 5 8 8
E G V V D V 2 0 0
TTGAAGGTGT TGTCGACGTC 6 4 8
K I R  F E D  220  
AAAAGATCCG ATTTGAGGAT 7 0 8
f
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221 I  P S Y I  A D D V V A T R K  E L I  S R L  2 4 0
709 ATACCAAGCT ACATTGCCGA TGACGTGGTG GCAACACGAA AGGAGCTTAT ATCAAGATTG 7 6 8
241 A D C D A E M E D V  F L N D  V E P  T A E  2 6 0
769 GCTGACTGTG ATGCCGAAAT GGAAGATGTT TTCTTAAACG ATGTGGAGCC TACAGCAGAG 8 2 8
261 Q I  H S A I R  R T T  I A N K  F V P  V L V  2 8 0
829 CAGATTCACT CAGCGATTCG GCGCACCACG ATTGCAAACA AGTTTGTGCC TGTGTTAGTG 8 8 8
281 G S A Y K N K  G I  Q L L L D  A V C  R Y L  3 0 0
889 GGTTCAGCCT ACAAGAACAA‘AGGCATACAA CTTCTTCTTG ATGCCGTCTG TCGTTACCTA 9 4 8
3 0 1 P S P M  E K P  N S G  Y S V T  K V K  D D E  3 2 0
949 CCTTCCCCAA TGGAGAAGCC AAATTCGGGT TACTCGGTGA CCAAGGTAAA GGACGATGAA 1 0 0 8
321 G N V A N V K  G E I  V P L A  T D D  E K P  3 4 0
1009 GGTAACGTTG CCAACGTTAA GGGCGAGATC GTTCCTTTAG CGACTGATGA CGAAAAACCT 1 0 6 8
341 L V A A I  F K L E E  T K K T  G L L  N Y I  3 6 0
1069 CTCGTGGCAG CTATATTTAA GCTTGAGGAA ACGAAGAAAA CCGGCCTTCT TAATTACATT 1 1 2 8
3 6 1 R V Y Q  G K M  R R E  H L L N  V R S  G K T  3 8 0
1129 CGTGTTTACC AGGGTAAAAT GAGAAGGGAA CATTTATTGA ATGTTCGTAG CGGAAAAACG 1 1 8 8
3 8 1 F L P Q  K L V  R M H  A N  39 2
1189 TTTCTTCCTC AGAAGCTGGT CCGTATGCAC GCGAATTC 1 2 2 6
Figure 3.4.2 The region of tbmefg that had been subcloned was sequenced on both strands 
to ensure accuracy, with ITP used to resolve compressions. The amino acid encoded for each codon 
is above the first base of each triplet.
targetting signal in the eukaryotic proteins, and as in this case, these signalling peptides 
are usually very poorly conserved (Hendrick etal., 1989).
The percentage identities given in Table 3.4.1 were calculated by comparing the 
predicted polypeptides over the region from the start of the eubacterial EF-G to the end 
of the available TbmEF-G sequence, therefore ignoring the N terminal extensions. 
TbmEF-G is more similar to the S. cerevisiae mEF-G than to either of the eubacterial 
proteins. In fact the 2 eukaryotic proteins share 52 % identity over this region, while 
only having 43-46 % identity to the bacterial EF-Gs, which have 59 % identity to each 
other.
A dendogram of the TbmEF-G protein with other reported sequences was 
computed (Figure 3.4.4). The sequences used included several eubacterial proteins, 
mitochondrial proteins from both rat and S. cerevisiae, and the partial sequence from 
the gene isolated from Leishmania mexicana which is expected to be the homologue of 
tbmefg (J. Mottram, unpublished results). It also includes a possible chloroplast EF-G 
from Soybean (Torres etal., 1993) and, as an outgroup, the protein (EF-2) which 
performs the equivalent function in the archaebacterium Methanococcus vannielii. It is 
immediately obvious that, as expected, the mitochondrial EF-G proteins form a separate 
group from the bacterial proteins, and that the Kinetoplastida proteins are more similar 
to each other than they are to either of the other eukaryote mEF-Gs.
3.4.3 Discussion of the Trypanosome mEF-G.
The T. brucei EF-G gene isolated is highly conserved, with 46 % identity to the
equivalent E. coli protein over the 433 amino acids presently predicted (Table 3.4.1).
A s  E F - G  i s  e x p e c t e d  t o  b e  e s s e n t i a l ,  a n d  i t  i n t e r a c t s  w i t h  a  l a r g e  n u m b e r  o f  p r o t e i n s  i n
the ribosome and other parts of the translational machinery, it is under a high degree of
functional constraint, which is presumably the reason for the high degree of
conservation present. It has been found that the L. mexicana crk3 gene also has a
downstream ORF that is also homologous to other EF-G genes and the N-terminus of
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Figure 3.4.3 Comparison of TbmEF-G with the S. cerevisiae homoloeue
and bacterial EF-G proteins
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-EEK  TQ KD S ----------- R S -T  M----L A -T  P V-------IV D -----
-G G E-L-EA E -K G -L-Q RVL N -E I I L -T C ----F -------- V -A  M-------- ID ------
-EG E E -E  LVA KG—  D L -IT — FL----L-------- V-----------------VD------
351 400
SPMEKPNSGY SVTKVKDDEG NVANVKGEIV PLATDDEKPL VAAIFKLEET
N -S -V L -T A L  D -S N  NEAK- N-VPAVQQ-F -GLA G
— V D V -A I N - ILDDG-DTPA ERHAS-D— F S -L A — IATD
— L D I - P I  K - T T P E G - ..V -  EIH P-PN G —  A -L A — IMAD
EF-GEF-GEF-GaEF-G
401  4 5 0 +
KKTGLLNYIR VYQGKMRREH LL.NVRSGKT FLPQKLVRMH AN +++
. - Y - Q - T - V -  RL-KGN Y IT — KT— K VKVAR SS +++
P F V -N -T F F - — S -W N SG D  TVL-SVKAAR ERFGRI-Q—  —  +++
P Y V -R -T F —  — S-TLTSG S YVY-TTK-RK ERVAR-L  —  +++
figure 3.4.3 Comparison of predicted EF-G protein sequences from; Tb - T. brucei, Sc 
laromyces cerevisiae, Ec - E. coli, Ta - T. aquaticus.
' 'dentical amino acid to the TbEF-G predicted residue.
• Gap in the sequence for alignment purposes.
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Table 3.4.1 Conservation between T. brucei mEF-G, yeast mEF-G 
and eubacterial EF-G.
ScmEF-G EcEF-G TaEF-G
TbmEF-G 52 (69) 46 (64) 46 (64)
ScmEF-G 43 (66) 45 (64)
EcEF-G 59 (76)
Table 3.4.1 The predicted protein sequences of the efg genes were compared 
using the GAP program. Sc - S. cerevisiae , Ec - E. co li, Ta - T. aquaticus , Tb - T. 
brucei. The area compared was just the region of TbmEF-G that has been sequenced, 
and also did not include the N-terminal extensions of the eukaryotic proteins. The 
first figure in each box is the percentage identity, the figure in brackets is percentage 
similarity.
Figure 3.4.4 Dendrogram of the putative Kinetoplastida mitochondrial Elongation Factor-G 
protein with EF-G proteins from other organisms.
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Figure 3.4.4 The dendrogram shows the relationship between the putative Kinetoplastida 
mitochondrial Elongation Factor-G proteins and other mitochondrial EF-G proteins (mEF-G), 
a chloroplast EF-G (cEF-G), bacterial EF-Gs and the archaebacterial homologue (EF-2).
T h e  n u m b e r s  r e p r e s e n t  t h e  b o o t s t r a p  s u p p o r t  f o r  e a c h  b r a n c h  p o i n t  a s  a  p e r c e n t a g e .
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the L. mexicana mefg has been sequenced (J. Mottram, unpublished results). The 
predicted protein has an N-terminal extension of the same length as TbmEF-G, but this 
is poorly conserved. Within these 20 residues only 5 are identical, including the 
initiating methionine. The rest of the sequenced gene gives a protein that shares 80 % 
identity (71/89 amino acids) with TbmEF-G. These N-terminal extensions show no 
clear homology to the limited consensus of other mitochondrial signal peptides, except 
that both are positively charged and share an initiator-Met-Arg-Arg motif with the 
extremely short signal peptides from Crithidia previously characterised (Xu and Ray, 
1993). The proteins with these signal peptides (which were apparently cleaved from the 
mature protein) were found in association with the DNA of the kinetoplast. The fact 
that there is a homologous gene downstream of tbcrk3 and lmmcrk3 is evidence that 
lmmcrlc3 and tbcrk3 are indeed equivalent genes. It is also an, at present rare, example 
of gene order being conserved between diverged species within the Kinetoplastida.
The hypothesis that TbmEF-G and LmmEF-G are mitochondrial proteins is 
supported by the fact that all other eukaryotes have the related protein, EF-2, as the 
cytoplasmic factor that controls ribosomal translocation. However, this protein has not 
been cloned in T. brucei or L. mexicana, and mitochondrial targetting of the 
kinetoplastid EF-G proteins, or proteolytic cleavage of the N-terminal extension, has 
not been shown.
One important difference between the EF-G and the EF-2 proteins is that EF-G 
does not contain the histidine residue responsible for EF-2's susceptibility to Diptheria 
toxin. This toxin causes the ribosylation of the conserved histidine in EF-2 resulting in 
the halting of translation. The rat efg gene has been isolated (Barker et al., 1993), and 
inhibition experiments with Diptheria toxin imply that this EF-G protein is part of the 
mitochondrial translation machinery only, as no cytosolic translation could be detected 
when cells were treated with the toxin. I am unaware of any attempts to block 
kinetoplastid translation by Diptheria toxin. If the experiment is possible (the toxin 
requires an activation step while crossing the plasma membrane into the cell, which
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may not occur in the trypanosome), and cytosolic translation is blocked, then it is likely 
that the efg genes isolated are only involved in mitochondrial translation.
3.5 Discussion.
The successful cloning of the tbcrk genes, using PCR hybridising to conserved 
domains of CDC2 related kinases shows that the isolation of trypanosome genes 
homologous to those in other organisms is possible when the functional constraints, and 
therefore selection, acting on a protein are high. By analogy with CDK's from other 
organisms, it is expected that the CRK proteins must interact with several other proteins 
in order to function correctly, and loss of activity would be lethal unless there were 
functional redundancy, or unless the product was only needed during specific life cycle 
stages. If there was redundancy, the fact that S. cerevisiae has retained an extremely 
high level of redundancy within the CDK/cyclin complexes, implies that if not lethal, 
the decrease in viability caused by CDK loss of function may result in selection against 
the mutated organism in the enviroment, even though cultured forms may show no 
effect on growth or viability. For instance, bloodstream form T. brucei that contain no 
kinetoplast (dyskinetoplastic) can be isolated, and grown, in culture (Agbe and 
Yielding, 1994), but only low levels (1-2 %) of such organisms have been found in 
vivo. Dyskinetoplastic strains of T. evansi, a parasite which only exists in the 
bloodstream form, have been isolated (Ou et al., 1991), although most strains still retain 
the kinetoplast. Equally, even if the protein was only essential in a specific life cycle 
stage, the loss of the encoding gene would result in an organism unable to complete the 
life cycle, and so unable to be transmitted by the normal routes of infection, as occurs is 
the case with T. equiperdum.
Although CDC2 related genes were isolated, it should be noted that the tbcrk
genes are notably more diverged from the cdk genes of other eukaryotes than other
CDC2 related genes previously found, probably due to the extreme evolutionary
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distance, and possibly also the high level of selection undergone by parasites. For 
instance, the region most commonly used to define a CDC2 related kinase, the PSTAIR 
box, is not well conserved in either TbCRK2 or TbCRK3, and therefore 
oligonucleotides designed to anneal to the PSTAIR box encoding region might not have 
isolated tbcrk2 or tbcrk3.
This variation in which regions are homologous, and the failure to clone a 
kinetoplastid cyclin, shows how important it is to choose the correct area for 
oligonucleotide design, especially when proteins are not expected to have perfectly 
conserved domains. A cyclin-like gene from T. brucei was successful cloned by PCR 
(Affranchino etal., 1993) using only one cyclin specific oligonucleotide. The second 
oligonucleotide was homologous to the Spliced Leader sequence, and the template used 
for the reactions was cDNA. This putative cyclin has an unusual structure with a 
possible destruction box situated towards the C terminus of the protein, and very little 
predicted protein sequence N-terminal to the cyclin box. The level of homology within 
the cyclin box between TbCYCl and either A or B type cyclins from other organisms, 
is considerably lower than usual, with a large number of both gaps and insertions 
necessary for alignment. The number of cyclins now isolated is far higher than in 1990, 
and the regions that are well conserved between widely diverged species are not 
necessarily those chosen at the start of this project. With hindsight, the divergence of 
the CRK PSTAIR regions implies that the kinetoplastid cyclins are likely to be notably 
different from cyclins isolated from other organisms, as this region appears to be 
involved in CDK/Cyclin complex formation (Pines and Hunter, 1989). The unusual 
nature of the T. brucei cyclin is probably going to be matched by other components of 
the kinetoplastid cell cycle machinery, e.g. the activating kinase CAK, Weel, and 
CDC25 homologues, but it is expected that these proteins will be conserved enough to 
he recognised as the Leishmania mexicana homologue of the S. pombe CDC2 complex 
component, plS"®1, has been successfully isolated (Mottram and Grant, 1996).
Aligning the CRK sequences with that of HsCDK2, for which a crystal structure
has been achieved (De Bondt etal., 1993), shows that many of the solvent accessible
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residues, which are expected to be involved in most of the binding reactions with other 
proteins, are not conserved (see Figure 3.3.7). This includes those residues implicated 
in sucl/HsCKSl binding (Bourne etal., 1996; Hayles etal., 1986; Ducommon etal., 
1991a), those in cyclin binding regions (Ducommon etal., 1991a; Ducommon etal., 
1991b), as well as those without any known function. This lack of conservation of the 
CRK surface residues means that assessment of their function by interactions with 
components from other systems, e.g. p l3 sucl, is likely to be difficult, with low affinity 
binding, and therefore problems with signal/noise ratios.
There are several feature that distinguish members of the CRK family.
TbCRK2 has a 40 amino acid N-terminal extention with no homology to any putative 
signalling peptide found in T. brucei, either from proteins expected to be targetted to the 
mitochondria (Peterson etal., 1993) or to those transported into glycosomes (Swinkels 
etal., 1986; Sommer and Wang, 1994). The extentions of TbCRK3 and LmmCRK3 
also have no homology to these putative signalling peptides from T. brucei, the N 
terminal extensions of kinetoplastid associated proteins from Crithidia (Xu and Ray, 
1993), or signalling peptides from other eukaryotes. Interestingly the CRK3 extensions 
also show little shared sequence with each other, with only 6/20 identical residues, 
including the starting methionine (Figure 3.5.1). The protein sequence in the rest of the 
TbCRK3 and LmmCRK3 proteins is very well conserved (80 % identity over 291 
amino acids), but at the residue that is normally the initiator methionine for the 
CDC2/CDK2/3 family, the conservation stops. The role of this extension could be 
structural rather than involved in targetting. Of the 6 conserved residues, 2 are glycine, 
and could be involved in 13-turns, and 2 are an aspartic acid and an arginine, that could 
form a salt bridge.
The TbCRK extensions bear no similarity to the N-terminal extensions of any of
the putative mitochondrial or chloroplast EF-G proteins from other organisms, or
TbmEF-G. There is therefore no evidence for either of the TbCRK extensions playing
a role in synchronising the division cycles of the nucleus and kinetoplast by causing the
complexes to shuttle between the cytosol and mitochondria.
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1Figure 3.5.1 Comparison of TbCRK3 and LmmCRK3
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Amino acid 21, under the *M* symbol, is the consensus start methionine in 
the CDC2/CDK2/3 family of proteins. The two proteins share 80% identity over the 
region from residue 21 to the C-terminus.
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The partial sequence of tbmefg clearly shows a high level of homology to genes 
from both eukaryotes and bacteria (Table 3.4.1). The phylogeny analysis using the 
partial sequences of predicted EF-G proteins does not show any unexpected results. 
Assuming the theory that the eukaryotic nuclear encoded efg genes were ancestrally 
part of the genomes of symbiotes which evolved into either cloroplast or mitochondria, 
then the chloroplast symbiotic event was, as may be predicted, different from that of the 
mitochondria. The data shown does not differentiate between a single symbiosis 
leading to Kinetoplast and higher eukaryote mitochondria, or separate symbiotic events 
in the different lines, as has been postulated to explain the presence of editing in the 
Kinetoplasts.
The high level of conservation seen in both protein and DNA comparisons 
between bacterial and eukaryotic efg genes shows again that the isolation of 
homologous genes which encode proteins that are both essential for in vivo viability and 
which interact with multiple other protein or RNA factors, can be achieved even when 
the organisms are extremely diverged.
CHAPTER FOUR 
ORGANISATION AND EXPRESSION OF THE TBCRK
GENE FAMILY
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4.1 Introduction.
The three tbcrk genes isolated were one of the first family of CDC2-related 
genes cloned from a single-celled organism. We were interested to determine whether 
they played a role in the complex trypanosome life cycle. As explained in Chapter 
1.1.2, T. brucei pass through stages which do not divide and which are essential to 
transmission between species. After transmission the non dividing forms undergo a 
transformation to a rapidly proliferating cell type to set up the infection.
After analysing the genomic organisation of the genes we then attempted to 
raise antisera to the three proteins using both conjugated peptides and fusion proteins 
expressed in E. coli. These antisera were used to characterise the expression of 
TbCRKl-3 in different life cycle stages.
4.2 Gene organisation.
4.2.1 Introduction.
As previously described (see Chapter 1.1.3), many of the genes isolated from 
trypanosomes have been found to be multicopy. These can be at one locus in a tandem 
array or at several locations within the genome. It was important to determine whether 
the tbcrk genes were single or multi-copy so that the attempt to create null mutants of 
the tbcrk genes via homologous recombination could be devised.
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4.2.2 Organisation of the tbcrk gene family.
From the sequencing of the tbcrk3 locus cloned into pBS it was clear that tbcrk3 
at least was not in a tandem array, unless pCD70E(S)8 contained the most 3' gene of 
such an array. Partial mapping of tbcrkl and tbcrk2 had already been done, and 
consulting these maps (see Figure 4.2.1) DNA fragments from each open reading frame 
were prepared. These fragments were labelled with 32-P by random priming and 
hybridised onto Southern blots of T. brucei DNA digested with different restriction 
enzymes (see Figure 4.2.2). Panels A, B and C are T. brucei DNA digested and run on 
a 0.8 % agarose gel in triplicate, blotted to Hybond-N and hybridised to labelled tbcrkl, 
2 and 3 respectively. Single bands were detected for all 3 genes in all four digests, with 
the band size ranging from 1.8 kb to >23 kb. All the bands in each digest are of a 
similar intensity taking into account the reduction in transfer efficiency for large DNA 
molecules. There is no evidence of other lower intensity bands which would be caused 
by regions flanking a tandem array, the implication being that all 3 genes are single 
copy. The lack of any bands the same size hybridising to different probes in any of the 
digests suggests that the genes are not closely linked in the genome. To further address 
the chromosomal location of each of the genes, Pulse Field Gel Electrophoresis (PFGE) 
was performed with T. brucei chromosomes.
4.2.3 Pulse Field Gel Electrophoresis of T. brucei chromosomal DNA.
It is now possible to separate many of the T. brucei chromosomes in agarose 
gels using PFGE (see Chapter 1.1.3). Depending on the parameters used, the small, 
intermediate and many of the megabase chromosomes can be separated, although the 
largest are often unresolved within the compression zone and in many stocks different 
chromosomes migrate at the same rate. PFGE with chromosomes from STIB247 and 
STIB386 was run in triplicate, Ethidium Bromide stained [see Figure 4.2.3(i)] and
transferred to Nylon membrane (performed by N. Buchanan and A. Tait).
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Figure 4.2.1 Restriction maps of the tbcrkl-3 genes.
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Figure 4.2.2 Southern blot of T. brucei genomic DNA. 1.5pig of STIB247 
genomic DNA was digested with each restriction enzyme, and 2.5 pi g of this DNA run 
per lane through a 0.8 % TBE/agarose gel. The gel was blotted to Hybond-N and 
hybridised to tbcrk gene specific probes. Lane \-Xhol, lane 2-EcoR\, lane 3-Bglll and 
lane 4- Bam HI. Panel (A)-probed with tbcrkl fragment, (B)-tbcrk2, (C)-tbcrk3. See 
Figure 4.2.1 for labelled fragments. The hybridisation was performed overnight at 65 
°C with 25 ng of P32 random primed probe and washed for 2 hours at 65 °C in 0.1 x 
SSC / 0.1 % SDS (see Materials and Methods).
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The karyotype clearly varies between the two stocks with all three types of 
chromosome showing different patterns.
The 3 strips were then hybridised to the gene specific probes previously used 
[Figure 4.2.3(ii)]. The three tbcrk genes were located to the megabase chromosomes in 
both of the stocks. 2 bands in the STIB247 extract were detected hybridising to the 
tbcrk2 probe (Panel B, lane 1), indicating that tbcrk2 is located on a different 
chromosome to the other two genes. It is common for homologous chromosomes in T. 
brucei to be different sizes and this is likely to be the case for tbcrk2. In this 
experiment the tbcrk2 probe also hybridised to some of the intermediate sized 
chromosomes. This had not been seen in previous PFGE blots, and may be due to this 
hybridisation being carried out in a higher salt buffer than usual, which may result in a 
higher level of non-specific hybridisation. It should also be noted that the tbcrkl probe 
is the only one of the three which includes some non-coding region, from the 3' 
untranslated region, which may be the reason for it containing DNA elements that 
hybridise to other parts of the genome.
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Figure 4.2.3. Panel (i) Ethidium bromide stained PFG. Lanes 1-STIB247, 
lanes 2-STIB386, lanes 3-S.pombe chromosome markers. The gel was run as described 
(Schweizer etal., 1994), blotted to Hybond-N and hybridised as before (see Figure 
4.2.2). Panel (ii) Autoradiograph of blotted PFG. Panel (A)-probed with tbcrkl 
fragment, (B)-tbcrk2, (C)-tbcrk3.
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4.3 Fusion protein expression for antibody production and analysis of antisera.
4.3.1 Introduction.
To study the expression of the tbcrk genes it was necessary to raise antibodies, 
preferably specific, to each encoded protein. These proteins would also allow the 
assessment of how much cross-reactivity was present between the TbCRK proteins 
when using the available antisera. Antisera available in the laboratory (full list in 
Materials and Methods, Table 2.2.2.1) included Monoclonal antibodies (mAb) raised to 
a 16-mer oligopeptide with the sequence of the human CDC2 PSTAIR box, which were 
a kind gift of Y. Nagahama (Yamashita etal., 1991), and had been previously shown to 
react to at least 2 proteins in T. brucei (Mottram etal., 1993). Also in the laboratory 
were antisera which had been raised to the C-terminal 16 residues of LmmCRKl 
(named CITAA), the C-terminal 16 residues of TbCRK2 (EVREE), and to the 16 amino 
acids of the substituted PSTAIR box of TbCRK2 (PSTA VR). These 3 antisera had 
previously been affinity purified using the respective oligopeptide bound to Aminolink 
coupling gel. It was intended that this project would raise antisera to the TbCRK3 
protein.
Several attempts were made to raise specific antisera to TbCRK3. The first
method tried was to generate a fusion of the tbcrk3 PCR fragment from pCDTrpLl with
Glutathione-S Transferase. The entire EcoRI fragment was cloned into the correct
reading frame of a pGEX vector and the junction sequenced to show that the tbcrk3
gene fragment was in the correct orientation and in frame. The protein formed was
insoluble, and so could not be purified on an affinity column. Small amounts could be
made soluble by treatment with 1 % Triton X-100 and DTT but the yield was very low
and unreliable. An alternative strategy was therefore adopted. An oligopeptide
(Pepl91) homologous to the N-terminus of TbCRK3 was synthesised commercially
(see Materials and Methods). This region was chosen as the N terminal extension was,
as far as we were aware, unique to this protein. It was designed to begin just after the
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second methionine in the protein, as we can not be sure if translation in vivo starts at the 
first ATG.
Predicted TbCRK3 sequence MTMLGALTGRQLSSGLKDQ. . .
Oligopeptide P e p l9 1  sequence CLGALTGRQLSSG
The first residue in the oligopeptide is a non coded Cysteine necessary for the 
manufacturing process. Several milligrams of the peptide had been linked to Keyhole 
Limpet Haemocyanin by the manufacturers ready for injection. Two rabbits were 
inoculated. Sera were taken from the rabbits after one month. They were then given 
booster injections and sera again taken after two weeks. These antisera were tested for 
cross reaction with western blots of T. brucei whole cell protein extracts. No proteins 
of approximately the correct size were detected. It was later shown that the sera from 
the two rabbits also did not react to a full length TbCRK3 fusion protein expressed in E. 
coli (see Figure 4.4.7). It may be that this region is very poorly immunogenic
A third method was tried to raise antisera to TbCRK3. A construct was 
generated containing the entire tbcrk3 ORF tagged with 6 histidine residues at the C- 
terminus (see Materials and Methods) and expressed in E. coli. This (His) 6 tag allows 
the purification of proteins on a Ni2+/agarose matrix, even in denaturing agents such as 
6 M Urea, which allows the purification of proteins that are usually insoluble. The 
protein extract is bound to the column and then washed with buffers of either 
decreasing pH, or increasing concentrations of imidazole (a competitor of the histidine). 
Most contaminating proteins should be removed by pH 6.0 buffer or 100-200 mM 
imidazole. The tagged proteins typically need a pH of 5.4, for monomer elution, or 4.0 
for multimer elution. The equivalent figures for imidazole are 250 and 500 mM. The 
binding and washing of the column has to be performed with solutions without EDTA 
as chelation of the nickel ions results in the complete loss of histidine binding. As the 
expression and purification of full length TbCRK protein would allow the assessment of 
antisera reaction to the protein without interference from other sources, it was decided
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to express TbCRKl and TbCRK2 as His-tagged proteins in E. coli as well for an 
equivalent analysis.
4.3.2 Cloning of the histidine tagged TbCRK proteins.
The expression vector pQE-60 (see Figure 4.3.1) contains restriction enzyme
sites to enable the cloning of ORFs in front of 6 histidine codons followed by a
termination codon. The initiator ATG is formed as part of an Ncol site at the 5' end of
the MCS. Oligonucleotides were designed to amplify the coding region of each of the
tbcrk genes (see Figure 4.3.1). The sequences of the oligonucleotides were altered so
that the sequence coding for the starting methionine included an Ncol site, while at the
3' end, the stop codon was removed and replaced with either a BamHl or a fig/11 site in
the correct frame for the histidine codons. As these enzymes leave compatible
overhangs the vector for all the ligations could be treated with Ncol and BamHl in
duplicate. The tbcrk2 3' oligonucleotide needed to use a fig/11 site as the gene includes
a BamHl site (see Figure 4.2.1). In each case the PCR, from plasmid [pCD70E(S)8 for
tbcrk3] or lambda (for tbcrkl and tbcrk2) template, gave a single band of approximately
1 kb as expected. Pfu DNA Polymerase was used for the PCR as this enzyme has a 3'-
5' proof-reading activity, unlike Taq DNA Polymerase, and so the mutation rate is
twelve fold reduced (see Materials and Methods). The PCR products were purified, the
D N A  w a s  d i g e s t e d  w i t h  Ncol a n d  t h e  3 '  e n z y m e  ( e i t h e r  BamHl o r  f i g / I I ) ,  a n d  l i g a t e d
into Ncol/BamHl cut pQE-60. Transformed colonies of Amp resistant XL-1 Blue were
screened by touching with a sterile toothpick, to transfer some of the colony to a 0.5 ml
cppendorf tube with 20/<l of water which was then boiled for 5 min. This was then
used as template for PCR with Taq DNA polymerase and the original oligonucleotides.
Colonies thought to contain the correct insert were grown up overnight, plasmid DNA
was prepared and then digested with several restriction enzymes to show that the
correct gene had been inserted properly into the expression vector. It is recommended
t h a t  p Q E - 6 0  r e c o m b i n a n t s  a r e  g r o w n  i n  a  b a c t e r i a l  s t r a i n  c o n t a i n i n g  a  m u l t i c o p y
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Figure 4.3.1 The Qiagen his-tagged expression vector and tbcrk oligonucleotides.
The pQE-60 Polylinker sequence
6xHis
CC ATG GGA GGA TCC AGA TCT 
Ncol BamHl BglII
IfTAA GCT TAA TTA GCT GAG 
Hindlll
G CCC ATG GGG AGT CGT TAC GAG C 
CGC GGA TCC GAA CTC GAC AGA AAA GTA T 
G CCC ATG GAG GTG CAG GTG CAG GAA GG 
CG CAG ATC TAG CTC CGT TGA ACC GCA TC 
CC ACC ATG GAC CGG TAT AGC CGA ATA 
GA GGA TCC ATG ACA ATG CTT GGG GCG 
GC AGA TCT AAA CAT GGC ATC ACT AAA 
AT CCC ATG GAC CGC TAT AAT CGA ATG
5' oligo 5'(-5'ext) oligo
tbcrkl/H PCR 5’ primer. 
tbcrkl/H PCR 3’ primer. 
tbcrk2/H PCR 5’ primer. 
tbcrk2/H PCR 3’ primer. 
tbcrk2/H (-5 'ext) PCR 5’ primer. 
tbcrk3/H PCR 5’ primer. 
tbcrk3/H PCR 3’ primer. 
tbcrk3/H (-5 ’ext) PCR 5’ primer.
tbcrk ORF
3' oligo
Figure 4.3.1. The oligonucleotides used to perform PCR so that the tbcrk genes could be 
cloned into pQE-60 are shown. The bases in bold are the engineered restriction sites for 
Ihe in frame insertion into the pQE-60 polylinker. The underlined bases in the polylinker 
are termination codons for all three reading frames.
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plasmid encoding the lacV^ gene, which ensures almost complete repression of the His- 
tagged gene's transcription, and so minimises any toxic effects. I found this was 
unnecessary in the case of the tbcrk genes, and so to make the analysis of plasmid DNA 
restriction digests easier, the subcloning and expression were done in XL-1 Blue, which 
repressed pQE-60 transcription effectively enough, as it contains a chromosomal copy 
of lacl^.
4.3.3 Expression and purification of TbCRK3/His.
Initial small scale expression screening of colonies containing the tbcrk3/h 
plasmid (pQCD236) showed that the protein was expressed and could be purified in 
denatured form using 6 M urea. However attempts at purification of the native form of 
the protein were unsuccessful. No soluble protein could be purified, but by SDS-PAGE 
and coomassie staining it was found that the insoluble pellet contained large amounts of 
a ~34 kDa protein.
The 6M urea extraction was scaled up for a 50 ml culture of cells that had been 
induced with IPTG for 4 hr. The extract was added to the Ni2+/agarose column, washed 
with increasingly acidic buffer, and finally eluted with pH 4.0 buffer. 20/d  of 0.5 ml 
samples were boiled in SDS-Final Sample Buffer (FSB) and run on 12 % SDS-PAGE 
(see Figure 4.3.2). Lane 1 shows the protein remaining after the cell extract has been 
allowed to bind to the Ni2+/agarose column. There is no intense band at 34 kDa, 
implying that the fusion protein has bound to the column. The next two lanes show 
early and late fractions from the first wash, which was performed with 5 ml of the 
column binding buffer B (pH8.0). The proteins washed off in this buffer (lane 2) are 
the proteins that do not bind to the Ni2+/agarose column. Washing with buffer C (pH 
6-0) eluted a large number of proteins (lanes 4-8), with a different profile to the flow 
through (lane 1). These are proteins that bind weakly to the Ni2+/agarose matrix.
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Figure 4.3.2 A 50 ml culture of induced XL-1 Blue/pQCD236 was pelleted, 
resuspended in 5 ml of 6 M urea, Buffer B, then spun at 10 000 g for 15 minutes at 4 
°C. The supernatant was loaded onto a 0.5 ml Ni2+/agarose column. This was washed 
with 5 ml of Buffer B. 0.5 ml fractions were collected after -1  ml (early fraction) and 
-4.5 ml (late fraction) of wash buffer had passed through the column. The Buffer C 
wash consisted of 5 ml collected in 9 fractions of -0 .5 ml. The bound protein was 
eluted with 4 ml of pH4.0 Buffer D, collected as -0 .5  ml fractions. 20 ^  1 of the fraction 
to be run on the gel was boiled for 2 minutes with 5 y \ of 5 x Final Sample Buffer 
(FSB) before loading onto 12 % SDS-PAGE.
Lanes 1-15. (l)-Extract after passage through Ni2+ /agarose column. (2)-Early 
fraction of the Buffer B wash. (3)-Late fraction of the Buffer B wash. (4-7)-Fractions 
2/4/6/8 of the Buffer C wash. (8-15)-Fractions 1-8 of Buffer "D" pH 4.0 elution. For 
Buffers A-D see Materials and Methods.
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The major band in the buffer C wash is actually the TbCRK3/H protein at 34 kDa. The 
elution of large amounts of TbCRK3/H in the wash buffer (Lanes 4-7) may be partially 
due to this buffer being a lower pH than planned when rechecked with indicator paper. 
However, substantial loses of protein during the washing of the column were seen with 
other protein purifications using other buffers. The protein coming off the column early 
may have been trimmed at the C-terminus, which would result in release from the 
matrix under less stringent conditions than usual. The purified protein seen on the 
coomassie stained gel does indeed consist of several closely spaced bands, but there 
appears to be no preferred elution of the lower bands. It is likely that most of the loss is 
due to the weak nature of the histidine/Ni2+ interaction resulting in the gradual loss of 
protein from the column. Treatment of the column with buffer D (pH 4.0) elutes more 
of the bound TbCRK3/H protein, this time in a predominantly pure form. The higher 
molecular weight bands that co-purify with the 34 kDa band are apparently a form of 
TbCRK3/H multimer, formed due to the high level of expression, that has not broken 
down in the FSB when boiled (see Figure 4.4.7, lane 1). The larger bands were not 
always seen when purified TbCRK3/H samples were run on SDS-PAGE and coomasie 
stained.
The protocol used above was scaled up further, and protein prepared from 500
ml of cells. The purified protein from the equivalent of lanes 8-12 was pooled, and then
dialysed into lower dilutions of urea every 10-14 hr. The 6/4/2/1/0 M solutions of urea
also contained 0.05 M Tris-HCl (pH 8.0). In an effort to keep the TbCRK3/H soluble,
the dialysis solutions included 0.005 % Tween-20, 2 mM reduced glutathione and 0.02
mM oxidised glutathione as suggested by the QIAGEN manual. When the
concentration of urea was between 4 M and 2 M the protein precipitated out of solution.
The TbCRK3/H protein was prepared for injection into rabbits by centrifugation of the
urea free material, at 15 000 rpm for 45 min in a microfuge. The supernatant was
carefully removed and the pellet dried under a vacuum before weighing. The pellet was
rcsuspended in dH20  by vortexing and repeated pipetting. Some of the urea free pellet
aud supernatant were run on SDS-PAGE and coomassie stained. All of the TbCRK3/H
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was in the pellet. Some of the TbCRK3/H was kept for analysis of antisera cross 
reaction (see Chapter 4.4.4).
4.3.4 Expression and purification of TbCRKl/His.
Small scale urea purifications of pQCD278.1h showed that tbcrkl/h was being 
expressed at high levels when IPTG was added to the culture medium. Unlike 
TbCRK3/H though, considerable amounts of a 34 kDa protein could also be seen in the 
supernatant of cells lysed without urea present. A native protein purification was 
performed on a 50 ml culture, induced for 4 hr. Instead of using buffers of varying pH 
for the purification, the wash and elution in this case was performed with a step gradient 
of 100/200/300/500 mM imidazole. 3 ml of each imidazole buffer were passed through 
the 0.5 ml column and 1 ml samples of the eluate taken (except for the 500 mM 
imidazole buffer which was collected as four 0.75 ml fractions. 20 ja\ of each sample 
were heated to 37 °C in FSB for 5min before running on 12 % SDS-PAGE (see Figure 
4.3.3). The protein samples containing imidazole were not boiled as the imidazole can 
promote proteolytic cleavage. It appears that although the volume of Ni2+/agarose was 
only 0.5 m l, the column is acting as if there is a 'dead space' of approximately 2 ml.
This may be due to the mixing of previous buffers with the each new imidazole buffer, 
so only slowly raising the competitor concentration with each step of the gradient.
With this interpretation Figure 4.3.3, lanes 3-5 of show that the majority of soluble 
proteins bound to the Ni2+/agarose column can be washed off using 100 mM imidazole. 
The 200 mM imidazole buffer elutes most of the remaining protein (lanes 6-8), but 
again , the histidine tagged protein (at 34 kDa) is eluted in considerable amounts by the 
wash buffer. While TbCRKl/H is preferentially bound to the column, and is the major 
component of the protein eluted by the 300 mM imidazole buffer (lanes 9 and 10), there 
ts a 45 kDa protein contaminating these extracts.
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Figure 4.3.3 A 50 ml culture of induced XL-1 Blue/pQCD278.1h was pelleted, 
resuspended in 5 ml of Sonication Buffer, and lysed by incubation with lysozyme 
followed by sonication. After centrifugation at 10 000 g for 15 minutes the supernatant 
was added to a 0.5 ml Ni2+/agarose column. The column was washed with 10 ml of 
Sonication Buffer, 10 ml of Wash Buffer and then the protein was eluted with a step 
gradient of 3 ml of Wash Buffer containing 100/200/300/500 mM imidazole. The 
imidazole containing buffer was collected as 1 ml fractions, except for the 500 mM 
elution which consisted of 4 x 0.75 ml fractions. 20 /d  of each fraction to be run on the 
gel was heated to 37 °C for 5 minutes with 5 /d  of 5 x FSB before loading onto 12 % 
SDS-PAGE.
Lanes 1-13. (l-3)-100 mM imidazole wash. (4-6)-200 mM imidazole wash. 
(7-9)-300 mM imidazole elution. (10-13)-500 mM imidazole elution.
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This protein bound relatively well to the Ni2+/agarose in other native purifications, 
with or without TbCRKl/H. No protein could be seen in the fractions eluted with 500 
mM imidazole. Presumably none of the TbCRKl/H was multimeric, and so all had 
been eluted by the buffers with a lower concentration of imidazole.
TbCRKl/H protein samples equivalent to Figure 4.3.3, lane 9 were used for the 
antiserum cross-reaction tests (see Chapter 4.4.2), and samples from the equivalent of 
lane 10 were used in the attempts to activate TbCRKl/H (see Chapter 5.3).
4.3.5 Expression of TbCRK2/His.
Small scale urea purifications of pQCD278.2 cultures failed to show any protein 
corresponding to the expected size of TbCRK2/H (approximately 40 kDa). When a 50 
ml culture was treated in parallel with the TbCRKl/H native purification in Figure 4.3.3 
no purification of TbCRK2/H was seen (see Figure 4.3.4). Urea based purifications 
were also unsuccessful. Comparisons between induced and non-induced 
PQCD278.2/XL-1 Blue, whether of pellet or supernatant, revealed very little difference, 
with a major band at 40 kDa in the uninduced bacteria masking any low level 
TbCRK2/H expression. I was unable to convincingly purify TbCRK2/H, but whole cell 
extracts boiled in FSB could be used for the assessment of antibody cross-reaction (see 
Chapter 4.4.3), if the antiserum had not been raised to protein made in E. coli (i.e. 
antipeptide antisera could be used).
4.3.6 Cloning and expression of TbCRK2 & TbCRK3 without the N-terminal 
extensions.
One possible reason for TbCRK2/H and TbCRK3/H not being expressed and 
being insoluble respectively, when TbCRKl/H was both highly expressed and soluble, 
could have been the presence of the N-terminal extensions. It was decided to make new
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Figure 4.3.4 The 50 ml culture of XL-1 Blue/pQCD278.2 was treated, and 
analysed in an identical manner to the TbCRKl/H native purification (see Figure 4.3.3).
Lanes 1-13. (1-3)-100 mM imidazole wash. (4-6)-200 mM imidazole wash. 
(7-9)-300 mM imidazole elution. (10-13)-500 mM imidazole elution.
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constructs by PCR to remove these sequences. Oligonucleotides were designed to 
anneal just 5' to the DNA encoding the ATP binding region (see Figure 4.3.1). As 
before, the oligonucleotides included a Ncol site for subcloning. The same 3' 
oligonucleotides as before were used, and transformants again screened by PCR and 
plasmid restriction mapping. Positive clones for both TbCRK2/H/-5'ext 
[pQCD307/2(2)] and TbCRK3/H/-5'ext [pQCD307/3(9)] were identified.
100 ml cultures of both pQCD307/2(2) and pQCD307/3(9) were induced for 
4hr, and a native protein purification performed without success, apparently for the 
same reasons as with the full length proteins. There was no clear expression of 
TbCRK2/H/-5’ext and no 40 kDa band could be preferentially bound to the 
Ni2+/agarose column (see Figure 4.3.5). TbCRK3/H/-5’ext was insoluble [compare 
Figure 4.3.6, lane 1 (insoluble fraction) with lane 2 (the soluble extract)]. By reducing 
the induction time to 1.5-2 hr, and lowering the growing temperature during this time to 
30 °C it seemed possible to get a low level of expression of soluble TbCRK3/H/-5'ext. 
For unknown reasons this protein was washed off the Ni2+/agarose column at low 
concentrations of imidazole (50-100 mM), and so could not be purified (Data not 
shown). For this reason, the goal of attaining soluble TbCRK3 was abandoned.
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Figure 4.3.5 A 100 ml culture of induced XL-1 Blue/pQCD307/2(2) was 
pelleted, resuspended in 10 ml of Sonication Buffer, and lysed by incubation with 
lysozyme followed by sonication. After centrifugation at 10 000 g for 15 minutes the 
supernatant was added to a 1 ml Ni2+ /agarose column. The column was washed with 15 
ml of Sonication Buffer and a sample collected of the final 0.5 m l. 1 ml of Wash Buffer 
containing 25 mM imidazole was added to the column, mixed for 5 minutes at 4 °C, 
then collected as the Wash Equilibrate fraction (WE). The column was then washed 
with a further 14 ml of the 25 mM imidazole solution, with 0.5 ml samples collected 
after 7 ml (Mid-wash fraction) and 13 ml (Late wash fraction) had flowed through the 
column. The protein was eluted with a step gradient of 6 ml of 50/100/200/500 mM 
imidazole in Wash buffer. Each concentration was first added as a 1 ml fraction, which 
was incubated with agitation to allow the column to equilibrate, as with the 25 mM 
Wash Buffer, then allowed to drain (called fraction E). The next 5 ml were then added 
to the column and collected in 1 ml fractions (I-V). The pellet was resuspended in 10 
ml of sonication buffer, and 20 /d  boiled with 5 /d  of 5 x FSB before loading on 12 % 
SDS-PAGE. 20/d  of the other fractions to be run on the gel were heated to 37 °C for 5 
minutes with 5 /d  of 5 x FSB.
Lanes 1-18. (l)-Resuspended pellet. (2)-Supematant. (3)-Supematant after 
passage through Ni2+/agarose column. (4)-Sonication Buffer wash, final 0.5 ml. (5)- 
Mid-wash fraction. (6)-Late wash fraction. (7-9)-Fractions E/II/IV of the 50 mM 
imidazole wash. (10-12)-Fractions E/II/IV of the 100 mM imidazole wash. (13-15)- 
Fractions E/II/IV of the 200 mM imidazole wash. (16-18)-Fractions E/II/IV of the 500 
mM imidazole elution.
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Figure 4.3.6 The 100 ml culture of XL-1 Blue/pQCD307/3(9) was treated in the 
same manner as for the purification of native TbCRK2/H/-5'ext (see Figure 4.3.5), 
except only 5 \t\ of each fraction was loaded in each lane.
Lanes 1-18. (l)-Resuspended pellet. (2)-Supematant. (3)-Supematant after 
passage through Ni2+/agarose column. (4)-Sonication Buffer wash, final 0.5 ml. (5)- 
Mid-wash fraction. (6)-Late wash fraction. (7-9)-Fractions E/II/IV of the 50 mM 
imidazole wash. (10-12)-Fractions E/II/IV of the 100 mM imidazole wash. (13-15)- 
Fractions E/II/IV of the 200 mM imidazole wash. (16-18)-Fractions E/II/IV of the 500 
mM imidazole elution.
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4.4 The detection of E. coli expressed TbCRK proteins by Western blotting.
4.4.1 Antisera believed to cross-react with the TbCRK proteins.
Antisera raised to PSTAIR or PSTAIR related sequences, (the PSTAIR mAb 
and PSTAVR) were available to be tested for their cross-reactivity to the TbCRK/H 
fusion proteins. There was also antiserum that was expected to be specific for TbCRKl 
(CITAA) and an antiserum raised to the TbCRK2 C-terminus (EVREE) (see Chapter 
4.3.1). There were also antisera from two rabbits injected with the denatured, purified 
TbCRK3/H (see Chapter 4.3.3). The rabbit anti sera were designated TC3HG and 
TC3HS.
4.4.2 Antibody detection of TbCRKl/H.
To test if TbCRKl/H cross reacts with the PSTAIR mAb, partially purified 
TbCRKl/H protein from the Ni2+/agarose column selection (see Figure 4.3.3, lane 9) 
was run on 12 % SDS-PAGE in duplicate, and then electroblotted to PVDF membrane. 
TbCRK2/H (unpurified whole cell extract) and purified TbCRK3/H (see Chapter 4.3.3) 
were also run in duplicate on this gel. Figure 4.4.1 shows the result of incubating one 
set of the 3 proteins with the PSTAIR mAb alone, and the duplicate set with antiserum 
which had been pre-absorbed with the PSTAIR oligopeptide (see Materials and 
Methods). Figure 4.4.1, lanes 1 and 4, show that the PSTAIR mAb detects TbCRKl/H, 
and that the recognition is blocked by addition of an oligopeptide consisting of the 
PSTAIR sequence.
To test which of the other antisera recognised TbCRKl, TbCRKl/H protein
from the Ni2+/agarose column selection was run on a 12 % Polyacrylamide preparation
gel and then electroblotted to PVDF membrane. Strips of the membrane were
incubated with various antisera (see Figure 4.4.2). Figure 4.4.2 shows that TbCRKl/H
is recognised by PSTAVR (lane 5) and CITAA (lane 6), but not EVREE
1 42
Figure 4.4.1 PSTAIR mAb detection of TbCRK/H proteins.
Figure 4.4.1 Extracts of proteins were run on 12 % SDS-PAGE and 
electroblotted to PVDF membrane. Lanes 1 & 4, 10 ng of TbCRK 1/H; lanes 2 & 5, 
whole cell E. coli extract expressing TbCRK2/H; lanes 3 & 6, 10 ng of TbCRK3/H. 
Lanes 1-3 were probed with PSTAIR mAb (1:250 dilution); lanes 4-6 were probed with 
PSTAIR mAb that had been preincubated with 1 \i% / ml PSTAIR oligopeptide.
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Figure 4.4.2 TbCRKl/H detection by CRK and CDK antisera.
1 2  3 4  5 6  7
kDa
Figure 4.4.2 10 ng of semi-purified TbCRKl/H was loaded per lane onto 12 % 
SDS-PAGE and electroblotted to PVDF membrane. Lanes probed with: (1)-TC3HG 
Pre-Immune serum (1:800), (2)-TC3HG Immune serum (1:800), (3)-TC3HS Pre- 
Immune serum (1:800), (4)-TC3HS Immune serum (1:800), (5)-PSTAVR antiserum 
(1:50), (6)-CITAA antiserum (1:50), (7)-EVREE antiserum (1:50).
144
(lane 7) or either of the TC3H antisera (lanes 2 and 4). The reacting bands in lanes 2 
and 4 are impurities that are detected by anti-E. coli antibodies in the polyclonal 
TC3HG and TC3HS sera.
4.4.3 Antibody detection of TbCRK2/H.
Although TbCRK2/H was not purified from E. coli it was thought that whole 
cell extracts from IPTG induced bacteria could contain enough TbCRK2 fusion protein 
to enable assessment of antisera reactivity by Western blotting. If the antisera had been 
raised to a protein expressed in E. coli, however, then the level of cross reaction with 
bacterial proteins precluded assessing TbCRK2/H reactivity. This is presumably due to 
contamination of the inoculated protein and was seen in antisera raised to both histidine 
tagged and GST fusion proteins purified from E. coli. For this reason it was not 
possible to show whether or not TbCRK2/H was recognised by either TC3HG or 
TC3HS. Of the antipeptide antisera; PSTAIR mAb (Figure 4.4.1, lane 2), PSTAVR 
(Figure 4.4.3, lane 2), and EVREE (Figure 4.4.4, lane 2) bind TbCRK2/H specifically, 
while CITAA did not (Figure 4.4.5, lane 2). There was found to be a 34 kDa protein in 
the E. coli extract that was detected by the affinity purified PSTAVR antisera (Figure
4.4.3, lane 2), but this recognition was not blocked by the addition of PSTAVR 
oligopeptide (see Figure 4.4.3, lane 5). Although this protein from the bacterial whole 
cell extract ran at approximately the same position as TbCRKl and TbCRK3, the loss 
of reacting bands in the lanes containing the purified histidine tagged proteins after the 
blocking oligopeptide addition showed that the recognised E. coli protein must be lost 
during the Ni2+/agarose purification. The 40 kDa band detected by the EVREE 
antiserum in the E. coli extract (Figure 4.4.4, lane 2) was notably larger than the 39 kDa 
band seen in the T. brucei long, slender extract (lane 1). The 6 histidine residues cause 
the bacterially expressed protein to be over 0.8 kDa larger.
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Figure 4.4.3 PSTAVR antiserum detection of TbCRK/H proteins.
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Figure 4.4.3 Extracts of proteins were run on 12 % SDS-PAGE and 
electroblotted to PVDF membrane. Lanes 1 & 4,3  ng of TbCRK 1/H; lanes 2 & 5, 
whole cell E. coli extract expressing TbCRK2/H; lanes 3 & 6, 10 ng of TbCRK3/H. 
Lanes 1-3 were probed with PSTAVR antiserum (1:50); lanes 4-6 were probed with 
PSTAVR antiserum that had been preincubated with 1 pig / ml PSTAVR oligopeptide.
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Figure 4.4.4 EVREE detection of TbCRK2/H.
Figure 4.4.4 Extracts of proteins were run on 12 % SDS-PAGE and 
electroblotted to PVDF membrane. Lane 1, whole cell long, slender T. brucei protein 
extract; lane 2, whole cell E. coli extract expressing TbCRK2/H. Both probed with 
EVREE antiserum (1:50).
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Figure 4.4.5 CITAA antiserum does not recognise TbCRK2/H.
kDa
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Figure 4.4.5 Extracts of proteins were run on 12 % SDS-PAGE and 
electroblotted to PVDF membrane. Lane 1, 10 ng of LmmCRKl/H (Purified by 
J.C.Mottram); lane 2, whole cell E. coli extract expressing TbCRK2/H. Both probed 
with CITAA antiserum (1:50).
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4.4.4 Antibody detection of TbCRK3/H.
TbCRK3/H purified using the method described in Chapter 4.3.3 was used for 
Western blotting. The protein was run on 12 % SDS-PAGE and electroblotted to 
PVDF membrane which was then cut into strips to be incubated with various antisera 
(Figure 4.4.6). These strips were processed in the same solutions as the TbCRKl/H 
western blot (Figure 4.4.2). No bands are visible when TbCRK3/H is incubated with 
either of the pre-immune TC3H antisera (Figure 4.4.6, lanes 1 and 3). When incubated 
with the TC3HG and TC3HS immune sera intense bands are seen at the expected size 
of approximately 34 kDa (lanes 2 and 4). The 34 kDa band is also present on the 
membrane exposed to the PSTAVR antiserum (lane 5), while no bands are seen in lanes 
incubated with CITAA (Lane 6) or EVREE (lane 7) antisera. Therefore TbCRK3/H is 
recognised by the TC3HG and the TC3HS antisera as well as the PSTAVR affinity 
purified antiserum. The TbCRK3 fusion protein is not recognised by either the CITAA 
antiserum, raised to the LmmCRKl C-terminal oligopeptide sequence, or the EVREE 
antiserum, raised to the TbCRK2 C-terminal oligopeptide sequence.
When membranes carrying TbCRK3/H were incubated with PSTAIR mAb a 34 
kDa band could be visualised (Figure 4.4.1, lane 3). This recognition could be 
abolished by pre-incubation of the antiserum with PSTAIR oligopeptide (Figure 4.4.1, 
lane 6), showing that the PSTAIR mAb cross reacts with the TbCRK3/H fusion protein. 
In the same manner recognition of TbCRK3/H by the PSTAVR antiserum (Figure
4.4.3, lane 5 and Figure 4.4.3, lane 3) could be blocked by pre-incubation of the 
antibody solution with the PSTAVR oligopeptide (Figure 4.4.3, lane 6).
Figure 4.4.7 shows that the antisera raised to the oligopeptide homologous to the 
N terminal extension of TbCRK3 failed to recognise the histidine tagged TbCRK3 
fusion protein (lanes 2 and 3). Lane 1 shows that protein recognisable by the PSTAIR 
mAb is on the membrane, and that the higher molecular weight bands co-purifying with 
the 34 kDa band in Figure 4.3.2 are also recognised by the PSTAIR mAb, and are
therefore likely to be multimeric forms of the TbCRK3/H protein.
1 4 9
Figure 4.4.6 TbCRK3/H detection by CRK and CDK antisera.
1 2  3  4  5  6  7
Figure 4.4.6 10 ng of semi-purified TbCRK3/H was loaded per lane onto 12 % 
SDS-PAGE. The gel was electroblotted to PVDF membrane. Lanes probed with: (1)- 
TC3HG Pre-Immune serum (1/800), (2)-TC3HG Immune serum (1:800), (3)-TC3HS 
Pre-Immune serum (1:800), (4)-TC3HS Immune serum (1:800), (5)-PSTAVR 
antiserum (1:50), (6)-CITAA antiserum (1:50), (7)-EVREE antiserum (1:50).
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Figure 4.4.7 TbCRK3/H is not detected by antisera raised to the N-terminal 
oligopeptide.
Figure 4.4.7 Purified TbCRK3/H, equivalent to that shown in Figure 4.3.2 lane 
2, was run on 12 % SDS-PAGE and electroblotted to PVDF membrane. Lanes 
incubated with: (l)-PSTAIR mAb (1:250), (2)-N-terminal oligopeptide antiserum A 
(1:250); (3)-N-terminal oligopeptide antiserum B (1:250).
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4.4.5 Discussion of antisera specificity.
The cross reactivity of the available antisera is compared in Table 4.4.1. It is 
immediately obvious that all three TbCRK proteins are detected by both antisera 
directed to the PSTAIR region. Figures 4.4.1 and 4.4.3 show that TbCRKl and 
TbCRK3 are very similar in size and may run together on SDS-PAGE, which is a 
possibly explanation for why only two bands were apparent in previous Western blots 
of T. brucei (of 33 and 39 kDa). The cross reactivity of the three TbCRK proteins with 
the PSTAIR mAb is surprising considering all of them contain substitutions in the 
PSTAIR box. TbCRK3/H has only 10/16 residues conserved with the 16mer 
oligopeptide to which the monoclonal antiserum was raised. While the conservative 
changes, I to L and L to I, would not be expected to radically alter the anti body/epitope 
recognition the non-conservative changes, S to Q and K to Q might. It is possible for a 
single residue change to destroy antibody recognition (Barnett et al., 1990).
The anti-C-terminal antisera are specific for the CRK family member they were 
raised to. EVREE only detects TbCRK2/H (see Figures 4.4.2,4.4.4 and 4.4.6), while 
CITAA detects both LmmCRKl/H (Figure 4.4.5, lane 1) and TbCRK 1/H (Figure 4.4.2, 
lane 6) but not TbCRK2/H (Figure 4.4.5, lane 2) or TbCRK3/H (Figure 4.4.6, lane 6). 
The 5 changes between the 16 C-terminal residues of LmmCRKl and TbCRKl did not 
appear to greatly affect the antibody recognition. The addition of the histidine tag to the 
C-terminus also did not appear to affect antibody binding in any of these cases.
As the TC3HG and TC3HS antisera had been raised to the entire ORF of 
TbCRK3/H it was important to test if the antisera cross reacted with the other TbCRK 
proteins especially as some regions of the CRK proteins are well conserved. The 
monoclonal PSTAIR and the polyclonal PSTAVR antisera had already shown the 
ability of antibodies to recognise sequences related to those that the antibodies had been 
raised to. The histidine tag is reported to be a poor immunogen, and this was confirmed 
when TC3HG and TC3HS were tested against TbCRKl/H as no binding to this protein
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Table 4.4.1 Recognition of the TbCRK proteins by various antisera.
PSTAIR mAb PSTAVR CITAA EVREE TC3HG&S
TbCRKl/H XXX XXX XXX __ __
TbCRK2/H XXX XXX __ XXX ND
TbCRK3/H XXX XXX __ __ XXX
Table 4.4.1 Antiserum/protein recognition.
+++ Protein recognised by antiserum.
No specific reaction seen.
ND Not Done, due to contaminant E. coli protein.
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was detected. The intense band around 27 kDa in these western blots (Figure 4.4.2, 
lanes 2 and 4) shows the strength of reaction to contaminating proteins from E. coli. 
Because of the recognition of this, and other, bacterial proteins, it was not possible to 
test if TC3HG or TC3HS cross reacted with the TbCRK2/H fusion protein. In an effort 
to reduce the cross reaction with E. coli proteins a 0.05 ml aliquot of the TC3HG 
antiserum was diluted 1:20 with 10 mMTris pH 7.5. This was then incubated with 
amino-link beads to which a protein extract from E. coli had been bound (previously 
prepared in WUMP). The flow through from this column [TC3HG(-Ec)]was used for 
some Western blots without a marked reduction in extraneous recognition, presumably 
due to overloading of the column.
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4.5 Analysis of TbCRK expression in different life cycle stages.
4.5.1 Available life cycle stages and protein extracts.
Of the major life cycle stages of T. brucei, it is possible to harvest and perform 
expression analysis with Western blotting techniques on three; the long slender (Is) and 
the short stumpy (ss) bloodstream forms, and in vitro grown procyclic (pc) forms. The 
long slender and procyclic forms are rapidly dividing stages, while the short stumpy 
form is blocked in G1 (see Chapter 1.1.2). It is not possible to purify short stumpy 
forms to homogeneity from a mixed population, however by using laboratory strains 
with high rates of short stumpy formation and infecting irradiated rats it is possible to 
get populations of >75 % short stumpy trypanosomes. 100 % long slender forms can be 
obtained from monomorphic strains of T. brucei. These strains have been selected for 
rapid growth in the rat due to the repeated bloodstream passage via inoculation, and a 
number of alterations have occurred. The rate of VSG switching has apparently 
decreased significantly (Barry and Turner, 1991) and, by definition, they have lost the 
ability to differentiate to the short stumpy form, a transition which must have cell cycle 
controlling protein involvement. Due to this, experiments on the CRK proteins using 
these strains should be interpreted with caution. For some of the Western blots mixed 
bloodstream form trypanosomes (BS) from a pleomorphic strain of T. brucei were used 
instead of purified populations of long slender and short stumpy forms.
Originally S100 extracts were used for Western blotting as the CDK proteins 
from other organisms are generally soluble. Using these extracts however, it was not 
possible to detect TbCRK3 and it was found necessary to use either whole cell extracts 
or both S100 and pellet fractions.
Unless otherwise noted, the procyclic extracts were made from freshly pelleted
STIB247 cultures during log phase growth. The mixed bloodstream forms and the short
stumpy forms are also from the STIB247 line. The monomorphic long slender line
usually used was IstatC123. Bradford assays were used to estimate the protein
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concentration and the extracts were first run on SDS-PAGE and stained with coomassie 
blue to check that there was approximately equal loading before the extracts were used 
for Western blots. Typically, 30 pig of total protein was run in each lane of a small gel, 
SO pig were run per lane on the larger equipment.
4.5.2 TbCRK expression in three life cycle stages of T. b. brucei.
EVREE antiserum, previously shown to recognise TbCRK2/H, was incubated 
with S100 extracts of mixed bloodstream form, short stumpy form and procyclic form 
T. b. brucei that had been run on SDS-page and electroblotted to PVDF membrane (see 
Figure 4.5.1). This Western blot was performed by Dr. Mottram. A 40 kDa protein is 
recognised in all three life cycle stage extracts. The antisera also recognises an 
unknown 50 kDa protein in all of the stages. Relative to the unknown protein it appears 
that the short stumpy forms have an increased amount of TbCRK2 but we do not know 
if the expression of the 50 kDa protein is constant between the three stages tested 
(although total protein loading should have been approximately equal in each lane).
Figure 4.5.2 shows whole cell extracts of long slender form (lane 1), short 
stumpy (lane 2) and procyclic (lane 3) T. brucei incubated with the TbCRK 1 specific 
CITAA antiserum [Plus one lane of long slender extract incubated with the PSTAIR 
mAb (lane 4)]. In all three life cycle stage extracts the predominant band is at 33 kDa. 
There are also varying lower molecular weight proteins recognised which may be due 
to proteolytic cleavage, which occasionally occurred even in the presence of protease 
inhibitors. The 33 kDa protein, presumably TbCRK 1, runs at the same size as the lower 
band of a 34 kDa doublet seen when the long, slender form extract was incubated with 
the PSTAIR mAb
156
Figure 4.5.1 TbCRK2 expression in T. brucei.
Figure 4.5.1 (Supplied by J.C.Mottram) S100 supernatant protein extracts were 
run on 10 % SDS-PAGE, electroblotted to PVDF membrane and incubated with 
EVREE antiserum (1:50). Lane 1-mixed bloodstream form, lane 2-predominantly short 
stumpy, lane 3-cultured procyclic.
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Figure 4.5.2 PSTAIR mAb reacting proteins in long slender form T. brucei and 
TbCRKl expression in different life cycle stages.
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Figure 4.5.2 Whole cell protein extracts from long slender (lanes 1 & 4), short 
stumpy (lane 2), and procyclic (lane 3) T. brucei were run on 12 % SDS-PAGE, 
electroblotted to PVDF membrane and probed with; lanes 1/2/3- CITAA antiserum 
(1:50); lane 4- PSTAIR mAb (1:500).
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antiserum (lane 4). As well as the 34 kDa doublet the long slender extract also shows a 
PSTAIR reactive band at 40 kDa. It is likely that the proteins recognised by the mAb 
are TbCRK 1 (33 kDa), TbCRK3 (34 kDa) and TbCRK2 (40 kDa).
Figure 4.5.3 shows the short stumpy form S100 extracts probed with the 
PSTAIR mAb. Only the 34 kDa and 40 kDa bands were visualised, but this is likely to 
be due to the underloading/underexposure of the blot. Therefore it is expected that the 
non-dividing short stumpy form trypanosomes contain TbCRK2 (the 40 kDa band) and 
at least one of TbCRKl or TbCRK3.
A Western blot of S 100 procyclic extract incubated with the PSTAIR mAb 
results in four distinguishable bands at 33, 40,48 and 60 kDa (see Figure 4.5.4). It is 
unlikely that the 34 kDa doublet of TbCRKl and TbCRKB would be resolved 
adequately on the small Bio-Rad gel kit used in this experiment. It is also possible that 
the doublet is not seen because TbCRK3 is insoluble under these conditions (see Figure 
4.5.7, lanes 3 and 4). The 40 kDa band was expected to be TbCRK2, but the identities 
of the 48 and 60 kDa proteins are unknown. A PCR generated fragment of a fourth 
TbCRK gene (TbCRK4) has been isolated and may be found to encode one of these 
proteins (J. Mottram, personal communication)
Figure 4.5.5 is a Western blot of mixed bloodstream form whole cell extract 
incubated with the PSTAIR mAb (lane 1) and TC3HG Immune antiserum (lane 2). The 
mAb detects the 34 kDa doublet, the 40 kDa protein and an 80 kDa protein as well.
The TC3HG antiserum recognises many proteins in the mixed bloodstream extract, one 
of which runs at the same size as the higher of the band sin the 34 kDa doublet.
Another band co-mi grates with the 40 kDa band from the PSTAIR mAb probed 
Western blot. This strongly suggests that TbCRK3 is expressed in bloodstream form T. 
brucei, and that the larger of the 34 kDa PSTAIR reactive bands is TbCRK3. It also 
implies that TC3HG may cross react with TbCRK2.
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Figure 4.5.3 PSTAIR mAb reacting proteins in short stumpy form T. brucei.
Figure 4.5.3 Whole cell protein extract from short stumpy T. brucei was run on 
12 % SDS-PAGE, electroblotted to PVDF membrane and probed with PSTAIR mAb 
( 1:1000).
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Figure 4.5.4 PSTAIR reacting proteins in procyclic T. brucei S100 supernatants.
Figure 4.5.4 S100 protein extract from procyclic form T. brucei was run on 12 
% SDS-PAGE, electroblotted to PVDF membrane and incubated with PSTAIR mAb 
(1:25) that had been affinity purified by J.C.Mottram.
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Figure 4.5.5 TbCRK expression in bloodstream form T. brucei.
Figure 4.5.5 Whole cell protein extract from mixed bloodstream form T. brucei 
was run on 12 % SDS-PAGE, electroblotted to PVDF membrane and probed with; lane 
1-Affinity purified PSTAIR mAb (1:50); lane 2, TC3HG(-Ec) (1:50).
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Figure 4.5.6 TbCRK3 expression in long slender form T. brucei.
Figure 4.5.6 Whole cell protein extract from long slender T. brucei, run on 12 
% SDS-PAGE and electroblotted to PVDF membrane, was probed with; lane 1-TC3HG 
Pre-Immune antiserum (1:800); lane 2-TC3HG Immune antiserum (1:800).
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Long slender whole cell extracts were run on SDS-PAGE, electroblotted to 
PVDF membrane and incubated with Pre-Immune or Immune TC3HG antisera (Figure 
4.5.6). No bands between 21 and 45 kDa are seen to react to the Pre-Immune (lane 
1).A protein of 34 kDa is detected by the TC3HG Immune antiserum, presumably 
TbCRK3 (see Figure 4.5.6, lane 2), but in this extract no 40 kDa protein was 
recognised.
In Figure 4.5.7 short stumpy S100 and pellet extracts have been run separately 
on SDS-PAGE, and the Western blot incubated with Pre-Immune (lanes 1 and 2) or 
Immune (lanes 3 and 4) TC3HG antisera. Again, the Pre-Immune TC3HG did not 
detect any proteins between 21 and 45 kDa in either the supernatant (lane 1) or the 
pellet fraction (lane 2). The Immune antiserum cross reacts with a 34 kDa protein in 
the pellet fraction (lane 4) and a 26 kDa protein in the S100 supernatant (lane 3). There 
is also a possible very faint band in the supernatant at 40 kDa when incubated with the 
Immune TC3HG. The association of TbCRK3 with the pellet implies that it is bound to 
the cytoskeleton or DNA within the cell. The 26 kDa protein has not been detected 
with the PSTAIR mAb, but if the change in size was due to the removal of 70-80 
residues from the N-terminus (consistent with the mobility change) then the PSTAIR 
box would be missing from the protein. Proteolysis of a CDC2-related kinase in this 
manner has not been seen previously, and as with the lower molecular weight CITAA 
reactive bands (see Figure 4.5.2) it is likely to be an artefact of the sample preparation.
Thd TC3HG antiserum gave high background when incubated with the 
procyclic whole cell extracts but it was just possible to detect a 34 kDa band as 
predicted for TbCRK3, reacting to the Immune serum (Figure 4.5.8, lane 2), while the 
Pre-Immune antiserum (lane 1) detected no bands in this region. Therefore TbCRK3 is 
being expressed in procyclic form T. brucei. No cross reaction of the TC3HG Immune 
antiserum with TbCRK2 was seen due to the level of non-specific signal.
The evidence strongly suggests that all three tbcrk genes so far cloned are 
expressed in the three life cycle stages tested.
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Figure 4.5.7 Insolubility of TbCRK3 in short stumpy form T. brucei.
1 2  3 4
Figure 4.5.7 S I00 protein extracts of short stumpy form T. brucei were run on 
SDS-PAGE and electroblotted to PVDF membrane. Lanes 1 & 3-supematant; Lanes 2 
& 4-pellet fraction. Lanes 1 & 2-TC3HG Pre-Immune antiserum (1:400). Lanes 3 & 4- 
TC3HG Immune antiserum (1:400).
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Figure 4.5.8 TbCRK3 expression in procyclic T. brucei.
Figure 4.5.8 Whole cell protein extract from procyclic T. brucei was run on 12 
% SDS-PAGE and electroblotted to PVDF membrane. Lanel-TC3HG Pre-Immune 
antiserum (1:600); lane 2-TC3HG Immune antiserum (1:600).
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4.6 Discussion.
The data obtained from Southern blots of the tbcrk genes shows that they are 
single copy per haploid genome. At the present time, few T. brucei genes isolated are 
single copy. It would seem unlikely that multiple copies are essential for high level 
expression as the high levels of VSG protein are expressed from a single telomere, 
therefore the VSG gene effectively has a copy number of 1/2 per haploid genome. The 
VSG, however, is transcribed by an alpha-amatin resistant RNA polymerase which 
affects transcription levels. More pertinent is the fact that deletion of two thirds of the 
tubulin genes in Leishmania enriettii by homologous recombination only results in a 
lowering of mRNA levels to 62-76 % of the normal (de Lafaille and Wirth, 1992). The 
evidence so far amassed suggests that mRNA levels for RNA polymerase II transcribed 
genes is regulated by post transcriptional methods. Because of the apparent general 
lack of promoter activation in the kinetoplastids it may be that the method used to allow 
rapid increases and decreases in mRNA levels is constant transcriptional initiation 
followed by variable stability. A single copy gene under these conditions would only 
slowly build up its RNA levels when the message was stabilised.
The TbCRK2/H protein expressed in E. coli had a very low level of expression, 
the reason for which is unknown. The codons used in TbCRK2/H synthesis do not vary 
in frequency fundamentally from the codon bias seen in E. coli ribosomal proteins, so 
limiting tRNA factors should not have caused reduced expression (Zhang etal., 1991). 
In addition Western blots shpw no sign of protein degradation, with the 40 kDa band 
being the only antisera specific band recognised (see Figures 4.4.1 and 4.4.3).
The TbCRK3/H protein expressed in E. coli was extremely insoluble. In this 
case the result does agree with the finding that TbCRK3/H is associated with the pellet 
fraction of S100 extracts (see Figure 4.5.7). In contrast to TbCRK3/H, LmmCRK3/H 
was soluble and could be purified in the native form (J. Mottram, personnel 
communication). Apart from the N-terminal extension, which has 6/20 amino acids
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identical (including the initial Methionine), the two proteins are 80 % identical, yet one 
is soluble in E. coli while the other forms inclusion bodies.
The N-terminal extensions of both TbCRK2 and TbCRK3 were shown to not be 
responsible for these problems. Engineered constructs lacking the extensions behaved 
in the same manner as the full length clones (see Chapter 4.3.6).
The detection of p33, p34 and p40 TbCRKl-3 proteins by the PSTAIR mAb and 
the affinity purified polyclonal PSTAVR antibodies shows that considerable variation 
in the protein sequence can be tolerated in the antibody/epitope recognition. Epitopes 
are typically 3-8 aa in length (Rajadhyaksha and Thanavala, 1995; Thomson etaL,
1995). The nature of an antibody/epitope recognition makes it likely that the region of 
the PSTAIR box that is recognised by the monoclonal antibody is one in which the T. 
brucei proteins have only conservative substitutions. These would make only small 
changes to the epitope's steric, hydrophobic and/or electrical characteristics. The 
probable epitope is contained in the sequence, TAIREISLL, which is bounded by the 
TbCRK3 substitutions, S55Q and K65Q (TbCRK3 numbering). Within this region the 
TbCRK proteins have the conservative changes, I to V, I to L and L to I. The detection 
of TbCRKl/H with the CITAA antiserum is another example of antibody tolerance of 
conservative changes. Within the 16 amino acids of LmmCRKl sequence to which the 
antiserum was raised, TbCRKl has 5 substitutions, with the longest string of perfectly 
conserved residues being only 5 long.
LmmCRKl C-terminal oligopeptide CITAADALNHPYFSLQF 
TbCRKl C^erminus L------Q— E ----------- V E -
The initial Cysteine of the CITAA peptide was necessary for the manufacturing
process. The conserved residues are represented by the -  marks. All of the
substitutions are relatively conservative (I to L, D to Q, N to E, L to V and Q to E),
although in at least one case, a D to Q substitution can result in a marked reduction in
antibody affinity for an epitope (Barnett et al., 1990).
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The three TbCRK proteins were detected in both dividing and non-dividing 
stages of the T. brucei life cycle. This, however, gives no clues to whether or not any of 
these proteins are involved in control of the cell cycle as the presence of the polypeptide 
does not necessarily mean that the kinase is active. In L. mexicana, LmmCRKl is 
present in the amastigote stage, but immunoprecipitates show no histone HI kinase 
activity (Mottram etal., 1993). Therefore, to test whether or not any of the TbCRK 
proteins' kinase activities correlate to the division status of the life cycle stage, protein 
specific purification and activity assessment will have to be carried out. At present 
most of the antisera available are not specific enough for immunoprecipitation, and the 
interaction between CITAA and TbCRKl, unlike that between CITAA and the 
LmmCRKl protein, does not allow immunoprecipitation (presumably due to amino 
acid changes within the recognised epitope/s).
It is also possible that the G1 cell cycle block in the short stumpy stage may be 
due to constitutive activity of a G1 specific CDK as opposed to a lack of activity. This 
would be analogous to the M phase block that occurs when CDC2 is not deactivated 
towards the end of mitosis. This can be caused by the expression of Mitotic cyclins that 
lack the N-terminal "destruction box" (see Chapter 1.2.3 and 1.2.6). When this occurs 
the cells are unable to exit from mitosis due to the continuous activity of the 
CDC2/cyclin complex, normally deactivated by proteolysis of the cyclin subunit 
(Draetta etal., 1989). It is also possible that, due to the divergence between the 
kinetoplastids and other eukaryotes, the TbCRK proteins have no role in controlling the 
cell cycle. There is evidence that LmmCRKl might not be involved in the control of 
the cell cycle (Mottram etal., 1993), at least not in all life cycle stages. The protein 
phylogeny analysis implies that TbCRK2 and TbCRK3 at least are related to the Gl/S 
phase activated CDK4 and CDK6 (see Figure 3.3.9). As noted though, this 
convergence may be an artifact, caused by the divergence of the TbCRK2/3 and the 
CDK4/6 proteins from the CDC2/CDK2 sub-family. Long branches within these 
analyses can cluster due to their differences from the conserved core sequence as
opposed to clustering due to their similarity to each other.
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The similar size of TbCRKl and TbCRK3 on SDS-PAGE, as shown by the 
Western blots of His-tagged proteins (Figures 4.4.1 and 4.4.3) may explain the fact that 
only two PSTAIR mAb reactive proteins were detected in T. brucei protein extracts 
when using the mini-gel SDS-PAGE system. Another explanation is that, at least in the 
short stumpy stage, TbCRK3 is associated with the membrane fraction of an S I00 
protein extract (Figure 4.5.7). Most of the previous Western blots were performed 
using the supernatant of protein extracts (Mottram etal., 1993), which would cause 
insoluble TbCRK3 to be lost. The L. mexicana homologue of TbCRK3 runs notably 
slower than TbCRK3/H on SDS-PAGE as a His-tagged protein (Figure 4.6.1), and so it 
should be easy to see separate bands for LmmCRKl and LmmCRK3 in L. mexicana 
protein extracts. In fact only one PSTAIR mAb reacting band is seen in L. mexicana 
S100 protein extracts, although a 35 kDa band can be seen in S100 extracts from L  
major promastigotes (Mottram etal., 1993). There is now evidence that LmmCRK3 is 
soluble and expressed in promastigote L. mexicana, but at very low levels (J. Mottram, 
personal communication). If so then the expression, and solubility of the CRK3 
proteins would appear to be another difference (to go with the lack of a leishmanial 
homologue of tbcrk2 ) between these two relatively closely related kinetoplastids in 
genes that would be thought to encode well conserved functions. The difference in 
CRK3 solubility when the proteins are extremely similar would imply that the 
association with the insoluble fraction is modulated either by protein modification or 
via association with another protein, because it is not purely to do with integral 
characteristics of the polypeptide primary sequence.
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Figure 4.6.1 Detection of LmmCRK3/H by the TC3HG antiserum.
Figure 4.6.1 Extracts of proteins were run on 12 % SDS-PAGE and electroblotted to 
PVDF membrane. Lane 1, 10 ng of TbCRKl/H; lane 2, 10 ng of semipurified 
TbCRK3/H;lane 3, 2 ng of LmmCRK3/H. The membrane was incubated with TC3HG 
Immune antiserum (1:800).
/
171
One puzzling finding was the occasional detection of an approximately 26 kDa 
protein with various antisera in different life cycle stages. This was detected by 
TC3HG Immune serum in the supernatant of short stumpy form S100 extracts (see 
Figure 4.5.7, lane 3), CITAA in procyclic extracts (see Figure 4.5.2, lane 3), and also by 
EVREE in procyclic trypanosomes (Figure 4.6.2). These bands were not always 
detected, but the recognition of a similar sized band by the three antisera is striking.
The CITAA and EVREE antisera are specific (at least among the CRK proteins) to 
CRK1 and TbCRK2 respectively. It is possible that TC3HG antiserum cross reacts 
with TbCRK2 as well as with TbCRK3 which adds another level of uncertainty as to 
whether the band seen in the short stumpy S100 supernatant is due to a partially 
digested TbCRK3 fragment. These bands would not be seen by PSTAIR box reactive 
antisera as the cleavage of the N-terminus to leave the C-terminal 230-240 amino acids 
(consistent with the mobility shift) would remove the PSTAIR region. It may be that 
there is a common pathway for the proteolytic destruction of the TbCRK proteins, 
presumably encoded by the primary sequence of the polypeptide chain. If the 26 kDa 
protein recognised by the TC3HG antiserum in short stumpy supernatant is a TbCRK3 
fragment, and there is a common degradation pathway, then the region of TbCRK3 that 
results in the sub-cellular localisation must be contained within the N-terminal 90 
residues.
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Figure 4.6.2 A 26 kDa band detected by the EVREE antiserum.
Figure 4.6.2 S100 protein extracts from procyclic T. brucei run on 12 % SDS-PAGE, 
electroblotted to PVDF membrane and probed with; lanel, EVREE antiserum (1:50); 
lane 2, CITAA anti serum (1:50).
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CHAPTER FIVE 
ANALYSIS OF TBCRK FUNCTION BY YEAST 
COMPLEMENTATION AND PROTEIN BINDING
STUDIES
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5.1 Introduction.
The inability to deduce the function of the TbCRK proteins based on amino acid 
sequence homology with CDK proteins with defined roles in other organisms (see 
Chapter 3.3), together with the expression data showing no clear variation between 
dividing and non-dividing form T. brucei (see Chapter 4.5), necessitated alternative 
approaches to the analysis of CRK function in trypanosomes. Two approaches were 
adopted.
(1) Genetic, using an assay based on complementation of a S. pombe cdc2 
temperature sensitive mutant. This method has been used to define cdk functional 
homology in other systems (Michaelis and Weeks, 1992a; Jimenez etal., 1990; Lee and 
Nurse, 1987).
(2) Biochemical, by purification of active kinase complexes. It is possible to 
purify and characterise other proteins which interact with CDC2, and related proteins, 
by isolating the kinase complex itself.
(a) One method which has been used is to produce CDC2 related 
kinases in a heterologous system, e.g. E. coli, in a translational fusion with a 
protein sequence which allows purification, e.g. an antigen tag for which 
specific antibodies enable immunoprecipitation of the kinase (Fisher and 
Morgan, 1994), or a polyhistidine tag which enables affinity purification by 
metal-chelate chromatography. Tagged kinase then can be activated using a 
lysate from the cells of interest. The exogenous kinase can then be purified 
using the tag, and proteins co-purified characterised. In this study an analysis 
of proteins associating with the TbCRK kinase was attempted by activation of 
purified His-tagged TbCRKl.
(b) Another method used to try to purify CRK complexes, which had 
proved successful in other organisms, was to exploit the binding of the 
complex to the S.pombe protein, p l3 sucl, or its homologues from other 
organisms (Azzi etal., 1992; John etal., 1991; Richardson etal., 1990). This
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protein can form multimeric complexes and binds CDC2 and closely related 
kinases with high affinity (see Chapter 1.2.4). A homologue of S. pombe sucl 
has been cloned from L. mexicana (Immcksl) (Mottram and Grant, 1996). 
LmmCKSl had been expressed and purified from E. coli and attached to an 
inert matrix to create an affinity column.
5.2 Complementation Assay of a S. pombe cdc2 temperature sensitive mutant with 
tbcrk3.
5.2.1 Introduction.
A method previously used successfully to isolate cdc2 homologues, and closely 
related proteins, from a wide variety of organisms was the expression of heterologous 
genes in yeast strains which contain mutations in the cdc2/CDC28 genes conferring 
temperature sensitive phenotypes (Jimenez etal., 1990; Lee and Nurse, 1987; 
Ninomiya-Tsuji etal., 1991). These strains of yeast grow normally at low 
temperatures, but mis-sense mutations in the gene result in a protein which is unstable 
at higher temperatures. This results in the mutant cells being unable to complete the 
cell cycle when thay are incubated at the higher, restrictive, temperature. If the 'foreign' 
gene is able to restore growth at the restrictive temperature then it may be because it is 
homologous enough to the mutated gene to replace it. If this is the case then the 
heterologous protein is interacting with the components of the yeast cell cycle correctly, 
and it is therefore likely to be cell cycle regulating in the organism it was originally 
cloned from. It is also possible that genes restoring growth to the mutated yeast strains 
are suppressers of the mutation. In these cases the heterologous protein synthesised 
does not replace the mutated protein, instead it may bind to and stabilise the mutated 
cdc2/CDC28 protein at the restrictive temperature, resulting in a functional kinase. 
Therefore restoration of growth at the restrictive temperature has also been seen with
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protein such as cyclins and p l3suc  ^ homologues (Surana etal., 1991; Hayles etal., 
1986).
It had been previously shown that Immcrkl could not complement a S. pombe 
cdc2-ts mutant (Mottram etal., 1993). As LmmCRKl and TbCRKl share sequence 
motifs in most of the important CRK control regions (see Chapter 3.3), it was thought 
unlikely that tbcrkl would complement the yeast mutant. Also the T. congolense 
homologue, tccrkl, had been found to be unable to complement yeast mutants (N. 
Murphy, ILRAD, personal communication). tbcrk2 had been shown to be unable to 
restore growth at the restrictive temperature in the same S. pombe mutant (J. Kinnaird, 
personal communication). It was decided to repeat the experiment with tbcrk3 as it was 
thought possible that it was the T. brucei cdc2 homologue. Although TbCRK3 lacked a 
well conserved PSTAIR box, the protein does have most of the other control regions 
relatively well conserved, e.g. the ATP binding region, the DSEI box and the region 
around Threonine-161 (see Chapter 3.3.5).
5.2.2 Cloning tbcrk3 into a S. pombe expression vector, and transfection of S. pombe 
cdc2-33.
The full length tbcrk3 ORF was generated using PCR with oligonucleotides
designed to the region of the start ATG, and just after the Stop codon. Restriction
enzyme sites were added to allow ligation of the gene into the S. pombe expression
vector, pMNS21L (Figure 5.2.1). The vector encodes the S. cerevisiae LEU2 gene
which can complement the S. pombe leul gene, so that transfection into a leul" strain of
S. pombe allows selection of successfully transfected cells on plates lacking leucine.
The promoter controlling the inserted gene's expression is repressed by the addition of 5
pig / ml thiamine to the growth medium (Maundrell, K. 1990). By plating on both
repressing and non-repressing media, this theoretically enables the experiment to show
that the rescue of mutant phenotypes is due to expression of the plasmid encoded gene,
and not a reversion of the temperature sensitive cdc2 nuclear copy to wild-type.
i l l
Figure 5.2.1 The S. pombe complementation vector and tbcrk3 oligonucleotides.
NdelJSaW(XbaD/BamHl/Smal
HindIII
Polylinker sequence
Translational start ATG
I
CAlRfGjrCGACTCTAGAGGATCCCCGGG
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EcoRl
EcoRl
Hindlll
Ndel
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Sma 1
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BamHl
OK3-ATG
tbcrk3 ORF
0K3-STOP
V .U I . Th, s . p . *  pMNS21L-
"heelled expression of the gene of interest, r e g u l a t e d  by the paesenee or absen
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However, we subsequently discovered that the repressed state still results in low level 
expression of the gene, and that the unrepressed state should cause extremely high level 
expression. This may result in problems with toxicity if the heterologous protein 
interferes with cellular functions, membrane integrity, or swamps the chaperone 
pathways protecting the cell from the effects of unfolded proteins.
The tbcrk3 gene was amplified from pCD70E(S)8, the insert of which consists 
of the 4.5 kb EcoBl fragment containing the tbcrk3 ORF. The oligonucleotides used for 
the PCR created an Ndel site at the 5' end of the tbcrk3 gene and a BamHl site at the 3' 
end to facilitate the ligation of the tbcrk3 ORF into pMNS21L. 10 rounds of 
amplification were performed using pfu DNA polymerase, which has proof reading 
ability, to reduce the probability of mutations being introduced into the tbcrk3 sequence 
(see Materials and Methods). Portions of the amplified DNA were mapped with a 
variety of restriction enzymes as a partial check for mutations. The rest of the amplified 
DNA was cut with Ndel and Bam HI, followed by ligation into Ndell BamHl cut 
pMNS21L. Plasmid DNA from transformed colonies was mapped with Hindlll and 
Ndel/BamHl to check for insertion of the correct DNA. One plasmid was found to be 
correct, pCD144m. This plasmid was renamed pMNSItbcrk3. Plasmid DNA for the 
yeast transfection was isolated using a large scale QIAGEN plasmid preparation with 
both the original vector and pMNSItbcrk3. Other control plasmids were provided by 
Dr. J. Kinnaird (WUMP). These consisted of the human cdc2 gene, also in pMNS21L, 
in both sense and antisense orientations (pMNSIHscdc2+ and pMNSIHscdc2- 
respectively), and the S.pombe cdc2 gene, this time in another, non-repressible, vector 
(pSpcdc2). The mutant S.pombe strain, cdc2-33, leul-32h~, grew normally at 25 °C, 
and did not divide at 36 °C due to the cdc2-33 mutation. The transfection was carried 
out using the Lithium acetate method (see Materials and Methods). Aliquots of the 
cells were spread onto 6 plates of minimal medium with or without thiamine (+/-thi). 
After 12-16 hr at 25 °C, for recovery, 3 plates from each set of 6 were moved to 36 °C, 
the restrictive temperature, and the plates left to grow for 3 days.
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5.2.3 Results of the complementation assay.
Table 5.2.1 shows the results of the complementation assay. The average 
number of colonies per plate, formed after 3 days at the indicated temperature are 
shown. The transfections using vectors based on pMNS21L all resulted in more than 
100 colonies per plate at the non-restrictive temperature, with or without thiamine. 
Therefore, there is no toxicity associated with TbCRK3 expression. pMNS/tf?cr£3 was 
found to be unable to complement the yeast mutation at the restrictive temperature. 
However, both plasmids containing the human CDC2 gene complemented the yeast 
mutation with limited penetration. The plasmid containing the S. pombe cdc2 gene 
gave a very low level of transfection, but given that, complementation occurred in most 
cases. Equivalent results were obtained using the same control plasmids and testing for 
complementation with a Theileria annulata cdc2 related gene, tacrkl (Kinnaird etal,
1996). The low level of complementation by both of the Hscdc2 containing plasmids 
was due to a mistake in cloning the gene. The 5' primer for the PCR had been designed 
to be complementary to sequence upstream of the ORF instead of being complementary 
to the sequence around the initiator ATG. This may have resulted in the cloning of part 
of the promoter region, which might have caused low level expression of the human 
protein from both plasmids. This may explain the increase in the number of cells 
complemented when thiamine was present, as in its absence the gene would be 
predominantly transcribed either from further upstream (pMNS//ftcdc2+) resulting in 
translation initiating before the in vivo start ATG, or the opposite strand would be the 
major mRNA (pUNS/Hscdc2~), presumably resulting in low levels of the sense strand 
RNA being available for translation.
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Table 5.2.1 Results of the complementation assay.
25°C -thiamine 25°C +thiamine 36°C -thiamine 36°C
pMNS Itbcrk3 123 174 0 0
pMNS21L(-ve) 112 150 0 0
pMNS//£sc<ic2- 174 207 3 8
pMNS IHscdc2+ 152 161 7 13
pSpcdc2 6 ND 3* ND
Table 5.2.1 The numbers in the table are the average number of colonies per 
plate formed after 3 bays at the indicated temperature.
ND - Not done as the plasmid promoter was not repressed by thiamine.
* - Only the result of one plate due to fungal contamination.
Figure 5.2.2 Bar chart showing the complementation results.
250
200
pSpcdc2pMNS/tbcrk3 pMNS21 L(-ve) pMNS/Hscdc2-
■  25 C-thiamine M
H I 36 C -thiamine
pMNS/Hscdc2+
25 C +thiamine 
36 C +thiamine
The vertical scale shows the average number of colonies per plate.
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The fact that similar numbers of colonies containing pMNSItbcrk3 grew at 25 
°C in the absence and presence of thiamine implies that expression of the tbcrk3 gene is 
not toxic to the yeast cells. In order to show that the TbCRK3 protein was being 
expressed in the yeast and to prove that even though the protein was present the gene 
was unable to complement the cdc2 mutation, Western blots were performed. Protein 
extracts of yeast cultures, grown at 25 °C, containing pMNS//6c/±? or pMNS///scdc2+ 
were made. These were then run on SDS-PAGE, blotted to nitro-cellulose membrane 
and probed with both the pre-immune and immune TC3H/G antiserum (Figure 5.2.3). 
Although both the pre-immune and the immune antisera recognise many different 
proteins in the yeast whole cell extracts, one significant difference is detected between 
the tbcrkS and Hscdc2 containing strains when probed with the immune antiserum. A 
34 kDa band is present in the strain containing pMNS/tbcrk3 (lane 4) which is not 
apparent in the strain expressing HsCDC2 (lane 3). This band is the expected size of 
TbCRK3, and is most likely to correspond to this protein. The data suggest that 
although the tbcrk3 gene is expressed in the yeast cells it is unable to complement the 
cdc2-Xs mutant.
5.2.4 Discussion.
There are a number of reasons why the TbCRK3 protein could fail to 
complement -the temperature sensitive cdc2 mutant. The most obvious is that tbcrk3 is 
not the cdc2 homologue of T. brucei, and that due to sequence divergence TbCRK3 is 
unable to correctly interact with other components of the yeast cell cycle machinery; 
specifically, due to the alterations in the PSTAIR region of TbCRK3, it is unlikely that 
the protein could form stable complexes with the S.pombe cyclin(s). It may be that the 
use of PCR to clone tbcrk3 into the yeast expression vector introduced a mutation into 
tbcrk3. The detection of the (approximately) correctly sized protein in the yeast 
extracts would appear to rule out a premature stop codon being introduced, but to
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Figure 5.2.3 Western blot showing the expression of TbCRK3 in S.pombe.
TbCRK3
Figure 5.2.3 Protein extracts from S.pombe strains containing tbcrk3 or human 
cdc2 were probed using TbCRK3 reactive antiserum. Lanes 1 and 3 contain whole cell 
extracts from S.pombe expressing Hscdc2, lanes 2 and 4 are whole cell extracts from S. 
pombe containing tbcrk3. The cells were grown at 25 °C before lysis. The extracts
were diluted into 1 x FSB and run on 12.5 % SDS-PAGE. The proteins were
/
electroblotted onto nitro-cellulose and incubated with either pre-immune antiserum 
(lanes 1 and 2), or immune T3H/G antiserum (lanes 3 and 4), before detection with the 
ECL system.
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absolutely rule out a missense mutation it would be necessary to resequence the gene. 
This was not achiev ed in the time available. Another possible explanation is suggested 
by the evidence that TbCRK3 is associated with insoluble components in the T. brucei 
cell (see Chapter 4.5). This could result in any complex formed in yeast being 
incorrectly targeted. There is also the possiblity that the T. brucei protein is unable to 
phosphorylate the correct yeast substrates. In addition the TbCRK3 protein may only 
be active in insect form trypanosomes, and therefore may be inactive at temperatures 
above those found in the fly (approximately 28 °C). One way to address this question 
would be to try complementation of a cold sensitive mutant.
The complementation data suggest that tbcrk3 is not the cdc2 homologue, 
however a full assessment of TbCRK3 activity during the cell cycle of the different life 
cycle stages is required to answer this question. Although CDC2 genes (and closely 
related genes e.g. CDK2) from many organisms can complement yeast mutants, no 
protozoan crk genes have so far been shown to function in this assay e.g. Theileria 
(Kinnaird etal., 1996), Leishmania (Mottram etal., 1993) and Plasmodium (Ross- 
McDonald etal., 1994), although the Plasmodium gene did not express, so the protein 
may still complement if expression could be achieved. Either none of these genes are 
the cdc2 homologue from that organism or, more likely, the evolutionary divergence 
between yeast and the protqzoans has resulted in cell cycle components that cannot 
interact with each other adequately. It is not possible, at present, to assay TbCRK3 
activity through a typical cell cycle as trypanosomes cannot be successfully 
synchronised, but it may be possible to reach some conclusions from other experiments, 
such as the binding of kinases to p l3 suc  ^ (or its homologues) (see Chapter 5.4), and 
reverse genetic approaches (see Chapter 6).
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5.3 The activation of histidine tagged TbCRK proteins in vitro.
5.3.1 Introduction.
One method previously used to characterise non-kinase components of the CDK 
complexes was to use tagged CDK proteins which could be purified from cell lysates. 
The tagged CDK proteins were either expressed in vitro (Fisher etal, 1994; Poon etal, 
1993), or in vivo (Desai etal., 1992), and the complexes isolated by 
immunoprecipitation. Other components of the complexes could by analysed by SDS- 
PAGE, Western blotting and protein sequencing. These modified CDK's were 
apparently functional in vivo, and therefore, presumably, both associated with their 
normal regulatory subunits and were under the control of the same post-translational 
modifications as the untagged, wild-type proteins. The poly-histidine tag used in the 
previous chapter allows purification of the tagged protein by metal-chelator affinity 
chromatography. As the expression and purification of TbCRK 1/H and TbCRK3/H had 
already been performed successfully these proteins were considered suitable for this 
experiment.
A second approach designed to produce histidine tagged TbCRK complexes was 
the use of homologous recombination to replace a wild type copy of the tbcrk gene with 
the histidine tagged version. This would then theoretically allow purification of the in 
vivo kinase complex directly from T. brucei cell extracts.
5.3.2 Activation of E. coli expressed TbCRKl/H.
TbCRKl/H was used for the attempted in vitro activation and purification as it
was expressed at high level in E. coli (unlike TbCRK2/H) and could be isolated in a
relatively pure form, and it was soluble (unlike TbCRK3/H) and so the activated
complex could be purified using non-denaturing conditions which would not be
expected to disrupt the kinase complex. The protocol used closely followed those
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which resulted in the activation of HsCDC2, HsCDK2 and HsCDK4 by CAK in other 
systems (Fisher etal, 1994; Poon etal, 1993). Purified TbCRKl/H was incubated with 
T. brucei cell lysates made from log phase procyclic form cultures, using a number of 
different methods of cell lysis including sonication and Triton X-100. ATP and Mg2+ 
were also added to the incubations, following the protocols used for CDK activation in 
other systems (Solomon etal., 1993; Desai etal., 1992). Control incubations using 
either no T. brucei cell extract or no purified TbCRKl/H were performed in parallel 
with the attempted activation. Because of the histidine/Ni2+ /agarose purification 
system used, the solutions used for lysis and activation had to be EDTA free, as this 
chelator would strip the Ni2+ from the agarose support (see Chapter 4.3.1).
In the first experiment a cell extract was made by sonicating the procyclic T. 
brucei in Lysis Solution with protease inhibitors, without EDTA and without Triton X- 
100 (LSI-ET). The protease inhibitors used were; 1, 10 phenanthroline (inhibits Zn2+ 
metallo-proteases), pepstatin A (inhibits aspartic, and many acidic, proteases), leupeptin 
(inhibits some serine and cysteine proteases) and phenylmethylsulfonylfluoride 
(PMSF), which irreversibly inhibits serine proteases. Affinity purified TBCRK 1/H was 
added to the whole cell extract and incubated for 30 minutes at either 4 or 25 °C. The 
incubated extracts were then centrifuged at 4 °C for 45 minutes at 15 000 rpm in a 
microfuge, and the supernatant transferred to another tube. One fifth of the supernatant 
(10 pi\) was retained for a histone HI kinase assay, while the rest was added to 10/d of 
Ni2+/agarose bead slurry, allowed to bind for 30 minutes at 4 °C before being 
centifuged and washed twice with 0.5 ml of Kinase Assay Buffer without EGTA (KAB- 
E). Protein bound to the beads was assayed for histone HI kinase activity in situ. The 
pelleted cell debris was resuspended and an aliquot used in the kinase assay. For the 
assay, each sample was added to a Kinase Assay Mix (KAM) containing ^P-yA TP and 
histone HI. 20y \  of each 50yX assay was run on 12 % SDS-PAGE, stained with 
coomassie blue 250, then dried down and exposed to X-ray film (see Materials and 
Methods).
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Figure 5.3.1 shows the results of the experiment performed at 25 °C. The 
experiment performed at 4 °C gave identical results. The lack of radioactive histone 
HI in lanes 1,4 and 7 show that purified TbCRKl/H from E. coli has no, or very low, 
kinase activity on its own. The low level of signal in lane 1 is possibly due to spillage 
from the next lane. The histone HI kinase activity in the T. brucei extract under these 
conditions is almost entirely in the fraction associated with the insoluble cell 
components (compare lanes 2 and 3 with 5 and 6). The other bands show 
phosphorylation of T. brucei proteins by cellular kinases. It may be that the 
predominantly insoluble nature of the kinase activity is contributed to by incomplete 
lysis of the cells. However, T. brucei lysate supernatant plus TbCRKl/H (lane 5), 
shows elevated histone HI kinase activity compared to both the TbCRKl/H only (lane 
4) and the T. brucei supernatant only (lane 6). It would appear that without the 
presence of detergent in the lysis buffer the TbCRK protein complexes are largely 
insoluble. The data suggest that TbCRKl/H is interacting with components of the 
lysate to give a low level of soluble active kinase. With the number of steps involved in 
activation of CDK kinases, it would seem unlikely that TbCRKl/H is being activated 
by a protein on the exterior of the procyclic trypanosomes. It may be that the added 
TbCRKl/H is forming active complexes with excess, soluble, regulatory subunits and 
being phosphorylated by kineses in the insoluble fraction. An alternative possibility is 
that the addition of an excess of TbCRKl/H may release the wild type, active TbCRKl 
complex from the insoluble fraction by competing for whatever is binding to the 
TbCRKl. In this experiment no activity above background was recovered on the 
Ni2+ /agarose beads, which may be due to the low level of activation and inefficient 
binding of the Ni2+/agarose to the histidine tag.
Other experiments were performed using T. brucei procyclic extracts lysed with 
Triton X-100 instead of sonication. These extracts were split into two. One portion 
was centrifuged for 30 minutes at 100 000 g (S100) prior to addition of the TbCRKl/H, 
the other portion was centrifuged after the 30 minute incubation with TbCRKl/H.
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Figure 5.3.1 Activation of TbCRKl/H using sonicated T. brucei procyclic extract, 
without added Triton X-100
1 2 3 4 5 6 7 8 9
Figure 5.3.1 Autoradiograph showing histone HI kinase activity of bacterially 
expressed TbCRKl/H incubated with T. brucei procyclic extract. The cell extract was 
prepared by pelleting 10 ml of log-phase (~8 x 106 cells / ml) procyclic T. brucei, 
washing with PBS, resuspending in 500 /d  of Lysis Solution plus Inhibitors, without 
EDTA, without Triton X-100 (LSI-ET) and sonicating, on ice, for 3 x 20 seconds. To 
one 38//I aliquot of cell extract was added 10 ng (in 5 /d) of E. coli expressed purified 
TbCRKl/H, to the another 38 /d  aliquot was added 5 /d  of the buffer used for 
TbCRKl/H purification. A third tube was prepared with 10 ng of TbCRKl/H and LSI- 
ET only. After the tubes were incubated for 30 minutes at 25 °C the mixtures were 
pelleted at full speed for 30 minutes in a microfuge at 4 °C. The supernatants were 
transferred to fresh tubes, and the pellets resuspended in LSI-ET. A 10 /d  aliquot of 
each of the supernatants was kept aside for the kinase assays. The supernatant was then 
added to 10 /d  of Ni2+/agarose bead slurry, incubated for 30 minutes at 4 °C, and 
washed twice with 0.5 ml of Kinase Assay Buffer (KAB). The beads, the retained 
supernatant and 1 /d  of the resuspended pellet fraction were used for the histone HI 
kinase assays. Lanes 1,4 and 7 contain kinase assays performed with the incubations 
containing only purified TbCRKl/H, lanes 3, 6 and 9 contain no added TbCRKl/H and 
lanes 2, 5 and 8 show the results of TbCRKl/H incubated with T. brucei extract. Lanes 
1-3 are kinase assays performed with the resuspended pellet, lanes 4-6 used the 
supernatant fraction and 7-9 contained the Ni2+/agarose beads.
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In both cases the activation incubation was performed at room temperature. The 
selection and kinase assays were performed in the same manner as before.
The assays using the Triton X-100 lysed extracts are shown in Figure 5.3.2. Panel
(A) shows the kinase assays using the whole cell extracts for the incubation with 
TbCRKl/H, while panel (B) shows the results of a parallel experiment using the S100 
extracts for TbCRKl/H activation. The addition of Triton X-100 solublises much of the 
kinase activity [compare Figure 5.3.2(A), lanes 1 and 3, and Figure 5.3.1, lane 3]. Most 
of the histone HI kinase activity is now present in the soluble fraction [Figure 5.3.2(A), 
lane 3], although considerable kinase activity is still detected in the assay with the 
insoluble fraction [Figure 5.3.2(A), lane 1]. It is plausible that some of this activity is 
due to TbCRK3, which is probably insoluble under these lysis conditions in 
bloodstream form T. brucei (see Chapter 4.5.2). Panel (A) lane 3 and Panel (B) lane 1 
show phosphorylation of higher molecular weight T. brucei proteins, as well as a very 
high level of phosphorylation of low molecular weight proteins. The coomassie 
staining of the SDS-polyacrylamide gel showed that these lower bands were 
predominantly products of histone HI degradation. The same degradation, though less 
complete, occurred in the assays using the Ni2+ /agarose selected extracts [Panel (A) 
lane 5, Panel (B) lane 3] showing that there was notable carry over of proteases, and 
therefore presumably other proteins, on the Ni2+ /agarose matrix. In both experiments 
the assay using the Ni2+/agarose beads in the presence of TbCRKl/H [Panel (A) lane 6, 
Panel (B) lane 4] shows a slightly higher level of kinase activity than the control lanes 
[Panel (A) lane 5, Panel (B) lane 3]. Although the increase is not substantial it is 
consistent. It is therefore possible that activation of the TbCRKl/H protein is occuring, 
and it appears possible to bind the active kinase complex to the Ni2+/agarose beads. If 
TbCRKl/H is being activated then the components responsible for this must be in the 
soluble fraction of the Triton X-100 lysed cells as S100 cell extracts are competent to 
activate the kinase. Due to the insoluble nature of TbCRK3 this experiment implies 
that TbCRK3 is not the T. brucei CDK activating kinase.
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Figure 5.3.2 Activation of TbCRKl/H using a T. brace; Triton X-100 procyclic extract.
histone HI
Degraded 
histone HI
histone HI —►
Degraded _► 
histone HI
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Figure 5.3.2 Histone HI kinase assays of either bacterially expressed 
TbCRKl/H incubated with T. brucei procyclic extract or just T. brucei procyclic 
extract. The extract was prepared by pelleting log phase procyclic T. brucei, washing 
with PBS and resuspending in Lysis Solution plus Inhibitors, without EDTA (LSI-E) 
which included 0.5 % Triton X-100. The extract was divided into two aliquots. One 
aliquot was processed as described in Figure 5.3.1(A), except that 20 ng of TbCRKl/H 
were used [Panel (A)]. The other aliquot was centrifuged at 100 000 g and the 
supernatant (S100) used for the activation incubation [Panel (B)]. As no kinase activity 
had been detected with the purified TbCRKl/H in the previous experiment, the 
TbCRKl/H only control was not performed.
Panel (A), lanes 1,3 and 5 contain no added TbCRKl/H, lanes 2, 4 and 6 show 
the results of TbCRKl/H incubated with whole cell T. brucei extract. Lanes 1 and 2 are 
kinase assays performed with the pellet resuspended after the activation incubation, 
lanes 3 and 4 used the supernatant fraction and the assays in lanes 5 and 6 contained the 
Ni2+/agarose beads.
Panel (B), lanes 1 and 3 contain no added TbCRKl/H, lanes 2 and 4 show the 
results of TbCRKl/H incubated with S I00 T. brucei extract. Lanes 1 and 2 contain 
kinase assays using the supernatant fraction and lanes 3 and 4 show the assays with the 
Ni2+ /agarose beads.
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It was not possible to reduce the degradation of the histone HI in this system 
(which lacked EDTA), even using a number of different protease inhibitors. Although 
degradation of T. brucei extracts was not seen when 10 mM EDTA was added to the 
Lysis Solution, this was not an option in this experiment as EDTA would have removed 
the Ni2+ from the agarose matrix. As the detected proteolysis occurs during the kinase 
assay, after the activation incubation, it seems likely that both the T. brucei proteins and 
the added TbCRKl/H would suffer degradation. This could have been checked by 
Western blotting with CITAA antiserum. Any degradation would explain the poor 
recovery of activity on the Ni2+/agarose beads. It also would make analysis of the 
active kinase complex difficult. With considerable proteolysis occurring in the samples 
it seemed unlikely that characterisation of other components in the complex could be 
carried out. Due to the inability to inactivate what appears to be a high level of metallo- 
protease activity without the chelating effect of EDTA it was decided to attempt other 
methods of CRK complex purification (see Chapter 5.4).
5.3.3 Attempted in vivo histidine tagging of TbCRK3.
One approach to isolating active TbCRK kinase complexes was the integration
of a tagged tbcrk gene into the genomic locus of the gene in place of a wild type allelle.
It was thought that it may be possible to integrate a copy of tbcrk3/H into the T. brucei
genome in place of one or both wild type alleles, and then use the poly histidine tagged
protein to purify the kinase complex. This was prior to the knowledge that TbCRK3 is
insoluble in the standard lysis solutions, and that proteolysis was difficult to inhibit
without EDTA present. Although the vector was constructed (Figure 5.3.3), the
replacement of one allele of the wild type gene was not successfully accomplished. It is
possible that the C-terminal histidine tag may interfere in TbCRK3 function, for
example giving a dominant negative phenotype in which case the integration event
would not be detected. A number of dominant cdc2 mutations have been found making
the scenario of a single replacement causing non-viability possible (Fleig and Nurse,
1 9 3
1991). However, C-terminal epitope tags in other systems have had little or no effect 
on CDK protein function (Desai etal., 1992), and a histidine tag on the C-terminus of 
the L. mexicana CRK1 protein caused no effect (Mottram etal., 1996). As the 
transfection was only performed once, it may simply be due to a technical problem in 
the experiment causing a lack of transfection or integration. Once it became clear that 
TbCRK3 was insoluble it seemed likely that the use of in vivo tagged TbCRK3 to 
isolate the kinase complex would not be such a useful approach. Treatment to 
solubilise the protein is likely to destroy the protein/protein interactions which hold the 
complex together. Also it is evident from the failed attempt to purify TbCRK2/H that 
effective purification of poorly expressed histidine tagged proteins is difficult, and 
according to the manufacturers purification from eukaryotes is generally more difficult 
than from E. co//(QIAGEN). The degradation of added histone HI during the 
attempted activation of TbCRKl/H showed that without EDTA in the lysis solution, T. 
brucei extracts contain active proteases, showing the importance of metallo-protease 
inhibition. It is therefore likely that using an epitope tagged version of the tbcrk genes 
would be a better approach to complex purification. This method has been used 
successfully in other organisms and recently in T. brucei (Bastin etal., 1996) and does 
not require a lack of EDTA, so proteolysis could be limited by the addition of high 
concentrations of the chelator to the cell extract. The epitope tag approach may not 
solve the problem of TbCRK3's insolubility however, as immunoprecipitation of 
insoluble proteins is difficult. Assessment of the function and components of this 
kinase complex may have to occur by other methods, such as reverse genetics.
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5.4 Isolation of TbCRK proteins by binding to p^DnmCKS1
5.4.1 Introduction
The sucl gene of S.pombe encodes a 13 kDa protein which associates tightly 
with the cdc2 kinase complex (Brizuela etal., 1987; Hindley etal., 1987). This tight 
binding has been exploited to isolate and characterise cdc2 homologues, and closely 
related proteins (e.g. CDK2), from other higher eukaryotes, as these proteins also bind 
to p l3sucl (John etal., 1991). A histone HI kinase activity from L. mexicana binds to 
p 13sue 1 (Mottram etal., 1993). This activity correlates with the division status of the 
life cycle stage, but does not appear to be encoded by Immcrkl or lmmcrk3 as the kinase 
is not recognised by LmmCRKl specific antisera or the PSTAIR monoclonal 
antiserum, which would be expected to recognise LmmCRK3. Homologues of sucl 
have been isolated and cloned from a number of organisms, including S. cerevisiae and 
humans, and have been named cks genes (for cdc2 kinase subunit) (Hadwiger et al., 
1989; Richardson etal., 1990). The L. mexicana homologue, Immcksl was isolated 
during my Ph.D. The predicted LmmCKSl protein is 11 kDa with 72% identity to 
human p9CKS1 and 50 % identity to S.pombe p l3sucl. p l 2 LmmCKSl binds yeast cdc2 
kinase complexes implying that it is a functional homologue of p l3 sucl (Mottram and 
Grant, 1996).
5.4.2 Preparation of p l3sucl beads
p l3suel bad been expressed in E. coli and semi-purified by gel filtration by Dr.
J. Kinnaird; this was made available for my studies. HPLC was performed with 3 mg
of this material which was applied to an anion exchange column and eluted using a
NaCl step gradient of 50/200/500 mM. Fractions were assessed for the presence of
protein by absorbance at 280nm and those with high readings were run on 17.5 % SDS-
PAGE and stained with Coomassie blue R-250. Fractions 75 to 81 inclusive were
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pooled and dialysed into 0.1 M phosphate buffer suitable for binding the protein onto 
amino-link gel matrix (Pierce). The dialysed sample was then concentrated by covering 
the dialysis tubing with PEG-6000 for approximately 1 hour. The concentration of the 
solution was then assayed by 280 nm readings and Bradford assays, which gave the 
value of approximately 2 mg / ml in 0.75 ml of buffer. 0.5 ml of p l3 sucl was then 
bound to 0.5 ml of the amino-link matrix to give a 2 mg / ml matrix (see Materials and 
Methods). Determination of the protein concentration left in solution after the binding 
reaction showed that 87 % of the p l3 sucl was successfully bound to the matrix. 2 ml of 
control beads, with Tris-HCl used as the coupling reagent instead of p l3 sucl protein, 
were made in parallel. Similar beads, at a protein concentration of 5 mg / m l, were 
made using histidine tagged p i2 LmmCKS 1, expressed in E. coli, and purified using 
Ni2+/agarose (Mottram and Grant, 1996).
5.4.3 Binding histone HI kinase activity to p l3 sucl/pi2LmmCKSl beads
As a p l3 sucl binding kinase had been described in L. mexicana (Mottram et al.,
1993) we were interested in whether there was a similar activity in T. brucei extracts.
S100 protein extracts were prepared from frozen pellets of long slender, short stumpy
and procyclic form T. brucei. These were incubated with p l3 sucl and control beads at 4
°C for 2 hours, washed extensively with Lysis buffer plus Inhibitors and then assayed
for histone HI kinase activity (see Materials and Methods). The phosphorylated
proteins were often kept at -20 °C overnight. 2 0 1  of the 50 pel kinase assay was run
on 15 % SDS-PAGE, the gel stained with Coomasie blue R-250, and then dried onto
3MM paper. The gel was stained with coomasie to check if the added histone HI
(typically the only visible bands) had been degraded during the assay. The dried gel
was then exposed to X-ray film overnight. Figure 5.4.1 shows the result of histone HI
kinase assays performed with extracts from long slender (lanes 1&2), short stumpy
(lanes 3&4), and procyclic (lanes 5&6) form T. brucei that had been bound to either
control (odd lanes) or p l3 sucl (even lanes) beads. A low level of kinase activity above
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background was detected in the long slender, and procyclic lanes (lanes 2&6) but this 
was not repeatable and indeed in some later assays the control beads were found to have 
higher activities than the p l3 sucl beads. To check that the p l3sucl beads and the other 
components of the assay system were functioning correctly the later experiments 
included assays performed with protein extracts from S.pombe which had been bound 
to the p l3 sucl beads in parallel with the T. brucei extracts. Figure 5.4.2 shows one such 
experiment. High levels of kinase activity were found to bind to the p l3 sucl beads 
using the S.pombe protein extracts (lanes 3&4), thus implying no fundamental problem 
with the components of the assay system.
Similar experiments were carried out with the p i2LmmCKSl beads and a 
procyclic extract. A significantly higher histone HI kinase activity was detected bound 
to the p l2fjnmCKSl beads in comparison to the control or the p l3 sucl beads (Figure 
5.4.3). This is presumably due to the putative cks gene of T. brucei encoding a protein 
which is considerably more homologous to p ^D ^C K S l than to p l3 sucl. A number of 
other proteins, presumably from the procyclic extract, were also phosphorylated during 
the kinase assay. The 23 kDa band is most likely to be degraded histone HI as it could 
be seen on the Coomasie stained gel, and proteolysis was occasionally seen when the 
protease inhibitors had not been made up immediately prior to the experiment. The 
higher molecular weight bands can be seen in other kinase assays performed with 
procyclic T. brucei extracts (see Figures 5.3.1,5.3.2 and 5.4.2), but the marked lower 2 
bands (21 kDa and 18 kDa) appear specific to the extract purified on the p^LmmCKS! 
beads, and may therefore be components of a kinase complex. To assess whether it was 
possibly TbCRK protein kinase activity that was being detected with this assay, 
proteins bound to the beads were eluted, run on 12.5 % SDS-PAGE, blotted onto nitro­
cellulose and probed with antisera tested for TbCRK reactivity.
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Figure 5.4.1 Histone HI kinase assay of T. brucei extracts bound to p !3sucl beads.
1 2  3  4  5  6
histone HI
Figure 5.4.1 Histone HI kinase assays using trypanosome extract bound to either 
p!3sucl bea(js (lanes 2 ,4  and 6) or control amino-link beads (lanes 1,3 and 5). S100 
extracts were made from procyclic form (lanes 1 and 2), short stumpy form (lanes 3 and 
4) and long slender form (lanes 5 and 6) T. brucei. 250 ]a \  of 2 mg / ml extract were 
incubated with 50 yi\ of the 50 % bead slurry at 4 °C for 2 hours with constant agitation. 
After repeated 250 ]a \  washes (1 x LSI, 2 x LSI+1M NaCl, 1 x LSI, 1 x Kinase Assay 
Buffer) the beads were transferred to eppendorf tubes for kinase assays. 20 /d  of each 
50 j a \  reaction were then run on 15 % SDS-PAGE, stained with Coomassie blue to 
check if there had been histone degradation, dried down and exposed to X-ray film.
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Figure 5.4.2 Histone HI kinase assay of T. brucei procyclic and S.pombe extracts
bound to p!3sucl beads.
histone HI
Figure 5.4.2 Histone HI kinase assays performed with freshly centrifuged 
cultured T. brucei procyclic form extracts (lanes 1 and 2) or S. pombe extracts (lanes 3 
and 4). The S100 extracts were incubated with p l3 sucl (lanes 2 and 4) or control beads 
(lanes 1 and 3) before being washed and used for the kinase assays as described in 
Figure 5.4.1.
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Figure 5.4.3 Histone HI kinase assay of T. brucei procyclic extracts bound to p l3sucl
or pl2LmmCKSl beads.
histone HI
Figure 5.4.3 Histone HI kinase assays using S I00 extracts made from procyclic 
form T. brucei. The extract was incubated with either control amino-link beads (lane 
1), p l3 sucl beads (lane 2) or p^LmmCKS* beads (lane 3) at 4 °C for 2 hours with 
constant agitation. After repeated washes with LSI the beads were transferred to 
eppendorf tubes for kinase assays. The products of the assay were then separated by 15 
% SDS-PAGE, stained with coomassie to check if there had been histone degradation, 
dried down and exposed to X-ray film.
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5.4.4 Detection of TbCRK proteins bound to pllLramCKSi beads by Western blotting
T. brucei S100 protein extracts were made from either freshly cultured procyclic 
forms or frozen pellets of mixed bloodstream T. brucei (i.e. containing both long 
slender and short stumpy forms). The extracts were incubated with p^L^nCK Sl or 
control beads, washed repeatedly, then treated with 5 x FSB and boiled for 5 minutes. 
After a 1 minute centrifugation in a microfuge 10//I of each extract was loaded onto a 
12.5% SDS-PAGE, along with 5 ja\ of the original cell extract. After electrophoresis 
these gels were electroblotted onto nitro-cellulose membrane and probed with CRK1, 
TbCRK2 and PSTAIR reactive antisera. As TbCRK3 is not present in S100 extracts 
the T3H/G and T3H/S antisera were not used.
CITAA antiserum, previously shown to recognise TbCRKl/H (see Figure 4.4.1) 
detected a 33 kDa protein in the procyclic S100 extract (see Figure 5.4.4, lane 1). This 
protein was not bound to the control beads (lane 2), but did bind to the p i2LmmCKSl 
beads (lane 3). Therefore TbCRKl either binds to p^LmmCKSl directly or is part of a 
complex that does.
Figure 5.4.4, lanes 4-6, shows the same extracts probed with the EVREE 
antiserum, which was raised to a peptide corresponding to the TbCRK2 C-terminal 16 
amino acids. The 39 kDa band in lane 6 is indication that TbCRK2 was bound to 
p^LminCKSl Other proteins in the procyclic cell extract (lane 4) which were 
recognised by the EVREE antiserum, notably the intense 50 kDa band, did not bind to 
the prclJnmCKSl beads, implying that the association of TbCRKl and TbCRK2 with 
p l 2 LmmCKSl ls specific, and not a general protein/protein interaction between the T. 
brucei proteins and
On a Western blot of procyclic cell extracts (Figure 5.4.4, lanes 7-9), 4 bands 
were recognised in the crude extract at 33, 40, 48 and 65 kDa by the PSTAIR m A b. 
The 33 and 40 kDa bands are presumably TbCRKl and TbCRK2 respectively, and as 
predicted, they bind to the p i2 LnimCKS1 beads specifically. The 48 kDa band also 
binds
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Figure 5.4.4 Western blot of T. brucei procyclic extract bound to pl2LmmCKSl or
control beads.
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Figure 5.4.4 A T. brucei S I00 procyclic form extract was incubated with either 
control amino-link beads or p l2LmmCKSl beads at 4 °C for 2 hours with constant 
agitation. After repeated washes with LSI the beads were transferred to eppendorf 
tubes, 1 x FSB was added and the extracts boiled. The samples, together with an 
aliquot of the starting cell extract, were then run on 15 % SDS-PAGE, electroblotted 
onto nitro cellullose membrane and used for a Western blot using TbCRK reactive 
antisera. Lanes 1/4/7 - S100 extract, lanes 2/5/8 - eluate from control beads, lanes 3/6/9 
- eluate from p l 2 LmmCKSl beads. Lanes 1-3 probed with CITAA (TbCRKl reactive) 
antiserum (1:50), lanes 4-6 probed with EVREE (TbCRK2 reactive) antiserum (1:50), 
lanes 7-9 probed with the affinity purified PSTAIR mAb (1:50).
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Figure 5.4.5 Western blot of T. brucei mixed bloodstream form extract bound to 
p l2LmmCKSl or control beads.
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Figure 5.4.5 A T. brucei S100 mixed bloodstream form extract was incubated 
with either control amino-link beads or p l2LmmCKSl beads at 4 °C for 2 hours with 
constant agitation. After repeated washes with LSI the beads were transferred to 
eppendorf tubes, 1 x FSB was added and the extracts boiled. The samples, together 
with an aliquot of the starting cell extract, were then run on 15 % SDS-PAGE, 
electroblotted onto nitro cellullose membrane and a Western blot performed using 
CITAA (TbCRKl reactive) antiserum (1:50). Lane 1 - original extract, lane 2 - eluate 
from control beads, lane 3 - eluate from p i2LmmCKSl beads.
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to the p l2LmmCKSl beads, while the 65 kDa band appears, surprisingly, to specifically 
bind to the control beads.
Figure 5.4.5 shows an experiment using the S I00 protein extracts from mixed 
bloodstream form T. brucei, with crude extract (lane 1), control beads (lane 2) and 
p l 2 L m m C K S l  beads (lane 3), probed with the CITAA antiserum. As was found with the 
procyclic extracts, a 33 kDa band was bound specifically to the p l2LmmCKS1 beads and 
not to the control beads, therefore TbCRKl is also in a complex which can bind to 
p^LmmCKSl jn bloodstream form trypanosomes.
The Western blots indicate that TbCRKl from both procyclic and bloodstream 
form trypanosomes binds to p^Ln^CKSl. TbCRK2 in procyclic extracts binds to 
p l 2 L m m C K S l j a n c j ft  j s  thought likely that the same protein in bloodstream form T. 
brucei will act in the same way, although this binding has not been shown. It is likely 
that both TbCRKl and TbCRK2 contribute to the kinase activity detected in the hi stone 
HI kinase assay. It is possible however that another kinase also contributes to the 
activity. The histone HI kinase in Leishmania that binds p l3 sucl, named Sucl Binding 
CDC2 Related Kinase (SBCRK), is not LmmCRKl. Therefore it is possible that there 
is a T. brucei homologue of SBCRK bound to the pl^HnmCSKl beads. SBCRK is 
unlikely to be encoded by a leishmanial homologue of tbcrk2. There is no evidence for 
a crk2 homologous gene and the TbCRK2 reactive antisera recognise no likely proteins 
in Leishmania protein extracts.
5.4.5 Metabolic labelling of T. brucei proteins to assess components of the complexes 
binding p^L^^C K Sl.
The low level of homology between cyclins (either classes within an organism
or within the same class between organisms) has , unlike the situation for CDC2 related
kinases, produced antisera that are either protein or species specific. Therefore these
heterologous antisera could not be used to detect trypanosome cyclins. To determine if
the CRKs which bind to p i2 LnunCSK1 were part of complexes possibly containing
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cyclins, procyclic T. brucei were metabolically labelled and extracts selected on 
p l 2 LnmiCSKl beads. Procyclic T. brucei were pelleted, washed, and resuspended in 
Eagles medium lacking methionine. SDM-79, the normal growth medium for procyclic 
trypanosomes, lacking methionine was unavailable, and for the short time needed for 
labelling, the trypanosomes appeared to continue division and remained motile in 
Eagles medium. After 30 minutes in culture, to deplete cellular stores of methionine, 
100p id  of 35S-methionine was added to the medium and the culture incubated for 6 
hours. The cells were washed, pelleted and an S100 extract made. The S100 extracts 
were incubated with either control beads or p^L^^C K Sl beads. After repeated 
washing the beads, the original extract and the unselected flow through from the 
column were diluted into 1 x FSB and boiled. These samples were then run on 12.5 % 
SDS-PAGE in duplicate. One of the gels was treated with Intensify (see Materials and 
Methods) before both were dried onto 3MM paper and exposed to X-ray film.
Intensify amplifies the radioactive signal by converting the low energy beta particle into 
light. This results in a greater proportion of decay events interacting with the X-ray 
film, but does cause an increase in band width, and resulting loss of definition. Figure 
5.4.6 shows lanes from the X-ray film either treated [panel (B)] or not treated [panel 
(A)] with Intensify. The S100 extract prior to adding to the beads is shown in (A) lane 
1. Panel (B), lanes 1 and 2 are the flow through from the p^PHnnCKSl an(j control 
beads respectively. There are no visible differences between the original extract and the 
flow throughs. No depletion of any of the original bands can be detected. The proteins 
which bound to the pi^DnmCKSl beads, plus or minus Intensify, are shown in (B)4 and
(A)2. Intensify treated gel showing the proteins bound to the control beads is shown in
(B)3. The different gels are used because, as noted before, although the Intensify 
causes the images of the labelled bands to become darker, and thereby makes it possible 
to see proteins not otherwise visible, it also has the effect of making the bands notably 
more diffuse.
Most, if not all, of the proteins over 45 kDa in size which bind to the
p l 2 LmmCKSl beads (panel (A), lane 2) do so non-specifically and can be seen, albeit at
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Figure 5.4.6 35S-Methionine labelling of procyclic T. brucei protein extracts selected 
on p l2LmmCSK1 beads.
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Figure 5.4.6 10 ml of log phase (~7 x 106 cells / ml) procyclic T. brucei 
cultures were pelleted, washed twice with PBS, and resuspended in 10 ml of Eagles 
media lacking methionine. After 30 minutes 100 piC\ of 35S-methionine were added to 
the medium and the culture incubated for 6 hours. The cells were pelleted and an S100 
extract made. To bind the extract to control and p i2LmmCSKl beads, 250pi\ of 2 mg / 
ml extract were incubated with 50 yi\ of the 50 % bead slurry at 4 °C for 2 hours with 
constant agitation. After repeated 250 ja\ washes (1 x LSI, 2 x LSI+1M NaCl, 1 x LSI)
1 x FSB was added and the extracts boiled. Aliquots of the original extract and the flow 
through from both columns were diluted into 1 x FSB and boiled. Duplicate 12.5 % 
SDS-PAGE gels were run. Before being dried onto 3MM paper, one gel was treated 
with Intensify which can increase the signal detected by the X-ray film.
Panel (A) shows film from the untreated gel, panel (B) shows the signal from 
the gel treated with Intensify. S100 protein extract (A)l. Row through from the 
control beads [(B)l] and the p l2LmmCKSl beads [(B)2]. Proteins bound to the control 
beads [(B)3]. Proteins bound to the p R 1-111111^ 81 beads [(A)2 and (B)4].
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a lower intensity, on the control beads (Panel B, lane 3). No large, mitotic cyclin-like, 
proteins could be distinguished from other proteins which bind to the matrix non- 
specifically. The bands below the intense, non-specific, band at 50 kDa are 
predominantly specific. There are labelled proteins in Panel A, lane 2 of approximately 
45 kDa, 44 kDa, 43 kDa, 40 kDa, 36 kDa and 34 kDa which do not have corresponding 
bands in the control lane. The two bands below these, at 33 kDa and 32 kDa, are 
possibly present in the control lane (B)3. It is possible that the -45  kDa protein might 
be the 48 kDa PSTAIR mAb reactive band seen bound to the p^DnmCKSl column in 
Figure 5.4.4 lane 9. It may be however that this protein's signal would be obscured by 
the intense, non-specific, 50 kDa band The 40 kDa protein is close in size to TbCRK2, 
which was shown by Western blotting to bind specifically to the p^LhuhCKSI beads 
(see Figure 5.4.4, lane 3). The relatively well labelled 36 kDa protein detected binding 
to the pIILhuhCKSI beads is the same size as the putative cyclin previously isolated 
from T. brucei (Affranchino etal., 1993) which was shown by immunoprecipitation and 
Western blotting to be part of a complex with a 34 kDa 'PSTAIR' containing protein.
Of the triplet around 33 kDa, the lower two proteins may be present in the control 
extracts, while the higher, 34 kDa band appears specific to the p^L^nC K S1 beads. It is 
possible that this 34 kDa protein is TbCRKl, which was also shown to bind to the 
p^DnmCKSl beads using Western blotting (see Figure 5.4.4, lane 6). There are three 
proteins with a Molecular weight lower than 30 kDa which appear to bind specifically 
to the p l2fjninCKSl beads [compare panel (B), lanes 3 and 4]. These proteins have an 
estimated mass of 28 kDa, 26 kDa and 21 kDa. The 21 kDa protein is the same size as 
some inhibitor proteins of CDK activity seen in other organisms, but there is no further 
evidence for this possibility. Recently two other T. brucei cyclins have been isolated 
(J. Mottram personal communication) with predicted sizes of 45 kDa (CYC3) and 24 
kDa (CYC2) respectively. These predicted sizes are similar to the estimated mass of 
two of the proteins bound to the p l2LnimCKSl beads.
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5.4.6 Discussion of p l3 sucVpl2 ljmmCKSl binding studies
There is a histone HI kinase activity in procyclic T. brucei protein extracts 
which binds to p^DnmCKSl^ but not to p l3 sucl (see Figure 5.4.3). Immunoblotting 
experiments with CRK1 and TbCRK2 specific antisera revealed the binding of 
TbCRKl and TbCRK2 to the p l2bmmCKSl beads (see Figure 5.4.4). Therefore the 
histone HI kinase activity is likely to be, at least partially, due to TbCRKl and 
TbCRK2. Evidence from metabolic labelling experiments suggests that these kinases 
are part of multi-protein complexes.
A histone HI kinase activity was detected in procyclic T. brucei which binds to 
p l2LmmCKSl (see Figure 5.4.3), but no such activity was demonstrated binding to 
p l3sucl [n either procyclic or bloodstream trypanosomes (see Figure 5.4.1). This is 
unlike the situation in L. mexicana which contains SBCRK, a p l3 sucl binding kinase 
(Mottram etal. 1993; Mottram and Grant, 1996). Histone HI kinase activity from S. 
pombe was selected on p l3sucl beads thereby showing no fundamental problem with 
the experimental procedure. It may be that there is a T. brucei homologue of SBCRK, 
but that it has different p l3 sucl binding characteristics. Another explanation for this 
difference would be that SBCRK is specific to Leishmania, and not present in T. brucei. 
SBCRK could be one of the many CDC2 related kinases in protozoa (Mottram, 1994), 
and may not be the functional CDC2 homologue, even though its activity appears 
related to the division status of the life cycle stage (Mottram etal. 1993; Mottram and 
Grant, 1996). The fact that SBCRK is not recognised by the PSTAIR antisera also 
provides some evidence that it is not as closely related to CDC2 as the TbCRK proteins. 
This is further support for the idea that many of the protozoan CDC2 related proteins 
are highly divergent, possibly evolved for tasks specific to the organism, and unlikely to 
be even functionally analogous to each other.
The kinase assays show a number of phosphorylated proteins that are not
derived from histone HI (the only exogenously added protein), and therefore are
components of the T. brucei extracts (see Figure 5.4.3). It is possible that the low
210
molecular weight proteins could be CKI related proteins. These inhibitory subunits are 
effective when bound to the CDC2/cyclin complex with a 1:1 stoichiometry. Therefore 
there could still be kinase activity if only a subpopulation of the kinase complexes 
contain the inhibitory subunits. The smallest protein at 18 kDa could be the T. brucei 
homologue of p^DnmCKSl $ cerevisiae p l3sucl homologue is 18 kDa 
(Hadwiger etal., 1989). In some organisms sucl/CKS proteins form dimers or 
hexamers, and so it is possible that hetero-complexes of leishmanial and trypanosome 
CKS proteins could form on the beads during the incubation with cell extracts. It is 
possible that the 21 kDa protein could be the CYC2 protein. The cyclins would be 
expected to be found in the p^HnmCKSl bound extract, and there is evidence for 
phosphorylation of cyclins by CDK complexes (Lanker etal., 1996). These 
phosphorylated proteins could also be binding non-specifically to the p^DnmCKSl 
beads, and contain consensus sites for phosphorylation by the CRK complexes.
The Western blot of T. brucei extracts bound to pilDnmCKSl beads using the 
CITAA (CRK1 reactive) antisera showed that a complex containing TbCRKl interacts 
with the L. mexicana CKS1 protein (see Figure 5.4.4, lanes 1-3). TbCRK2 containing 
complexes were detected bound to pilDnmCKSl beads using the EVREE (TbCRK2 
reactive) antisera (see Figure 5.4.4, lanes 4-6). Therefore it is likely that these proteins 
would interact with a T. brucei CKS1 homologue. The sucl gene is essential in S. 
pombe and well conserved homologues have been isolated from S. cerevisiae, 
Leishmania and H. sapiens, making it extremely likely that there is a T. brucei 
homologue. The PSTAIR mAb also detected the binding of a 48 kDa protein to the 
p l2DmnCKSl beads (see Figure 5.4.4, lanes 7-9). This possible kinase may be involved 
in the phosphorylation of histone HI, but this is unlikely to be the sole HI kinase as the 
activation experiments using TbCRKl/H did show some kinase activity which was 
correlated to selected His-tagged TbCRKl (see Figure 5.3.2). Subsequently histone HI 
was shown to be a relatively poor substrate for the LmmCRKl/H protein kinase so 
other substrates may be more suitable for continuations of these experiments (J. 
Mottram, personal communication).
211
Using 35S-methionine labelling, several proteins were detected that specifically 
bound to the p^LnnnCKSl beads (see Figure 5.4.6). The 36 kDa protein could be the 
CYC1 protein isolated previously (Affranchino etal., 1993). CYC1 was shown, by 
immunoprecipitation experiments, to interact with a 34 kDa protein recognised by the 
PSTAIR mAb. As TbCRKl is approximately 34 kDa and reacts with the PSTAIR 
mAb, it is possible that TbCRKl is a kinase subunit for CYC1. A 39 kDa PSTAIR 
reactive band was not seen in CYC1 immunoprecipitates (Affranchino etal., 1993), 
implying that TbCRK2 has different complex components. These would probably 
include one or more of the other proteins detected bound to the p l2LmmCKSl beads, two 
of which could be the CYC2 or CYC3 proteins. The lower molecular weight protein 
(21 kDa) specifically bound to the p^U ^C K S l beads in the 35S-methionine labelling 
experiment (see Figure 5.4.6) may be the same as the 21 kDa phospho-protein detected 
previously in the p ^ D ^ C K S l bound kinase assays (see Figure 5.4.3).
TbCRK3 was found in the insoluble fraction after lysis in Triton X-100 and so it 
was not possible to determine if TbCRK3 could bind to the p^DnmCKSl beads using 
this protocol. It may be possible to solublise TbCRK3 using other buffers such as high 
salt, or different detergents, but these treatments could not be too stringent if the 
complex is to remain intact.
5.5 Discussion
Various methods of analysis were used for the characterisation of the TbCRK
family. As with Immcrkl and tbcrk2 , tbcrk3 was found to be unable to complement a
cdc2-ts mutant of S.pombe. It is possible that there is no cdc2 complementing gene in
T. brucei, although the equivalent experiments in S. cerevisiae may be tried. Attempts
to complement a S. cerevisiae CDC28-XS mutant using a T. brucei cDNA library proved
unsuccessful (Neuville and Mottram, unpublished). This is further evidence for the lack
of a complementing cdc2 related kinase. There is evidence that there are other cdc2
related genes in T. brucei (see Figure 5.4.4, lane 7), but due to the methods used to
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clone tbcrkl-3 (degenerate oligonucleotide PCR and library screening), it seems likely 
that any other tbcrk genes will be less conserved than those already isolated. It is 
possible that T. brucei contains a homologue of the Crithidia fasciculata crk gene 
(Brown et a l., 1992). This gene encodes a CDC2-related protein (CfaCRK) with a 
degenerate PSTAIR box (12 out of 16 amino acids conserved) and two large insertions 
resulting in a 53 kDa protein, a size not too dissimilar to the 48 kDa band recognised by 
the PSTAIR mAb. The PSTAIR mAb used in this paper did not recognise the CfaCRK 
protein, but it is possible that this mAb recognises a different epitope to the mAb used 
during my Ph.D.
The activation of TbCRKl/H, and the purification of the activated kinase, 
showed that this method was a viable means of isolating active kinase complexes if 
proteolysis could be controlled. The dependance of the kinase activity on the exposure 
to the cell extract implies that the TbCRKl protein requires the binding of other 
proteins and/or modifications (such as phosphorylation) for correct function. This 
accords with what is known from other cdc2-related proteins. The Plasmodium 
falciparum protein PfPK5 is associated with a weak kinase activity when purified from 
E. coli (Ross-MacDonald etal., 1994), but this activity is considerably stimulated by 
replacement of the equivalent of the Thr-161 residue by an acidic amino acid, 
simulating the phosphorylated state (Graeser etal., 1996). Similar results have been 
found with other CDK subunits where phosphorylation of the Thr-161 equivalent is 
necessary for kinase activity, while cyclin binding is required for optimal activity 
(Desai etal., 1992). One exception to this is CDK5 which has kinase activity when 
complexed with its p35 subunit without needing phosphorylation (Qi et al., 1995).
The in vitro activation result also implies that, at least with this protein, the
histidine tag does not seriously interfere with the protein function. This has been
confirmed in vivo in Leishmania where LmmCRKl-his is functional (Mottram etal.,
1996). It seems probable that modification of this technique, possibly by using an
epitope tagged protein allowing immunoprecipitation, would allow analysis of the
protein factors and modifications involved with the activation. For this to happen
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though, it would be best to use a specific antiserum that does not cross react with T. 
brucei proteins, and so far this has been difficult to obtain in antisera with high enough 
affinity to allow immunoprecipitation. The fact that the activation took place when the 
TbCRKl/H was added to S100 supernatant from the lysed cultures implies that 
TbCRK3 is not involved in the activation, as under these conditions TbCRK3 is 
insoluble and remains in the pellet fraction. If epitope tagged proteins can be isolated 
efficiently from T. brucei then the targeted replacement of the wild type genes with the 
tagged version would also allow assessment of the components of the kinase 
complexes, although due to its insoluble nature this still might not work as well for 
TbCRK3. Although immunoprecipitation of TbCRK3 may be difficult, the epitope 
tagged version would allow easy localisation of the protein in fixed cells using 
fluorescent antibodies.
The lack of a histone HI kinase activity binding to the p l3 sucl beads is another 
indication of the evolutionary distance between T. brucei, yeast and metazoans. This 
lack of an association could be one reason why the tbcrk genes failed to complement S. 
pombe cdc2-\s mutants. It would appear, however, that T. brucei does contain a p l3 sucl 
related protein. A homologous gene (Immcksl) has been isolated from L. mexicana and 
the binding of both TbCRKl and TbCRK2 to the pnDnmCKSl beads suggests that 
there will be a related gene in trypanosomes. As a number of trypanosome CRKs were 
found to bind to the p^L^nCRS! beads it is difficult to assess which of the proteins 
contributed to the kinase activity detected. The TbCRKl protein bound to the 
p^LmmCKSl column may contribute to the isolated kinase activity, but this is not 
definite as the form bound to p^L^HCKSl may be inactive. Equally, there is no 
evidence that the TbCRK2 isolated is active. The 48 kDa PSTAIR reactive band in the 
procyclic extract (see Figure 5.4.4, lanes 7-9), which bound to the p^DnmCKSl beads, 
may also contribute to the histone HI kinase activity.
Labelling procyclic form T. brucei cultures with 35S methionine showed several
proteins which specifically bound to the pllLmmCK81 beads, although others may have
been obscured by non specific bands. Of the specific bands, one was the approximate
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size of CYC1, a cyclin like protein previously isolated from T. brucei (Affranchino et 
al., 1993) which according to immunoprecipitation experiments interacted with a 34 
kDa PSTAIR containing protein, presumably TbCRKl. There is also the possibility of 
TbCRKl and TbCRK2 being detected.
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CHAPTER SIX 
ASSESSMENT OF TBCRK3 FUNCTION BY REVERSE
GENETICS
2 1 6
6.1 Introduction.
As it was not readily possible to analyse TbCRK3 function either by in vitro 
expression or in vivo purification due to the insoluble nature of the protein combined 
with the need to retain an intact protein complex, the assessment of TbCRK3 protein 
function by in vivo mutagenesis was attempted. The creation of mutants by 
homologous recombination using constructs with antibiotic resistance markers has 
previously been performed with a number of different genes in the kinetoplastids (see 
Chapter 1.1.3(h)). As procyclic form T. brucei are considerably easier to grow in vitro 
than bloodstream form, procyclic cultures were used. Dependent on whether tbcrk3 
was essential for trypanosome growth or not, different results could be expected:
(1) if the gene was non-essential in the procyclic form, null mutant T. brucei 
would be isolated, and it would then be necessary to analyse the cells to assess any 
phenotypic effect of the knockout, such as early or delayed division.
(2) if tbcrk3 was essential in the procyclic form, either no mutants would be 
isolated or parasistes resistant to both antibiotic markers used for gene targetting would 
be isolated but at low numbers, and as described in Chapter 1.1.3(h), the cells would 
retain a copy of the wild type gene through recombination, duplication, retention of an 
episomal copy or changes in ploidy.
(3) the gene might be essential in some life cycle stages and not others, thus it 
would be stage specific lethal. Although the protein is expressed in all the stages tested 
(see Chapter 4.5) it is possible that in some forms there would be functional 
redundancy, as found with the CLN cyclin genes of S. cerevisiae (Rowley e ta l., 1992). 
Null mutants may be generated in procyclic form T. brucei that would be unable to 
complete the life-cycle if the gene was essential in the bloodstream form.
This approach was not attempted with tbcrkl because an attempt to create null
mutants in the single copy Immcrkl gene was unsuccessful, although tetraploid
Leishmania were isolated following the second round of transfection (J. Mottram,
personal communication). This implies that the gene is essential for the growth of
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promastigote form L. mexicana. The closely related gene from T. brucei {tbcrkl) is 
able to complement Immcrkl mutants in Leishmania following the deletion of both 
copies of the Immcrkl gene. It is therefore likely that tbcrkl is functionally 
homologous to Immcrkl and an essential gene in the T. brucei procyclic form.
6.2 Creation of putative null mutants of tbcrk3.
6.2.1 Construction of the plasmid background for resistance cassette insertion
No czs-introns in protein coding genes have been found in T. brucei. Therefore
it would be very unlikely for a resistance cassette integrated into a genomic locus to be
spliced out of the transcribed RNA thus resulting in a functional gene product from the
disrupted locus. However, the gene knockout vectors were designed to not only
integrate a resistance cassette into the middle of the gene but also to remove part of the
tbcrk3 ORF when integrating into the genomic loci. This approach would ensure the
removal of TbCRK3 function. The CDK genes are usually transcribed at relatively low
levels in other organisms (Welch and Wang, 1992) and therefore low levels of drug
resistance may occur at this locus. As the ble resistance gene product provides
resistance in a non-catalytic manner (Jefferies etal., 1993) by binding to and
sequestering the drug, it therefore might need a high level of expression to achieve good
resistance. For this reason the drug resistance genes were placed under the control of
the highly active PARP/procyclin promoter, rather than relying on read through
transcription of the presumably polycistronic RNA from the tbcrk3 region. The
resistance cassettes were inserted between the Xbal site and the most 3' Xhol site within
the tbcrk3 ORF (Figure 6.2.1). This results in the deletion of 388 bp (over one third of
the ORF), from the region just upstream of the PSTAIR box, to just downstream of the
DSEI region (amino acids 88 to 215 inclusive). pBlueScript (pBS) contains both Xbal
and Xhol sites in the MCS, and so these plasmid sites had to be destroyed to allow the
subcloning of the resistance cassettes into the tbcrk3 ORF. To do this pBS SK+ was
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first digested with Xbal and SpeI. The sites for these enzymes have compatible 
overhangs, and are adjacent in the pBS MCS. The digest was precipitated with iso­
propanol, which is less efficient than ethanol at precipitating small DNA molecules, 
thereby removing the 6 bp Xbal I Spe I DNA fragment. The DNA was resuspended and 
ligated with T4 DNA ligase. After transformation of E. coli, colonies were picked at 
random, plasmid DNA prepared, and the DNA incubated separately with Xbal (to check 
for the loss of the site) and Xhol (as a control for digestion). A plasmid negative for the 
Xbal site were called pBS(-S/X). This plasmid was then treated with Xhol and Sab. 
These enzymes also have compatible overhangs, and are adjacent in the pBS MCS. In 
this case it was found necessary to re-precipitate the ligation reaction, resuspend the 
DNA and incubate it again with Xhol before transformation. This procedure linearised 
molecules which had not been digested in the first reaction, or in which the MCS 
fragment had religated, and so reduced the background of the pBS(-S/X) plasmid to a 
low level. Colonies were picked at random after the transformation and plasmid DNA 
prepared from overnight cultures. The DNA was tested with Xbal, Xhol and EcoKl in 
separate reactions. The plasmid which failed to digest with either of Xbal or Xhol, but 
which was linearised by £h?RI was named pBS(-2S/2X). Both digestion/ligation 
reactions retained the original lacZ open reading frame. This plasmid was the backbone 
for the knockout vectors.
The tbcrkS ORF was located on a 2.6 kb Hindlll fragment of pCD70E(S)8. As
a Hindlll site was present within the tbcrk3 gene a partial digest was performed in order
to isolate the complete gene on a 2.6 kb Mwdlll fragment. A 100 p i digest containing
10p g  of pCD70E(S)8 plasmid DNA was performed with 10 U of Mwdlll. 20 pi
samples were taken at 5, 10, 20,30, and 45 minutes. 4 p i of each sample were run on a
0.7 % agarose gel containing EtBr. The sample showing the highest proportion of the
2.6 kb band was then run on another 0.7 % agarose gel, followed by excision of the
band and purification of the DNA using Geneclean (see Materials and Methods). This
was then ligated into pBS(-2S/2X) cut with Hindlll and transformed into competent
XLl-Blue cells. After plating on X-gal/IPTG containing plates, white colonies were
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selected and grown in LB medium overnight, and the prepared plasmid DNA was 
treated with a variety of restriction enzymes, including Hindlll, Xhol with Xbal, EcoRl 
and Sail to determine if the correct cloning had been achieved. The correct plasmid 
was named pCD172[Hd-(Hd)-Hd] (see Figure 6.2.1).
6.2.2 Construction of the replacement vectors.
The plasmid containing the Bleomycin resistance cassette (pBle) was a gift of 
Dr. S. Graham. The cassette contained the ble resistance gene under the control of the 
PARP promoter, with a splice acceptor site for correct trans-splicing, and the PARP 3' 
untranslated region for polyadenylation (see Figure 6.2.1). pBle had a pUC18 
background, and did not have a Xhol site. The resistance cassette was removed from 
the vector with EcoRl and Xbal, and ligated into pBS SK+ which had been cut with 
£a?RI and A M . This resulted in a plasmid [designated pBS(Ble)] containing a ble 
resistance cassette which had a Xbal site at the 5' end, and a Xhol site at the 3' end. 
After digestion with Xbal and Xhol, the 1.1 kb resistance cassette was ligated into 
XballXhol cut pCD172[Hd-(Hd)-Hd]. This plasmid was named pCD175BKOV 
(Bleomycin KnockOut Vector) (see Figure 6.2.1).
A plasmid containing a Neomycin resistance cassette was the gift of Dr. D.
Jeffries. The plasmid (pNT) contained the neo gene (which conveys resistance to the
antibiotic G418) under the control of a region containing the PARP promoter, with the
3' untranslated region of the T. brucei alpha-tubulin gene. The downstream region of
this construct did not contain restriction sites usable for the insertion strategy and so it
was necessary to move the promoter and neo gene into another plasmid. The pNT
DNA was digested with EcoRV which removed a 2.0 kb fragment that contained both
the PARP promoter and the neo resistance gene. The 2.0 kb fragment was gel purified
using a spin-X column (Materials and methods). The pBS(Ble) plasmid, containing the
ble resistance cassette ligated into the EcoRl and Xbal sites of pBS SK+, was digested
with Bam HI, which cut out the PARP promoter and the ble resistance gene. The digest
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Figure 6.2.1 The tbcrk3 knockout vectors.
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was followed by the filling in of the overhang with Klenow fragment DNA polymerase, 
and treatment with Calf Intestinal Phosphatase. This vector was gel purified and 
ethanol precipitated together with the PARP/neo EcoKV fragment before resuspension 
and ligation. After transformation, randomly picked colonies were grown overnight, 
DNA prepared, and the insertion event was assessed with EcoRl and Spe I. The correct 
plasmid was called pCD255. pCD255 DNA was then digested with Xbal and Xhol to 
remove the neo resistance cassette, which was gel purified and ligated into the 
Xbal/Xhol cut pCD 172[Hd-(Hd)-Hd], resulting in pCD272NKOV (see Figure 6.2.1).
6.2.3 Disruption of one allelle of tbcrkl with the Bleomycin KnockOut Vector.
100 p g  of BKOV DNA, which had been purified using a QIAGEN Midi­
column, was digested with Apal and Notl to linearise the molecule and to leave the 
tbcrk3 sequences near to the ends of the DNA to facilitate homologous integration. To 
reduce the probability of the plasmid recircularising and forming stable episomes within 
the trypanosomes, the insert DNA was gel purified to remove the pBS plasmid. After 
this procedure approximately 20 p g  of purified insert DNA was left, which was ethanol 
precipitated, dried in a sterile hood, and resuspended in 10 p \ of sterile water. 
Approximately lxlO8 cells of STIB247 procyclic form T. brucei in log phase growth 
were pelleted and resuspended in 2 ml of ZPFM electroporation buffer. 10 p g  of the 
purified insert DNA was added to 1 ml of the resuspended cells and electroporated at 
1500 V and 25 p F (see Materials and Methods). After electroporation the cells were 
split into 2 flasks, each containing 5 ml of SDM-79 medium with no antibiotic 
selection. A control was performed in which cells were treated in an identical manner 
except that instead of the DNA solution, 5 p  \ of sterile water was added to the 1 ml of 
resuspended cells. After approximately 16 hours (overnight) the cell density was 
counted using a haemocytometer, the cultures were passaged to a level of 1 x 106 cells / 
ml into SDM-79 medium containing 20 pg  / ml of phleomycin, an antibiotic to which
the ble gene conveys resistance. The transfected cells were split into two flasks. After
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less than one week no phleomycin resistant trypanosomes were observed in the control 
flasks, whereas all of the DNA transfected cultures resulted in populations of resistant 
trypanosomes. However, three of the flasks became contaminated and so only one line 
could be analysed. Although none of the cultures were clonal, the rapid growth 
supported the idea that each flask had contained cells from multiple independent 
integration events and so each flask was probably representative of the others. 
Therefore, this one culture [designated the Ble(M) line] was analysed.
Genomic DNA was prepared from the Ble(M) line and from the wild type
STIB247 using the Nucleon protocol (see Materials and Methods). The DNA was
digested with £c<?RI or Pstl and two lanes of each were run on a 0.7 % TBE/agarose
gel, followed by Southern blotting. The duplicate blots were either hybridised to a
mixture of the Hindlll insert fragments from pCD172[Hd-(Hd)-Hd], or to the ble gene,
labelled by random priming (see Materials and Methods). From the previous Southern
blots performed with STIB 247 DNA (see Figure 4.1.2) the expected sizes of the tbcrk3
hybridising bands from wild type DNA were 4.4 kb in the Zsco RI digest and 2.8 kb in
the Pstl digest. Following the integration of BKOV, EcoRl and Pstl sites would be
inserted into the tbcrk3 ORF, and so two extra bands hybridising to tbcrk3 would be
expected in both digests. These would be expected at 2.3 kb and 2.9 kb for the EcoRl
digest, and 2.0 kb and 1.7 kb in the Pstl digest. The 2.3 kb band from the EcoRl digest
and the 2.0 kb band from the Pstl digest would be expected to hybridise to the ble gene
probe. If the BKOV had not integrated and was being maintained as an episome then
the tbcrk3 probe would recognise the wild type bands and two extra bands at 2.3 kb and
1.1 kb for the EcoRl digest and 4.8 kb and 1.4 kb in the Pstl digest. Of these bands, the
2.3 kb(£c0RI) and the 4.8 kb (Pstl) bands would also hybridise to the ble gene probe.
Figure 6.2.2 shows the resultant autoradiograph. The odd lanes contain DNA from
STIB247, the even lanes from Ble(M). The ble gene probe hybridised to Ble(M) DNA
(lanes 6 and 8) but not to DNA from STIB247 (lanes 5 and 7). The sizes of the new
bands in lanes 2 and 4 are those predicted for the insertion of the ble resistance cassette
into the tbcrk3 ORF. The ratio of intensity of the 3 bands in lanes 2 and 4 might be
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Figure 6.2.2 Southern blot of DNA from the phleomycin resistant T. brucei culture 
showing disruption of one tbcrk3 allelle.
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Figure 6.2.2. Genomic DNA was prepared from procyclic cultures of STIB247 
or Ble(M) (see Materials and Methods). 20 |/g  of DNA was digested in a total volume 
of 78 ]A containing 30 U of either EcoRl or Pstl. After 2 hours a further 20 U of 
enzyme were added. After 2 more hours Loading Buffer was added to a final volume 
of 100 ]i\. 50pi\ of the digest was loaded into each lane of a 0.7 % TBE/agarose gel and 
run overnight at 30 V. The gel was then stained with Ethidium Bromide and 
photographed before being treated for Southern blotting. The DNA was fixed to the 
Hybond-N filter by baking at 80 °C for 2 hours before prehybridisation. Hybridisation 
was performed overnight at 65 °C.
Odd number lanes contain DNA prepared from the STIB247 cell culture, even 
lanes contain DNA from the Ble(M) culture. Lanes 1, 2, 5 and 6 were digested with 
EcoRl, lanes 3 ,4 ,7  and 8 were digested with Pstl. Lanes 1-4 were hybridised to the 
tbcrk3-containing fragments from pCD172[Hd-(Hd)-Hd], lanes 5-8 were hybridised to 
the ble ORF.
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expected to be approximately 2:1:1 if each cell had had one copy of tbcrk3 disrupted. 
This is not the case, as the bands corresponding to the insertion event are less intense 
than expected. This may be due to the loss of 388 bp of hybridising sequence from the 
two lower bands due to the integration event, and the increased diffusion of smaller 
molecules during electrophoresis. Also the molecule used for the labelling was dCTP, 
and the region of tbcrk3 deleted by the insertion event has a base composition of 46 % 
GC, while those regions of the flanks that have been sequenced have only 41 % GC, 
therefore the labelled molecules hybridising to the wild type locus are likely to be of a 
higher specific activity. The lack of Restriction Fragment Length Polymorphisms 
(RFLPs) detected at the tbcrk3 locus (see Figure 4.1.2) meant that integrations at the 
two loci could not be distinguished, and the inability to separate the two homologous 
chromosomes (see Figure 4.1.3) meant that they could not be distinguished using pulse 
field gel electrophoresis. Therefore it was unknown whether the integration events 
occurred preferentially in one chromosome or randomly.
6.2.4 Integration of the Neomycin resistance gene into tbcrk3.
Several results were theoretically possible following transfection of the 
neomycin KOV into the phleomycin resistant procyclic line, Ble(M), dependent on 
whether TbCRK3 function was essential for cell viability. If tbcrk3 is not essential then 
doubly resistant T. brucei would be recovered if both antibiotic selection pressures were 
applied. If only G418 selection is applied then it should be possible to isolate 
trypanosomes in which the NKOV had replaced the BKOV, as well as trypanosomes in 
which the NKOV had inserted into the other copy of tbcrk3.
If tbcrk3 was essential then either no viable cultures would grow in medium 
containing both antibiotics, or the cultures would contain cells which had undergone 
rearrangements or changes in ploidy, which resulted in the maintenance of at least one 
wild type copy of tbcrk3. If the medium only contained G418 then the resistant cultures
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would only contain cells in which the neomycin knockout vector had replaced the 
bleomycin resistance cassette.
As the neomycin resistance cassette contains an Apal site, the pCD272 (NKOV) 
plasmid was digested with Notl and Pvul, for which there is a site approximately 250 bp 
upstream of the start ATG for tbcrk3. QIAGEN purified NKOV DNA was digested, 
separated by agarose gel electrophoresis, purified by Geneclean, precipitated and 
resuspended in sterile water. 10 pig of the DNA was transfected into the Ble(M) 
trypanosomes (treated as the STIB247 cells in Chapter 6.2.3), which after the overnight 
recovery were passaged to 1 x 106 cells / ml in medium containing 20 pi g / ml of 
phleomycin and 8 pig / ml of G418. Of four such flasks, one gave rise to a slow 
growing culture which appeared resistant. No such culture was seen in the four control 
flasks which contained Ble(M) trypanosomes electroporated in the presence of sterile 
water. A stabilate was prepared of the entire culture in parallel with STIB247 and 
Ble(M) cultures, due to an enforced absence from the laboratory. When the stabilates 
were defrosted a month later and placed into medium free from antibiotics, the 
STIB247 and Ble(M) stocks recovered rapidly, but the putative doubly resistant line 
failed to recover.
The transfection was repeated with 2.5 x 108 mid-log phase Ble(M) cells
resuspended in 4 ml of ZPFM. 2 ml were transfected with NKOV insert DNA in two
batches of 1 ml (batch A and B), while 2 ml were electroporated without DNA present.
Each 1 ml was immediately split into 2 flasks for the overnight recovery, so that each of
the four experimental flasks transfected with NKOV insert DNA [designated A(l/2),
A(3/4), B(l/2) and B(3/4)] would contain independent transfection events. Each of
these four cultures were then passaged into ten flasks consisting of two sets of five
different G418 concentrations (0/5/7.5/10 and 15pig / ml), i.e. A(l/2) was passaged into
flasks labelled A1(0), A 1(5), A 1(7.5), Al(10), Al(15) and A2(0/5/7.5/10 and 15) and
so forth. Therefore the four groups of flasks, A1&2, A3&4, B1&2 and B3&4, contain
independent events. Each of the four control cultures were passaged into one set of five
flasks with the same range of G418 concentrations. Both controls and transfected cell
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lines grew at 5 pi g / ml of G418, though at a reduced rate. At 7.5 pi g / ml of G418, no
antibiotic resistant cells were recovered from the four control flasks, whereas six of the
eight NKOV transfected lines gave rise to G418 resistant cultures after two weeks
(NA1/3/4, NB1/2/4). There was no G418 resistant growth in the flasks containing 10 or
15pig / ml of G418. The six G418 resistant cultures (which were non-clonal) were
grown up, DNA purified, digested with /scoRI, and a Southern blot performed (Figue
6.2.3). As controls, EcoRl digested DNA from STIB247 and Ble(M) lines was run on
the same gel. The blot was hybridised to the tbcrk3 containing fragments from Hindlll
digested pCD172[Hd-(Hd)-Hd], labelled by random priming. The bands expected to
hybridise to tbcrk3 after a NKOV integration event were 2.9 kb (the equivalent DNA
fragment to that seen in the ble integration [see Figure 6.2.1]) and 1.2 kb. If tbcrk3 was
essential, or if the integration event could not occur at the second allelle due to
differences in the nucleotide sequence, then the cultures would only contain cells in
which the neo resistance cassette had replaced the ble cassette and the second BKOV
associated band at 2.3 kb should be missing from the Southern blots. If cells lacking
tbcrk3 were viable then mixed populations of both double knockout events and
replacement events would be detected assuming that null mutants could multiply at a
similar rate to the tbcrk3 containing trypanosomes. DNA from such a mixed population
would show four bands, the wild type (4.4 kb), the Ble(M) bands (2.9 kb and 2.3 kb),
and the new NKOV band at 1.2 kb. If the NKOV was retained as an episome then the
hybridising bands would be at 1.0 kb and 1.2 kb. Figure 6.2.3 shows the resultant
autoradiograph. Lanes 1 and 2 are STIB247 and Ble(M) DNA respectively, while lanes
3-8 contain DNA from each of the G418 resistant lines (NA1, 3 and 4, NB1, 2 and 4).
The 2.3 kb band specific to the ble insertion event is not present in any of the lanes
containing DNA from the G418 resistant cultures (compare lane 2 with lanes 3-8). The
1.2 kb band can be seen in five of the six G418 resistant lines (lanes 3-7) and may not
be visible in lane 8 due to the underloading of this sample. Therefore all of the
integration events appeared to be replacements of the ble cassette by the neo containing
vector. This implied that tbcrk3 is an essential gene, or that its loss greatly impairs the
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Figure 6.2.3 Southern blot of DNA from the G418 resistant T. brucei cultures showing 
replacement of the ble resistance cassette by the neo resistance cassette.
Figure 6.2.3. Genomic DNA was prepared from G418 resistant cultures 
(Scotlab). DNA (up to 10pig) was digested in a total volume of 39 \i\ containing 15 U 
of EcoRl. After 2 hours a further 10 U of enzyme were added. After 2 more hours 5 x 
Loading Buffer was added to a final volume of 50|<1 and this was loaded onto a 0.7 % 
TBE/agarose gel and run overnight at 30 V. The gel was then stained with Ethidium 
Bromide and photographed before being treated for Southern blotting. The DNA was 
fixed to the Hybond-N filter by baking at 80 °C for 2 hours before prehybridisation. 
Hybridisation to labelled tbcrk3-containing fragments from Hindlll digested 
pCD172[Hd-(Hd)-Hd], was performed overnight at 65 °C. Lanes 1 and 2 contain DNA 
previously prepared from the STIB247 and the Ble(M) cell culture respectively, lanes 
3-8 contain DNA from G418 resistant cultures: lane 3 - NA1, lane 4 - NA3, lane 5 - 
NA4, lane 6 - NB1, lane 7 - NB2, lane 8 - NB4.
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growth of T. brucei such that null mutants are outgrown by those cells undergoing 
replacement events. It was possible, however, that the copy of tbcrk3 which had 
already been disrupted may have had a predisposition to integration events and the 
sensitivity of the Southern blot was not good enough to spot a small number of null 
mutants. To assess this possibility it was decided to perform PCR, using 
oligonucleotides homologous to the 5' and 3' ends of tbcrk3, on the G418 resistant 
cultures when they were still at a low density, soon after the transfection event. This 
approach could detect such rare events. The preferred option of cloning individual cell 
lines from the population and assaying their genotype and phenotype was curtailed due 
to lack of time.
6.3 Analysis of the putative tbcrk3 null mutants.
6.3.1 PCR analysis of tbcrk3 mutants
PCR was performed using oligonucleotides previously employed in the cloning 
of tbcrk3 into the yeast complementation vector, and were homologous to the regions of 
the tbcrk3 initiation ATG and the termination codon (see Chapter 5.2). As the PCR was 
to be performed on cultures immediately after selection, with low cell density, it was 
decided to utilise a crude boiled cell extract as the starting template without further 
DNA purification. Template DNA was prepared by pelleting 100 /d  of culture, 
washing with 1 ml of 1 x Phosphate Buffered Saline (PBS), resuspending the cells in 
100/d of 5 mM EDTA and then boiling for 10 minutes. Each 50 /d  PCR contained 1 /d  
of the template solution.
The first PCR was performed on cells from the NB1 culture that had undergone
2 weeks of G418 selection only. Figure 6.3.1 shows the EtBr stained agarose gel on
which 10/d  of the PCR had been loaded (lane 1), along with control lanes containing 5
]A of PCR reactions which used purified pCD172[Hd-(Hd)-Hd], pCD175BKOV or
pCD272NKOV as template (lanes 2-4). The wild type gene was expected to result in a
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PCR product of ~1 kb, the ble resistance cassette should give a product of 1.6 kb, and 
the neo resistance cassette should result in a band of 3 kb. The pCD172[Hd-(Hd)-Hd] 
plasmid (lane 2) and the pCD272NKOV plasmid (lane 4) gave the correct size 
fragments of 1 kb and 3 kb respectively. An unexpected result however, was obtained 
for the pCD175BKOV template (lane 3) which gave a 700 bp PCR product instead of 
the 1.6 kb product expected. Mapping this DNA fragment with various restriction 
enzymes (including Bam HI, H i n d l l l ,  Pstl, Spel, Xbal and Xhol), showed that the tbcrk3 
flanking sequences have amplified correctly, but the ble cassette was almost entirely 
deleted. The reaction using template prepared from the NB1 culture (lane 1) shows 3 
bands of 700 bp, 1 kb and 3 kb, each the same size as a product in one of the control 
lanes. The 700 bp PCR product correlating to the ble resistance cassette is considerably 
less intense than the other 2 bands from the NB1 template. Although PCR is difficult to 
analyse quantitatively without careful controls, this low intensity band implied the 
presence of trypanosomes carrying both ble and neo resistance markers in this culture.
It was not possible from this experiment to distinguish whether they were null mutants 
or if they had retained a wild type copy of tbcrk3 by increasing tbcrk3 copy number, 
either through ploidy changes or episome formation. Each of the G418 resistant cell 
lines was split in half, with one half being added to medium containing both G418 and 
phleomycin while the remaining culture was only exposed to G418. Of the six G418 
resistant lines, only two (NB2 and NB4) gave rise to cultures which were resistant to 
both antibiotics (called B2D and B4D respectively). Suprisingly, NB1, the culture used 
for the PCR and which showed the presence of both ble and neo resistance markers, did 
not give rise to doubly resistant trypanosomes. Both B2D and B4D grew extremely 
slowly. The cultures under phleomycin and G418 selection barely increased in cell 
density over several weeks, but unlike other lines under the same selection, they did not 
die. The cells were regularly spun down, and resuspended in fresh medium containing 
G418 and phleomycin to ensure that the medium did not become depleted of nutrients. 
As the trypanosomes did not increase in number, there were not enough cells to prepare 
DNA for Southern blots, or protein extracts for Western blots. Eight weeks after the
Figure 6.3.1 PCR of tbcrk3 mutant cell line NB1 with tbcrk3 specific oligonucleotides.
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Figure 6.3.1 PCR was performed on template from the NB1 culture (lane 1), 
pCD 172[Hd-(Hd)-Hd] (lane 2), pCD175BKOV (lane 3), and pCD272NKOV (lane 4). 
100\i\ of cells from the NB1 culture were pelleted, washed in 1 ml of PBS and then 
boiled in 100 ja  1 of 5 mM EDTA. All control plasmids had been prepared using 
QIAGEN miniprep columns and mapped to ensure they were correct. The final control 
template concentration was 0.1 ja  g / m l. The oligonucleotides used were homologous to 
the 5' and 3' ends of the tbcrk3 ORF. The PCR was performed using Tciq DNA 
Polymerase in a total reaction volume of 50 j a \ .  After an initial denaturation at 95°C for 
5 minutes, 30 cycles were performed with annealing at 60 °C for 1 minute, extension at 
72 °C for 2 minutes 30s, and denaturation at 95 °C for 45s. 10 ]a \  of the NB1 culture 
PCR and 5 ja  \ of each control PCR was loaded in each lane.
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double selection procedure the cell density of the cultures began to decrease. Light 
microscopy of the cultures did not show noticeable levels of cellular debris, unlike that 
seen in cultures undergoing antibiotic selection where cells were not resistant. The light 
microscopy also appeared to show a higher ratio of cells in the early/medium stages of 
cytokinesis, when the cell bodies remain at 45-90° to each other, compared to other cell 
lines, and comparatively few in the final stages where the cells are joined at the most 
posterior point (see Figure 1.2.2 for diagram of cell division). PCR was used to 
characterise the tbcrk3 loci in these populations (see Chapter 6.3.2), and Giemsa and 
DAPI staining of fixed cells was used to assess the phenotype (see Chapter 6.3.3). The 
cultures continued to decrease in cell density, even after the transfer of cells into non- 
selective medium, until no cells could be seen in repeated observations (approximately 
11 and 12 weeks after selection for B2D and B4D respectively). The single 
replacement line, NB4, from which B4D had been derived, was passaged into 
phleomycin/G418 containing medium to assess the resultant effects on the cells, and it 
was also passaged into medium containing G418 which was supplemented with 25 % 
conditioned medium from the dead B4D culture (to assess if the loss of viability was 
due to contamination of the B4D cell line with a virus, or other organism invisible 
under the microscope). Neither of these conditions resulted in the same phenotype 
observed with the B2D and B4D lines (see Chapter 6.3.3). The NB4 cells treated with 
phleomycin died rapidly, with high levels of debris apparent and no obvious signs of 
delayed or altered cytokinesis, while the cells passaged into B4D medium grew as well 
as those in fresh medium.
6.3.2 PCR analysis of the T. brucei B4D cell line: null mutants or multiple tbcrk3 loci?
The two cell cultures to be used for the PCR reactions (B2D and B4D) were
prepared in the same manner as previously, except that the medium containing the cells
was treated with DNAsel for 30 minutes before the cells were spun down, washed,
resuspended and boiled. This treatment was used to avoid any contamination by
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plasmid or genomic DNA left in the culture medium after transfection and selection 
(specifically the integration plasmid). The two sets of oligonucleotides used for 
amplification were specific to the tbcrk3 ORF (see Chapter 5.2) and the ble ORF (gift 
of Dr. D. Jeffries). PCR using the template prepared from the B2D culture did not give 
reproduceable PCR products, but as the B2D culture acted in a very similar manner to 
the B4D line (B2D was maintained at a slightly lower cell density after selection than 
the B4D culture, and reached zero approximately one week earlier) the genomic events 
which created the two lines could be expected to be similar. Although the wild type 
tbcrk3 ORF was amplified from unpurified T. brucei genomic template routinely, the 
loci with ble and neo cassette insertions only amplified occasionally even though 
amplification from plasmid template occurred without difficulty. It may be that, for 
differing reasons, these two PCR's had a relatively low efficiency. The ble cassette 
always resulted in a much smaller band than expected (see Figure 6.3.1), indicating that 
the PCR was not performing as predicted, and the neo cassette results in a 3 kb band 
using the tbcrk3 oligonucleotides, which is towards the limits of the PCR protocol used 
in these experiments.
The result of a PCR reaction using the tbcrk3 specific oligonucleotides is shown 
in Figure 6.3.2. Only the wild type loci have amplified from the phleomycin and G418 
singly resistant cultures (lanes 3 and 4), and no such band is present in the reaction 
using B4D DNA as template (lane 5). Lane 6 shows the result of a PCR using B4D 
template purposefully contaminated with pCD172[Hd-(Hd)-Hd] plasmid, which 
contains the tbcrk3 ORF. This results in the correct size band, and therefore shows no 
general inhibition of the taq DNA polymerase activity by the B4D extract. The lack of 
the 930 bp band in lane 5, which was repeated on several occasions, indicates that the 
BD4 culture does not contain a wild type tbcrk3 allelle.
PCR was also performed using the ble 5' and 3' oligonucleotides (Figure 6.3.3).
These oligonucleotides would not be expected to amplify any products from wild type
T. brucei DNA, but the reaction using STIB247 template resulted in a large number of
non-specific bands. However, the reaction did not contain the expected 380 bp product
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(lane 1). Both Ble(M) and B4D template containing reactions did amplify the correct
'
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Figures 6.3.2 PCR of wild type and tbcrk3 mutant cell lines using tbcrk3 specific
oligonucleotides
1 2 3 4 5 6
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Figure 6.3.2 The template from T. brucei procyclic cultures was derived from 
500 pi\ of cells. The samples were treated with DNAsel at a final concentration of 40 
pig / m l, at 28 °C for 1 hour. EDTA was then added to 5 mM before the cells were 
pelleted. The supernatant was removed to leave ~15 pi\ of solution. The pellet was 
resuspended in this and boiled for 15 minutes. The PCR was performed using Taq 
DNA Polymerase in a total reaction volume of 50 ja\. The primers were those 
previously used to amplify tbcrk3 for subcloning into the S.pombe expression vector, 
pMNS21L (see Chapter 5.2). After an initial denaturation at 95 °C for 5 minutes, 30 
cycles were performed with annealing at 60 °C for 1 minute, extension at 72 °C for 2 
minutes 30s, and denaturation at 95 °C for 45s. Lane 1 was a no template DNA 
control, lane 2 - STIB247 wild type DNA, lane 3 - Ble(M) DNA, lane 4 - NB4 DNA, 
lane 5 - B4D DNA, lane 6 - B4D DNA plus 0.1 pg  /ml pCD172[Hd-(Hd)-Hd].
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Figure 6.3.3 PCR of wild type and tbcrk3 mutant cell lines using ble amplifying
oligonucleotides.
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Figure 6.3.3 The template from T. brucei procyclic cultures was derived from 
500]i\ of cells. The samples were treated with DNAsel at a final concentration of 40 
pig / ml, at 28 °C for 1 hour. EDTA was then added to 5 mM before the cells were 
pelleted. The supernatant was removed to leave ~15 pi\ of solution. The pellet was 
resuspended in this and boiled for 15 minutes. The PCR was performed using Taq 
DNA Polymerase in a total reaction volume of 50 pi\. The pimers used annealed to the 
5' and 3' ends of the ble ORF. After an initial denaturation at 95 °C for 5 minutes, 30 
cycles were performed with annealing at 60 °C for 1 minute, extension at 72 °C for 2 
minutes 30s, and denaturation at 95 °C for 45s. Lane 1 - STIB247 wild type DNA, lane 
2 - Ble (M) DNA, lane 3 - B4D DNA.
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Figure 6.3.4 PCR of wild type and tbcrk3 mutant cell lines using tbcrk3 amplifying
oligonucleotides with a longer extension time.
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Figure 6.3.4 The template from T. brucei procyclic cultures was derived from 
500]i\ of cells. The samples were treated with DNAsel at a final concentration of 40 
pig / ml, at 28 °C for 1 hour. EDTA was then added to 5 mM before the cells were 
pelleted. The supernatant was removed to leave ~15 pi\ of solution. The pellet was 
resuspended in this and boiled for 15 minutes. The PCR was performed using Taq 
DNA Polymerase in a total reaction volume of 50 pi\. The pimers used annealed to the 
5' and 3' ends of the tbcrk3 gene. After an initial denaturation at 95 °C for 5 minutes, 
30 cycles were performed with annealing at 60 °C for 1 minute, extension at 72 °C for 
3 minutes 30s, and denaturation at 95 °C for 45s. Lane 1 - no template DNA, lane 2 - 
STIB247 wild type DNA, lane 3 - Ble(M) DNA, lane 4 - NB4 DNA, lane 5 - B4D 
DNA.
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size 380 bp product (lanes 2 and 3), indicating that the Ble(M) and B4D cultures 
contain the ble resistance gene.
The products of another PCR performed with tbcrk3 specific oligonucleotides is 
shown in Figure 6.3.4. The wild type tbcrk3 gene is amplified as a 930 bp product, and 
is present in STIB247 (lane 2), Ble(M) (lane 3), and NB4 (lane 4) templated reactions, 
but not in the B4D reaction (lane 5). In both NB4 and B4D PCR reactions (lanes 4 and 
5) a product of 2.9 kb was detected, the expected size of the amplification product of 
the neo resistance cassette. This indicates that the B4D cells contain the neo gene 
inserted into a tbcrk3 ORF. It is not known why the neo resistance cassette was 
amplified in these reactions but not the ble resistance cassette.
Evidence from the PCR experiments suggest that the doubly resistant cultures, 
B2D and B4D, contain both antibiotic resistance cassettes, and are lacking any wild 
type tbcrk3 gene copies. The phenotype of these cultures should, therefore, show 
evidence of the function of the TbCRK3 protein.
6.3.3 Analysis of tbcrk3 mutants using DAPI staining and fluorescence microscopy.
Samples of the B2D and B4D cultures, and the NB4 culture as a control, were
pipetted onto slides and allowed to dry in a sterile hood. Once dried, the cells were
fixed with methanol, washed with PBS and again allowed to dry. The slides were either
stained with Geimsa or DAPI (see Materials and Methods) and examined under the
microscope. DAPI is a fluorescent dye which intercalates DNA allowing the
visualisation of both the nucleus and kinetoplast. It was difficult to see the kinetoplast
with Geimsa staining and so the assessment of phenotype was performed with DAPI
stained cells, scoring each cell for the number of nuclei and kinetoplasts present. The
microscope used had a moveable stage with a vernier scale. To ensure cells were only
counted once each, the count started at the back, left comer of the slide. The stage was
then gradually moved rightwards, scoring the phenotype of each cell within the field of
vision. At the right-hand edge of the slide, the stage was moved forwards across 3
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fields of vision before moving right, back across the slide, scoring more cells. The NB4 
culture was used as a control because it had been treated in an identical fashion to the 
B2D cell line, and it was identical to the B4D cell line, up to their selection with 
medium containing both phleomycin and G418. It therefore controls for the fact that 
these cultures have undergone two rounds of transfection, integration and selection 
including prolonged growth in the presence of phleomycin, an antibiotic that damages 
DNA (Xu and Johnston, 1994).
Both B2D and B4D showed elevated numbers of cells with abnormal 
kinetoplast/nuclear ratios (Table 6.3.1, shown graphically in Figure 6.3.5). There are 
125 % and 50 % more cells without nuclei (ON XK) respectively, reduced numbers of 
cells in the Gl/S phases of the cell cycle (IK IN) even ignoring the fact that many of 
these cells in the null mutants had abnormal morphology, and a large increase in the 
numbers of cells with two nuclei; both with the correct number of kinetoplasts (2N 2K) 
and with incorrect N/K ratios. The control sample using the NB4 line does show a 
higher level of unusual forms than another such survey (Das etal., 1994), which may be 
due to several reasons. Firstly, the rate of imperfect cytokinesis may vary between 
various laboratory strains. The study by Das etal was performed with the TREU667 
strain as while these mutant cultures were derived from the STIB247 line. It is also 
possible that the cells are in some way affected by the G418 in the medium, even 
though they are resistant to the drug. There is also the possibility that the single 
replacement event results in lower levels of TbCRK3 in the cell, and that this causes a 
mild version of the phenotype seen in the null mutants. The data suggest that the null 
mutant cell lines had a defect in cell division, although as cells from all points in the 
cell cycle were detected there appeared to be no particular restriction point in the cell 
cycle that the cells could not pass through.
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Table 6.3.1 Analysis of the number of nuclei and kinetoplasts in 
tbcrk3 mutant cell lines.
NB4 (Controls) B2D B4D
ON XK 8% (9) 18% (23) 12% (18)
IN OK 4% (5) 2% (2) 3% (5)
IN IK 81% (93) 30% (37a) 56% (85b)
IN 2K 4% (5) 4% (5) 1% (2)
IN >2K 0 0 1% (1)
2N OK 0 4% (5) 5% (7)
2N IK 2% (2) 30% (37) 17% (26)
2N 2K 1% (1) 8% (10) 3% (4)
>2N XK 0 4% (5) 2% (3)
The first column shows the numbers of nuclei (N) and kinetoplasts (K) 
present in each cell. The percentage of the total population in each category 
is shown in each column, with the figures in brackets being the actual number 
of cells scored for each category. The rows in bold type are cell morphologies 
expected to be seen in a normal T. brucei cell cycle (Gull, 1985).
a - Of the 37 cells in this set, 20 were malformed in some manner. 3 
had two or three flagella, although the most common abnormality was that the 
kinetoplast and /or the nucleus were not located in the expected position in 
the cell.
b - 26 of the 85 cells in this set were malformed, in a similar manner 
to those in the B2D cell line.
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Figure 6.3.5 The percentage of cells in each category for each cell line 
(Data taken from Table 6.3.1).
ONXK 1N0K 1N1K 1N2K 1N>2K 2N0K 2N1K 2N2K >2NXK
NB4 (Controls)
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Figure 6.3.6(A) Phase contrast and fluorescence photographs of DAPI stained cells
from the NB4 culture treated with phleomycin.
(1) (2)
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Figure 6.3.6(A) 100 pi\ of NB4 culture, 6 days after the start of treatment with 
20/* g / ml phleomycin was spun down at 1000 rpm for 5 minutes. The cells were then 
gently resuspended in the supernatant. The centrifugation was performed so that the 
cells were treated in the same manner as the putative null mutants which needed 
concentration to make the analysis easier. 20 y \  of the culture was then aliquoted onto a 
slide and allowed to dry in a tissue culture hood before fixing and staining with DAPI. 
Photographs 1,3 and 5 - phase contrast microscopy, photographs 2 ,4  and 6 - the same 
fields of view under fluorescence.
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Figure 6.3.6(B) Phase contrast and fluorescence photographs of DAPI stained cells
from the NB4 culture grown in the presence of medium from the B4D culture.
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Figure 6.3.6(B) 100 pi\ of mid log phase NB4 culture was spun down at 1000 
rpm for 5 minutes. The cells were then gently resuspended in the supernatant. 20 ]a  \ of 
this was then aliquoted onto a slide and allowed to dry in a tissue culture hood before 
fixing and staining with DAPI.. Photographs 1,3 and 5 - phase contrast microscopy, 
photographs 2 ,4  and 6 - the same fields of view under fluorescence.
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Figure 6.3.6(C) (1-6) Phase contrast and fluorescence photographs of DAPI stained 
cells from the B2D putative null mutant culture
Figure 6.3.6(C) 100 pi\ of the B2D culture was spun down at 1000 rpm for 5 
minutes. 80 yi\ of the supernatant was removed and the cells gently resuspended in the 
remaining liquid. This was then aliquoted onto a slide and allowed to dry in a tissue 
culture hood before fixing and staining with DAPI.. Photographs 1, 3, 5 ,7 , 9 and 11- 
phase contrast microscopy, photographs 2 ,4 ,6 , 8, 10, and 12 - the same fields of view 
under fluorescence.
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Figure 6.3.6(C) (7-12) Phase contrast and fluorescence photographs of DAPI stained
cells from the B2D putative null mutant culture
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Figure 6.3.6(D) (1-6) Phase contrast and fluorescence photographs of DAPI stained
cells from the B4D putative null mutant culture.
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Figure 6.3.6(D) 100 pi\ of the B4D culture was spun down at 1000 rpm for 5 
minutes. 80 /d  of the supernatant was removed and the cells gently resuspended in the 
remaining liquid. This was then aliquoted onto a slide and allowed to dry in a tissue 
culture hood before fixing and staining with DAPI. Photographs 1,3, 5,7, and 9 - 
phase contrast microscopy, photographs 2 ,4 ,6 ,8  and 10 - the same fields of view 
under fluorescence.
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Figure 6.3.6(D) (7-10) Phase contrast and fluorescence photographs of DAPI stained
cells from the B4D putative null mutant culture
(7) (8)
Photographs of DAPI stained cells, representative of the various cell lines, were 
taken. Figure 6.3.6 shows the photographs, both phase contrast, showing cell 
morphology, and fluorescent, showing the kinetoplast and nucleus number, and their 
positions. Figure 6.3.6(A) shows cells from NB4, the G418 resistant line, 6 days after 
treatment with 20 yi% / ml phleomycin. In each case the cells contain one kinetoplast, 
one nucleus and one flagellum. The patchy nature of the staining in the nucleus of 
these cells (particularly in 2 and 4) is presumably due to DNA damage caused by the 
phleomycin. Figure 6.3.6(B) shows cells from the NB4 line, grown in medium 
containing 25 % medium from a BD4 culture. As with Figure 6.3.6(A), the cells appear 
normal. Photographs (B)3 and 4 show a cell which has two kinetoplasts, which have 
separated prior to nuclear division, as expected for a cell in G2.
Figures 6.3.6(C) and (D) show cells from the two null mutant cultures B2D and
B4D respectively. In (C)2 DAPI staining shows a cell with 2 nuclei but either no, or
possibly one (at the right hand edge of the left hand nucleus), kinetoplast. (C)3/4 shows
a normal appearing cell, although the kinetoplast does appear relatively large, perhaps
having undergone replication without division. The cell in (C)5/6 appears to have
separated its kinetoplasts, though again they are considerably larger than is typical.
(C)8 clearly shows a cell which has two nuclei and only one kinetoplast, which is
positioned between the two nuclei. This perhaps indicates that the cell has recently
undergone an incorrect cytokinesis which resulted in the posterior kinetoplast being
separated as a 'zoid'. In (C)10 there is a cell which has no nucleus, one kinetoplast and
two flagella [see (C)9]. (C)l 1/12 show a cell with an unquantifiable number of nuclei
and kinetoplasts. In this case division is clearly not occurring correctly. The
kinetoplasts have not separated correctly, and they are not in the expected positions for
a cell undergoing cytokinesis. The cell also appears to be starting cytokinesis from the
wrong end. The cells in the B4D culture show similar phenotypes. (D)l/2 show a cell
in which there is either one huge kinetoplast with more than the normal DNA content,
and two nuclei, or there are three nuclei. The cell in (D)3/4 appears to be undergoing
cytokinesis. Both nuclei are in what would become one of the daughter cells, while the
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other cell only contains a kinetoplast. Neither of the cells visible in (D)5/6 are aberrant, 
and one is apparently progressing through the cell cycle, containing two, separated, 
kinetoplasts. The two cells in (D)7/8 however are both unusual. The lower cell has no 
kinetoplast, although the flagellum appears present, while the other has the kinetoplast 
incorrectly positioned, anterior to the nucleus. The cell in (D)9/10 is dividing. It 
contains the correct number of nuclei and kinetoplasts for a dividing cell (two of each), 
but as above, the kinetoplasts are not in the correct positions. They do not appear to 
have separated properly, and are both posterior to the more posterior nucleus, instead of 
one being between the two nuclei, as would be expected (Gull etal., 1990).
6.4 Discussion
An analysis of TbCRK3 function was performed using homologous 
recombination to create procyclic form tbcrk3 mutants. After one allelle was disrupted 
by the insertion of, and selection for, a bleomycin resistance cassette, the culture was 
again transfected, this time with a neomycin resistance cassette. Selection with both 
phleomycin and G418 antibiotics gave rise to a slowly growing population of cells. 
Analysis of these lines by PCR indicates that the cultures do not contain a wild type 
tbcrkS gene, and do contain both the ble and neo resistance genes inserted into a tbcrk3 
ORF. These mutants displayed a very slow rate of growth before the population died. 
This phenotype displayed by the null mutants of tbcrk3 was unexpected. It was thought 
that a protein controlling the cell cycle would be essential, and if it was not essential, 
e.g. due to redundancy such that another TbCRK would function in place of the 
TbCRK3 protein, then it was probable that no phenotype would be seen. As the 
cultures did die it seems that the TbCRK3 protein is essential for cell viability. The 
relative longevity of the null mutants therefore has to be explained, as well as the lack 
of selection of tetraploid or rearranged genomes seen in other cases.
One possibility is that the mRNA, or the TbCRK3 protein, or both, are relatively
stable with a long half life. If this is the case then the selection pressure against changes
2 5 5
in ploidy must be enough to remove those cells during the null mutants’ early growth.
It may be that aneuploid cells could not be isolated because other genes on the tbcrk3 
containing chromosome are under dosage control, but the large variations in karyotype, 
post-transcriptional control shown after gene deletion (de Lafaille and Wirth, 1992) and 
especially the isolation of triploid trypanosomes after genetic crosses (Gibson etal., 
1992; Wells etal., 1987) makes this unlikely.
The phenotype displayed by the null mutant cell lines varied from cell to cell, 
both in the abnormality seen and in the severity of the condition. By light microscopy 
many cells appeared to be normal, even during the final stages of the cultures. In 
abnormal cells, commonly the cell organelles were incorrectly positioned, notably the 
kinetoplast/s were often misplaced, or not separated after replication. There was often 
an incorrect number of nuclei and kinetoplasts, and many of the kinetoplasts were 
unexpectedly large by DAPI staining. This may be due to the cells replicating their 
kDNA but not dividing the mitochondrion. Due to the longitudinal arrangement of the 
T. brucei cell, cytokinesis in T. brucei demands the accurate positioning of several of 
the cell's components, including the nucleus, kinetoplast and basal body/flagellum. The 
failure to accurately align these cellular structures would cause aberrant divisions, 
leading to the abnormal ratios of nuclei to kinetoplasts. There are other notable 
differences as well. Strikingly, the linkage between the kinetoplast and the flagellum 
was lost in a number of cases (see Figure 6.3.6(C) 9/10 and (D)7/8). During normal 
division there is a physical link between the kinetoplast and the basal body (Robinson 
and Gull, 1991) and there is one flagellum for each kinetoplast. However in the two 
mutant cultures, cells could be seen with more flagella than kinetoplasts, and vice versa. 
Possibly the most extreme alteration of cytokinesis was shown by the cells where 
cytokinesis appeared to be starting at entirely the wrong end of the organism (See
Figure 6.3.6(C) 11/12).
A linking factor in these events is a role for the cytoskeleton. TbCRK3 may be
involved in regulation of the cytoskeleton and its re-organisation during the cell cycle.
Its loss results in a phenotype reminiscent of the mitotic catastrophe seen in yeast, with
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the number of viable cells in a culture dropping as mistakes in division accumulate. 
This association could also explain the insoluble nature of TbCRK3 in Triton X-100, as 
this detergent keeps the cytoskeleton essentially intact. However, the cells 
predominantly retained their characteristic shape showing that TbCRK3 is unlikely to 
play a role in the organisation of the sub-pellicular microtubule ‘basket’ which runs 
underneath the cell membrane.
A role for TbCRK3 in cytoskeletal organisation though does not explain why
tetraploid, and other forms of tbcrkS, ble and neo gene containing cells, were not found,
since tbcrk3 is essential. When Immcrkl was targeted in a similar experiment (Mottram
etal., 1996), null mutants could not be obtained, which is the expected outcome for an
essential gene. One theory which would explain these results is that one role of
TbCRK3 may be to phosphorylate a stable protein which is part of a cellular structure
involved in the control of organellar positioning. If this cellular structure is
conservatively reproduced during the cell cycle, then one daughter cell would receive
the old, already phosphorylated, structure while the other cell inherits a new one. If
TbCRK3 and its mRNA are both relatively stable then after the second integration
event the cell cycle could continue relatively unaffected for several generations until
TbCRK3 is diluted out by subsequent cell divisions. As the levels of TbCRK3 drop the
two daughter cells would become non-equivalent, as one would inherit an adequately
phosphorylated structure while the other would inherit a structure consisting of newly
sythesized protein lacking complete modification. While there was enough TbCRK3 in
the cells it would be possible for the new structure to be phosphorylated before the next
cell division occurred. However, as the levels of TbCRK3 decrease this would no
longer be possible, and at this point aberrant division of the daughter cell with the
unphosphorylated structure would begin. As the levels of TbCRK3 decreased still
further then the cells would not keep up with the turnover of the phosphorylated protein
and therefore increasing numbers of cells would start to exhibit the mutant phenotype.
This theory would explain the observed population dynamics of the null mutants,
consisting of a growth phase (when both daughter cells could successfully divide
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again), a plateau (when one daughter cell could no longer divide) and the population 
crash (when every cell undergoing cytokinesis is dysfunctional).
One possibility for a cell structure which is likely to be conservatively replicated 
within procyclic T. brucei is the basal body. This structure is found in a precise 
position in the cell and is involved in the connection between the flagellum and the 
kinetoplast, a connection that is disrupted in the null mutant cell lines. After division, 
each cell contains one basal body and one pro-basal body. During the early G1 phase 
of the cell cycle, the pro-basal body elongates to become a full basal body. The new 
flagellum starts to form on the new basal body, and two new pro-basal bodies are 
formed. Interestingly, the two basal bodies are not equivalent as when they are 
separated, the old basal body with the older, longer, flagellum, always moves to become 
the more anterior of the basal bodies.
A single round of transfection with a tbcrk3 deletion construct allowed stable 
integration of a resistance gene into the tbcrk3 locus, with concomitant elimination of 
part of the tbcrk3 ORF, creating cells haploid for tbcrk3. Following a second round of 
transfection with a construct containing a second drug resistance marker, a population 
of cells resistant to both drugs could be isolated, but these cultures were not viable over 
the long term. This lack of viability appeared due to an increasing proportion of cell 
division events being aberrant, resulting in T. brucei with incorrect numbers of nuclei 
and/or kinetoplasts. It seems likely that the mutant phenotype is due to a failure to 
regulate cytoskeletal components correctly, although gross morphological changes were 
only rarely seen, usually in cells lacking a nucleus. These cases appeared similar to that 
seen in non-resistant control cells and so were likely to be caused by the cell losing the 
resistance gene for one of the antibiotics due to incorrect separation of the nuclear 
DNA. The lack of morphological change implies that TbCRK3 does not play an 
important role in the organisation of the microtubular cytoskeleton.
The cause of the aberrant divisions was a loss of organisation at the organellar
level, resulting in misplaced kinetoplasts, duplicated kinetoplasts that did not separate
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correctly, cytokinesis occuring in an incorrect plane, and cytokinesis starting at the 
wrong end of the cell. There was also a loss of the connection between the flagellum 
and the kinetoplast with many cells no longer showing a 1:1 ratio. In the context of 
abnormal cytokinesis, it is striking that the cells continued to attempt to divide even 
when there were gross organisational changes. It may be that the fact that all three 
TbCRK proteins lack residues, conserved in other organisms, that affect S and M phase 
checkpoint control (Basi and Enoch, 1996) means that selection for parasitic rapid 
growth has resulted in an organism with few such checkpoint controls. This could be a 
reason for the lack of success in synchronisation of T. brucei cultures.
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CHAPTER SEVEN 
DISCUSSION OF THE DATA AND FURTHER WORK
2 6 0
7.1 Conclusions.
In this study a cdc2 related protein ]dnase ( tbcrkS) was cloned from a T. brucei
DNA lambda library and the open reading frame sequenced . Two other T. brucei
genes from this family, tbcrkl and tbcrk2 (Mottram and Smith, 1995) have also been
characterised. Each of the three TbCRK proteins have the same level of similarity to
CDC2 kinases from other organisms (~50 % identity). None of the three T. brucei
proteins was predicted to contain all of the conserved domains found in the cdc2/CDK2
sub-family of CDKs (see Figure 3.3.8), leaving the question of which is likely to be the
functional homologue unclear. TbCRKl and TbCRK2 are poorly conserved in regions
involved in the control of the activating Threonine-161 phosphorylation (the DSEI box
and the region around Thr-161 itself), while the lack of a well conserved PSTAIR box
in TbCRK2 and TbCRK3 (even though these proteins are recognised by the PSTAIR
monoclonal antiserum) suggests that they will not interact correctly/adequately with
mitotic cyclin type proteins from other organisms, making complementation assays
unlikely to work. Alignments of the predicted protein sequences with sequence data
from the family of cdc2 related kinases in higher eukaryotes and phytogeny analysis fail
to convincingly place any of the T. brucei proteins in any of the known classes of
Cyclin Dependant Kinases (CDKs). The inability to find a p l3 sucl binding kinase
activity in T. brucei protein extracts is evidence that the soluble TbCRK proteins are
divergent enough that they do not interact with this conserved component of the yeast
cdc2/cyclin complex. The related trypanosomatid, Leishmania mexicana, contains
homologues of two of the T. brucei genes (Immcrkl and lmmcrk3) but no equivalent of
tbcrk2 has been found to date. tbcrk2 was isolated by heterologous hybridisation of a
Immcrkl fragment to a T. brucei genomic library whereas tbcrkl and tbcrk3 were
isolated by PCR with degenerate primers designed to anneal to conserved domains.
The heterologous hybridisation approach has not yet been tried with Leishmania, but
the lack of detection of a protein of similar size to TbCRK2 in Leishmania protein
extracts by either TbCRK2 or PSTAIR reactive antisera would imply that a leishmanial
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homologue does not exist.. Previous evidence suggests that Immcrkl is not the master 
regulator of the cell cycle in L. mexicana, although it does appear to be essential for cell 
growth in cultured promastigote forms. Immcrkl was unable to complement a S. 
pombe cdc2-ts mutant (Mottram etal., 1993). Amastigote form L. mexicana which are 
slowly dividing do not show LmmCRKl kinase activity, while the non-dividing 
metacyclic stage do contain LmCRKl kinase activity, although as previously noted, 
constitutive activity of a CDK can result in a cell cycle block. It is possible that the G1 
cell cycle block in the pre-adapted life cycle stages of the kinetoplastids may be due to 
the constitutive activity of a G1 specific CDK as opposed to a lack of activity. This 
would be analogous to the M phase block that occurs when cdc2 is not inactivated. 
When mitotic cyclins that lack the N-terminal "destruction box" are transiently 
expressed the cells are unable to exit from mitosis due to the continuous activity of the 
cdc2/Cyclin complex which would normally be deactivated by proteolysis of the cyclin 
subunit (Draetta etal., 1989). It is also possible that due to the extreme divergence 
between the Kinetoplastida and other eukaryotes the TbCRK proteins do not control the 
cell cycle. Given the sequence conservation between the CRKs and other cdc2-related 
kinases this would seem unlikely. Because of the sequence divergence (see Chapter 
3.5) the failure of the T. brucei genes to complement a yeast cdc2-ts mutant was not 
unexpected.
The protein phylogeny analysis (Figure 3.3.9) implies that TbCRK2 and 3 play a 
role in cell cycle control as they cluster near the CDK4/6 proteins which have been 
shown to be involved in the control of Gl/S phase transitions (Xiong etal., 1992; Lucas 
etal., 1995). This convergence may be artefactual however, due to the divergence 
between the CRK and the CDK4/6 proteins, and the cdc2/CDK2 protein sub-family. 
Diverged branches can cluster due to their differences from the conserved sequence, as 
opposed to clustering due to their similarity. The TbCRK 1 protein, although containing 
the least degenerate PSTAIR box of the TbCRK proteins, is placed on an outlying 
branch of the analysis.
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The tbcrk3 gene was found to be closely linked to the gene for the mitochondrial 
elongation factor G (tbmefg), a link which was found to be conserved in the lmmcrk3 
gene locus in L. mexicana (J. Mottram, unpublished). Although the genes are tightly 
linked, and TbCRK3 does contain a N-terminal extension, there is no evidence for 
TbCRK3 being targeted to the mitochondrion. The TbCRK3 extension has no 
homology with the mitochondrial protein extensions found in the kinetoplastids, but as 
these mitochondrial targeting signals have no clear consensus in other better 
characterised organisms this cannot be ruled out.
When TbCRK3 was expressed in E. coli, with a poly-histidine tag to allow
purification by metal-chelator chromatography, it was found to be insoluble. This was
not found for TbCRKl, and surprisingly LmmCRK3 was soluble as well, even though
the CRK3 proteins are ~80 % identical. The purification of tagged TbCRK3/H enabled
the raising of polyclonal antibodies in rabbits. Western blots using crude E. coli
lyssates expressing TbCRK proteins or proteins purified from these lysates allowed the
testing of the available antisera for cross-reaction between epitopes on the CRKs. The
affinity purified polyclonal CITAA and PSTAVR antisera were both shown to
recognise, not only the protein which contained the sequence of the peptide to which
they were raised (LmmCRKl and TbCRK2 respectively), but also other members of the
kinetoplastid CRK family. CITAA recognised TbCRK 1 (with 11/16 residues identical),
and PSTAVR also recognised both TbCRK 1 (10/16) and TbCRK3 (10/16). The
PSTAIR monoclonal antiserum was also shown to recognise related sequences even
when they contained multiple substitutions. TbCRKl (14/16 identical residues),
TbCRK2 (12/16) and TbCRK3 (10/16) were all detected when expressed in E. coli.
Western blots with T. brucei protein extracts from different life cycle stages showed
that the three TbCRK proteins are expressed in the non-dividing short stumpy stage as
well as in the replicating procyclic and long slender forms. The PSTAIR monoclonal
antiserum also detects a 48 kDa and an 80 kDa band in some extracts suggesting the
presence of at least two more genes with a similarity to cdc2. A cdc2-related kinase
protein (CfCRK4) of 53 kDa which is not homologous to any of the three TbCRK
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proteins studied in this thesis has been isolated from Crithidiafasciculata (Bran et al, 
1992). The 48 kDa T. brucei protein may be the trypanosome CRK4 homologue. The 
evidence from T. brucei protein extracts is that TbCRK3 is insoluble in 1 % Triton X- 
100 in vivo, unlike TbCRKl and 2. The insoluble nature of TbCRK3 could be another 
possible reason for the failure of tbcrk3 to complement a S. pombe cdc2-ts mutation.
There was evidence on the Western blots for a conserved degradation pathway 
for the TbCRK proteins with antibodies specific for the three proteins all detecting a 26 
kDa band in some extracts. The antisera which detected these bands were all raised 
either to the C-terminus of the respective proteins (CITAA vs LmmCRKl, EVREE vs 
TbCRK2) or against the entire protein (TC3H/G). The antisera raised to the region of 
the PSTAIR box detected no such fragments. This implies a common C-terminal 
fragment can be protealytically cleaved from the TbCRK protein under certain 
conditions. The 26 kDa putative TbCRK3 fragment was detected in the soluble fraction 
of the S100 protein extracts implying that the insoluble nature of TbCRK3 may be 
modulated by the N-terminal 80-90 amino acids that would be removed from the 
TbCRK3 protein to leave a 26 kDa fragment.
The TbCRK proteins were detected by Western blotting in the different life 
cycle stages, however this gives no evidence as to whether the kinases are active or not. 
In the absence of high quality antisera capable of immunoprecipitation, assays using 
protein bound to pl3sucl or a homologue (p^LmmCKSl) were used to begin to answer 
this question. The p l3 sucl failed to reproducibly bind a histone HI kinase activity in T. 
brucei extracts, unlike the result from L. mexicana where a kinase activity related to the 
division status of the life cycle stage was observed (Mottram etal., 1993; Mottram and 
Grant, 1996). It is now believed that the kinase subunit of the Sucl Binding Kinase 
(SBCRK) may be encoded by lmmcrk3 (Mottram and Grant, unpublished). LmmCRK3 
is expressed at very low levels and has proved difficult to purify. If LmmCRK3 is the 
SBCRK then one would expect that the TbCRK3 protein would also be capable of 
interacting with p l3 sucl, but its insoluble nature in the buffers used for lysis caused it to
remain in the pellet fraction of the protein extracts used to isolate the activity. When T.
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brucei extracts were bound to the pl2LnmiCKSl column significant levels of histone HI 
kinase activity could be recovered. Protein was eluted from these columns for Western 
blotting. Both TbCRKl and TbCRK2 were detected binding specifically to the beads, 
as was another, 48 kDa, PSTAIR mAb reactive protein. Therefore the recovered kinase 
activity could be due to any, or all, of these three proteins, or even to another protein 
not detected by any of the antisera used. To begin to assess the expected other 
components of the TbCRK complexes 35S methionine labelled procyclic cell extracts 
were bound to the p l2kmmCKSl column before elution, SDS-PAGE and 
autoradiography, although several proteins bound to the column in a non-specific 
manner, many proteins could be seen to bind only to the p l2LmmCKSl beads. By the 
estimated molecular weights of these proteins it would seem possible that the column is 
binding TbCRK complexes containing putative T. brucei cyclins.
The tbcrk genes are single copy (but diploid) making it relatively easy to create
null mutants by two rounds of homologous recombination using two antibiotic
resistance genes flanked by DNA from the genomic locus of interest. When this was
performed in Leishmania with Immcrkl, null mutants could not be isolated. Doubly
resistant clones could be selected for, but analysis showed the cells to have retained a
wild type Immcrkl gene either through aneuploidy or by the retention of episomal
resistance genes. This has been seen previously with gene knockouts in the
kinetoplastids and has been assessed as evidence for the gene being essential to cell
survival. When this approach was attempted with tbcrk3, doubly resistant cells could
be isolated, but on both occasions the cells grew slowly and eventually the cultures
died. Because of the small number of cells available in the cultures PCR was used to
analyse the genotype of the phleomycin/G418 resistant cultures. PCR using primers
which correctly amplified the tbcrk3 ORF from wild type STIB247 and from single
replacement mutants, failed to display the correct 1 kb product when B4D was used as
template. The results indicated that these cells were null mutants containing both ble
and neo resistance genes within the tbcrk3 ORF. As the B2D and B4D cultures aged it
became clear that the cells were displaying a phenotype of slow growth with a possible
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defect in cytokinesis. These cells were not dying due to necrosis initiated by antibiotic 
selection as control cultures did not exhibit the same phenotype. In control cultures 
treated with G418, the procyclic cells were killed by the antibiotic over a ten day 
period, treatment with phleomycin killed the cells considerably faster than this. In the 
putative null mutant cultures most cells died in the seven days after transfer to double 
selection medium, but the cultures then slowly increased in cell density for two/three 
weeks. The cultures remained at this plateau for over a month before slowly dying over 
a period of three to four weeks. To further evaluate this phenotype, aliquots of cells 
from the culture were fixed and stained with DAPI which allows the visualisation of 
nuclei and kinetoplasts. Light microscopy showed that the cells displayed a number of 
different phenotypes, with many cells having incorrect ratios of nuclei to kinetoplasts.
It was also obvious that the positioning of the kinetoplasts in most cells was improperly 
regulated, with kinetoplasts often not separating correctly after replication. Nuclear 
positioning was also affected with some dividing cells partitioning both nuclei into one 
daughter cell, creating large numbers of so called "zoids" with a flagellum and 
kinetoplast but no nucleus. It was also possible to find cells where the linkage between 
the kinetoplast and the flagellum appeared to have broken down with some cells having 
a flagellum without a kinetoplast. There were also, occasionally, more severe cases 
where the cell polarity had appeared to have broken down. In these cells it could be 
seen that cytokinesis had started from the opposite end to normal.
Although the phenotype initially resembled the mitotic catastrophe seen in some 
yeast mutants, where the cells divide whether or not the nucleus is ready , the later 
disassociation of the kinetoplast from the flagellum, and the loss of cell polarity implies 
roles for TbCRK3 other than the timing of cell division. These phenotypes, along with 
the insolubility of TbCRK3 in 1 % Triton X-100 suggest that the TbCRK3 kinase is 
involved in regulating cytoskeletal functions possibly including; organellar movement 
(both of the nucleus and kinetoplast), the attachment of the kinetoplast to the basal 
body, and the organisation of the anterior/posterior axis within the cell.
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7.2 Future work.
7.2.1 T. brucei Elongation Factor-G.
To obtain the entire open reading frame of the tbmefg gene will either require 
further subcloning from the lambda clone previously isolated when screening for tbcrk3 
or further screening of a library using an probe consisting of the 3' end of the available 
tbmefg sequence. To check for cellular localisation it will be necessary to raise 
antibodies either to fusion proteins or synthesised oligopeptides. Another option would 
be to express an epitope tagged protein in procyclic form T. brucei by DNA 
transfection. In combination with antibodies raised to the N-terminal extension it 
should be possible to show whether the putative signal sequence is cleaved on 
translocation into the mitochondrion, as with the kinetoplast associated proteins from 
Crithidia(Xu and Ray, 1993), or not. Null mutants could be constructed to assess if 
tbmefg is essential and to assess the relevance of mitochondrial translation to 
trypanosome survival both in procyclic culture and, by passage through Tsetse flies, in 
the mammalian bloodstream.
7.2.2 The TbCRK family
Northern blots using total cellular RNA were attempted but without achieving a 
significant signal. It is likely that the tbcrk genes are expressed at low levels and 
poly [A]+ selection of mRNA would be needed to visualise the transcripts by Northern 
blotting. It could be possible to use Reverse Transcriptase-PCR to assess expression at 
the RNA level. It would be interesting also to examine the expression of tbmefg in 
relation to tbcrk3 and also in the different life cycle stages.
In an attempt to solublise TbCRK3 the composition of the lysis buffer used to 
extract T. brucei proteins could be altered. It may be useful to try other detergents and 
other salt concentrations. If TbCRK3 is binding to the cytoskeleton then it may be 
possible to release the protein into solution by the use of microtubule or actin
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depolymerising drugs. The sub-pellicular array of microtubules can be disrupted by 
calcium ions (Robinson and Gull, 1991). This would be a test for whether these are the 
insoluble components that TbCRK3 is associated with, and if so could be a relatively 
mild way of solublising TbCRK3. If solublisation could be achieved then p^DnmCKSl 
binding could be assayed, although if more stringent conditions are used then this might 
result in CRK complex disassociation, and in order to be active the kinase is likely to 
require a cyclin partner.
It should be possible to use specific antisera, such as the TbCRKl reactive 
CITAA, to localise the protein to specific areas of the cell by immunolabelling of fixed 
T. brucei cells. Analysis of a dividing population may allow assessment of whether the 
protein undergoes positional regulation during the cell cycle as has been reported with 
cdc2 in other organisms. By using purified TbCRK3/H blotted onto filters it should be 
possible to purify TbCRK3 specific antibodies from the TC3H/G and TC3H/S antisera. 
These purified antibodies could also be used for localisation studies, with particular 
regard to whether TbCRK3 is associated with the cytoskeleton, or even a particular part 
of it. Double label in situ localisation could be performed alongside either gamma- 
tubulin or Tyrosine-tubulin antibodies to look for an association with microtubule 
organising centres or growing microtubule ends.
Another method to further analyse the TbCRK proteins would be to use epitope 
tagged constructs integrated into the genomic loci. These proteins could then be 
immunoprecipitated for kinase assays, for assessment of complex components, or the 
antibodies could be used to localise the tagged proteins within the cells. This could 
allow appraisal of the kinase activity of specific TbCRK proteins in the various life 
cycle stages (assuming the mutant could be successful passaged through tsetse flies or 
that bloodstream form transformation could be performed). It may also be possible to 
follow the various kinase activities through the short stumpy to procyclic 
transformation. This differentiation is concurrent with the reinitiation of the cell cycle 
(Matthews and Gull, 1994a; Affranchino etal., 1993) and provides a model for the 
initiation of a new round of cell division. Although the concomitant alteration of cell
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type could pose problems for the analysis, the transformation step is, at present, the best 
synchronous model of the cell cycle available for T. brucei.
Further studies are available by using reverse genetics technology. Null mutants 
of tbcrk2 are still to be assessed; will the gene be essential like crkl and crk3 or does 
the probable lack of a leishmanial homologue imply redundancy (at least in culture)? 
The function/s, if any, of the unusual N-terminal extensions of both TbCRK2 and 
TbCRK3 have not begun to be elucidated. By using heterozygous strains of T. brucei 
haploid for tbcrk2 or tbcrk3 (generated by one round of targeted deletion) it would be 
relatively easy to create mutant cell lines containing one null gene and one gene lacking 
the region coding for the N-terminal extension of one of these proteins. Alternatively, 
especially if the double mutants are non-viable, these minus-N terminal mutants could 
also be epitope tagged and transfected into wild type cultures. Along with full length 
epitope tagged constructs it should be possible to analyse changes in kinase activity, 
complex subunit composition and cellular localisation caused by the loss of the N- 
terminus.
A way to side-step the inability to create null mutants of essential genes such as 
the tbcrks in sufficient quantities for analysis would be to attempt to use the inducible 
expression systems becoming available for trypanosomes. One method is to create a 
gene under the control of an inducible/repressible promoter that is integrated into a 
silent region of the genome. Strains carrying this integration can then have the wild 
type chromosomal copies of the gene of interest removed by homologous 
recombination using the flanking regions of the gene locus. While the gene is being 
expressed, under the control of the tet repressor with tetracyclin added to the medium, 
there should be no phenotype, allowing large numbers of cells to be grown. When 
expression is shut off by the removal of the tetracyclin, it should be possible to analyse 
the result of a lack of the TbCRK protein i.e. do the cells stop growth at specific cell 
cycle points or at random. The draw back of this system is the need for multiple 
selectable markers (two for the knockout cassettes, one for the integrated gene and, 
because the inducible systems use components from heterologous systems, at least one
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for the system supplying the regulatable expression components). There are enough 
selectable markers for trypanosomes (five) but the logistics and large amount of 
subcloning necessary can make the task time consuming. cdc2 related genes in other 
organisms have been mutated to give dominant negative phenotypes (Reig and Nurse, 
1991; Reig etal., 1992). The altered proteins are apparently inactive but still capable 
of binding the cyclin regulatory subunits, and possibly other complex components as 
well. It is believed that these inactive kinase proteins titrate out the positive regulators 
of CDK function. The residues needing to be altered for this result are conserved 
between proteins and species, and are conserved in the TbCRK proteins. Therefore the 
same principle could be applied to the trypanosome crks. If these alterations create 
dominant negative proteins in T. brucei then only two (or three) markers would be 
necessary to assess the mutant phenotype, an easier scenario.
7.3 Concluding remarks.
This study begins the analysis of the tbcrk family, and their roles in the control 
of the cell cycle in Trypanosoma brucei. The facts are at present unclear and although 
it seems likely that the TbCRK proteins are involved in regulation of trypanosome 
growth, it is still not known which, if any, of the three genes is the functional cdc2 
homologue.
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